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1.1 SUMMARY 
Messenger RNA (mRNA) encodes the information for cellular protein biosynthesis. To 
maintain correct protein levels, which is essential for cell function, strict control over mRNA levels 
is crucial. The CCR4-NOT complex is a key regulator of gene expression and uses transcriptional 
as well as posttranscriptional mechanisms to fine-tune the expression of mRNAs in diverse 
biological contexts. Its best characterized function is to trigger cytoplasmic mRNA decay: The 
complex deadenylates bulk and targeted mRNAs, which ultimately leads to their degradation. 
Over the past years, research in the RNA decay field has focused on understanding how the 
multisubunit CCR4-NOT complex assembles, and on identifying regulatory proteins that 
specifically modulate the repressive activity of the complex towards individual transcripts. RNA-
associated proteins that recruit the CCR4-NOT complex to mRNA targets provide a unique 
opportunity to specifically control mRNA translation and decay. However, no general principle 
underlying this recruitment has been found. In fact, it appears that every RNA-associated protein 
uses an individual mode to interact with the different subunits of the complex. Thus, to understand 
the function of these regulatory proteins, it is crucial to reveal the molecular mechanisms they use 
to recruit CCR4-NOT. 
During my doctoral studies, I aimed to shed light on the recruitment of the CCR4-NOT 
complex by RNA-associated proteins to target mRNAs. I characterized at the molecular level how 
the Drosophila melanogaster (Dm) proteins Roquin and Bag-of-marbles (Bam) interact with the 
CCR4-NOT complex to induce repression of their targets. Roquin carries at least two distinct 
motifs, which both contribute to a direct interaction with the CCR4-NOT complex. These are a 
NOT module binding motif (NBM) and a CAF40 binding motif (CBMR; where the subscript R 
refers to Roquin). In contrast to Roquin, Bam harbors only one motif, a CBMB, that directly recruits 
the fully assembled CCR4-NOT complex. Subsequently, my work on Roquin and Bam led to the 
identification of a CBMN in Dm NOT4, a protein that is a stable subunit of CCR4-NOT in yeast. 
In conclusion, my studies identified a previously unknown peptide-binding surface on the 
CAF40 subunit of the CCR4-NOT complex, which is bound by at least three distinct proteins via 
their CBMs, suggesting mutually exclusive binding. Surprisingly, Roquin, Bam and NOT4 CBMs 
show a similar way of interacting with CAF40 despite the lack of sequence conservation. This 
implies convergent evolution of the CBMs and suggests that CAF40 provides a binding platform 
within the CCR4-NOT complex for additional, yet unidentified proteins. The CBM-containing 
proteins presented in this study add to a growing body of peptide-mediated associations in the 
highly complex network of CCR4-NOT-mediated mRNA regulation. 
Zusammenfassung 
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1.2 ZUSAMMENFASSUNG 
Messenger RNA (mRNA) enthält die kodierte Information für die zelluläre 
Proteinbiosynthese. Für die korrekte Ausführung vieler zellulärer Aufgaben ist es unabdingbar, 
korrekte Proteinkonzentrationen zu gewährleisten, was wiederum eine strenge Kontrolle der 
mRNA-Konzentrationen voraussetzt. Eine Schlüsselrolle bei der Kontrolle von mRNA 
Konzentrationen hat der CCR4-NOT-Komplex, einer der wichtigsten Regulatoren der 
Genexpression auf der transkriptionellen sowie der post-transkriptionellen Ebene. Die am besten 
charakterisierte Funktion des CCR4-NOT-Komplexes ist die allgemeine oder gezielt ausgelöste 
Deadenylierung von cytosolischen mRNAs, die letztendlich zu deren komplettem Abbau führt. 
In den vergangenen Jahren hat sich die Erforschung des mRNA-Abbaus verstärkt damit 
befasst, zu verstehen wie sich der CCR4-NOT-Multiproteinkomplex aufbaut, und regulatorische 
Proteine zu identifizieren, welche den Komplex dahingehend modulieren, spezifische Transkripte 
zu reprimieren. RNA-assoziierte Proteine, die den CCR4-NOT-Komplex zu spezifischen mRNAs 
rekrutieren, stellen eine einzigartige Möglichkeit dar, um die Stabilität von einzelnen mRNAs 
gezielt zu kontrollieren. Ein genereller Mechanismus, der dieser Rekrutierung des CCR4-NOT-
Komplexes unterliegt, ist allerdings nicht bekannt. Vielmehr scheint jedes RNA-assoziierte Protein 
die Untereinheiten des Komplexes über individuelle Interaktionen zu kontaktieren. Um die exakte 
Funktion dieser regulatorischen Proteine zu verstehen ist es somit nötig den molekularen 
Mechanismus der CCR4-NOT Rekrutierung zu charakterisieren. 
Das Ziel meiner Doktorarbeit war es, zu verstehen, wie der CCR4-NOT-Komplex durch 
RNA-assoziierte Proteine zu Ziel-mRNAs gebracht wird. Ich habe auf molekularer Ebene 
charakterisiert, wie die Drosophila melanogaster (Dm) Proteine Roquin und Bag-of-marbles (Bam) 
mit dem CCR4-NOT-Komplex interagieren, um ihre Ziel-mRNAs zu reprimieren. Roquin enthält 
mindestens zwei Peptidmotive die beide zu einer direkten Proteininteraktion mit dem CCR4-NOT-
Komplex beitragen. Diese sind ein NOT-Modul-bindendes Motiv (NBM) und ein CAF40-
bindendes Motiv (CBMR; wobei das tiefgestellte R für Roquin steht). Im Gegensatz zu Roquin 
enthält Bam nur ein Motiv (CBMB) das direkt an CAF40 bindet um den kompletten CCR4-NOT 
Proteinkomplex zu rekrutieren. Meine Arbeit an Roquin und Bam führte auch zur Identifikation 
eines CBMN in Dm NOT4, einem Protein das in der Hefe eine stabile Untereinheit des CCR4-NOT-
Komplexes ist. 
Schlussendlich identifizierte meine Arbeit eine bisher unbekannte Peptidbindestelle auf der CAF40 
Untereinheit des CCR4-NOT-Komplexes, die von den CBMs von mindestens drei verschiedenen 
Proteinen genutzt wird und wobei sich die einzelnen Wechselwirkungen wohl gegenseitig 
Zusammenfassung 
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ausschließen. Überraschenderweise ähneln sich die Interaktionen der CBMs von Roquin, Bam und 
NOT4 mit CAF40 trotz fehlender Sequenzkonservierung. Dies lässt auf eine konvergente Evolution 
der CBMs schließen und darauf, dass die Bindetasche in CAF40 auch von weiteren, bislang noch 
nicht identifizierten Proteinen genutzt werden könnte. Die in dieser Arbeit präsentierten CBM-
enthaltenden Proteine gesellen sich zu einer wachsenden Anzahl peptidvermittelter Assoziationen 
im hochkomplexen Netzwerk der von CCR4-NOT gesteuerten mRNA Regulation.  
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2. INTRODUCTION 
Gene expression is a tightly controlled process that determines when, where and how much of 
a gene product is produced in a cell. Often gene products are proteins, however, genes can also 
encode for functional RNAs, including ribosomal RNAs (rRNAs), transfer RNAs (tRNAs) or small 
nuclear RNAs (snRNAs). The central dogma of molecular biology explains how genetic 
information, encoded in DNA, is transcribed into RNA by a process called transcription. The RNA 
can then be decoded into proteins in a process called translation. In eukaryotes, DNA is first 
transcribed into a precursor messenger RNA (pre-mRNA) by RNA polymerase II in the nucleus. 
The pre-mRNA is then processed into a mature messenger RNA (mRNA). 
RNA processing includes co-transcriptional capping (addition of a 7-methyl guanosine cap 
structure at the 5’-end), removal of introns by splicing, and 3’-end cleavage and polyadenylation. 
The added 5’-cap structure and the poly(A) tail at the 3’-end protect the mRNA from nuclease 
digestion (Shatkin & Manley 2000). Subsequently, the mRNA is transported through the nuclear 
pore complex to the cytoplasm where it is translated into a functional protein by ribosomes, and 
eventually degraded. mRNA can also be localized to specific subcellular locations, a particularly 
important feature in neurons and embryogenesis, where spatially controlled protein synthesis is 
crucial (Parton et al. 2014). During their entire cellular lifespan, mRNAs are coated with a variety 
of proteins, forming messenger ribonucleoprotein particles (mRNPs) (Rissland 2017). mRNP 
composition dictates every phase of the mRNA life (Mitchell & Parker 2014). 
The amount of proteins within a cell is controlled at both transcriptional and 
posttranscriptional levels to allow cells to rapidly adapt to various stimuli and environmental 
changes. mRNA degradation ensures a rapid regulation of transcript levels and is interconnected 
with translation. Both processes, together with transcription, have to be balanced to maintain cell 
function and survival (Moore 2005). An overview of gene regulation mechanisms is shown in 
Figure 1. 
Introduction 
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2.1 Eukaryotic mRNA translation 
Translation is the process by which an mRNA is translated into proteins by the ribosomes and 
it involves three steps: initiation, elongation and termination. The presence of the cap structure and 
the poly(A) tail stimulates the initiation of protein synthesis and consequently the amount of protein 
that is produced from the mRNA. 
During cap-dependent translation, the cap structure is recognized by the eukaryotic translation 
initiation factor 4F multisubunit complex (eIF4F; containing the scaffold protein eIF4G, the cap-
binding protein eIF4E and the RNA helicase eIF4A) (Marcotrigiano et al. 1997, Sonenberg & 
Dever 2003). The eIF4F complex (via eIF4G) in turn interacts with the cytoplasmic poly(A) 
binding protein (PABP) that binds to the poly(A) tail of the mRNA (Tarun & Sachs 1996, Imataka 
et al. 1998). Thus, the interaction between eIF4G and PABP induces the closed loop mRNA 
conformation, promoting mRNA stability and translation initiation (Wells et al. 1998, Amrani et al. 
2008). Conversely, removal of the poly(A) tail and the 5’-cap structure destabilizes mRNAs leading 
Figure 1: Schematic overview of eukaryotic gene expression. DNA is first transcribed into a pre-
mRNA that is processed in the nucleus and then exported to the cytoplasm. Ribosomes associate 
with the mRNA to translate it into a functional protein. Prior to translation, the mRNA can be 
localized within the cell. Subsequently mRNA stability is controlled by degradation mechanisms. 
Introduction 
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to their degradation (Coller & Parker 2004, Meyer et al. 2004). Notably, poly(A) tail length 
generally does not correlate linearly with translation efficiency and stability of mRNAs. In fact, 
recently it was shown that eukaryotic mRNAs with a short, “pruned” poly(A) tail (less than 60 nt 
and thus able to accommodate 1 to 2 PABP molecules) are more abundant and translated efficiently 
(Lima et al. 2017). 
2.2 Eukaryotic mRNA turnover  
Multiple mRNA decay pathways ensure a tight surveillance of gene expression by eliminating 
the templates for protein production in a cell (Houseley & Tollervey 2009). mRNA decay is 
initiated by the shortening of the poly(A) tail at the 3’-end - a process known as deadenylation - 
which results in the release of PABP proteins and disruption of the closed loop conformation 
(Garneau et al. 2007, Parker & Sheth 2007, Wahle & Winkler 2013). In the canonical 5’-to-3’ 
decay pathway, deadenylation is followed by decapping, where the 5’-cap structure is removed 
from the mRNA by the DCP1/DCP2 decapping complex. Several accessory factors are required for 
efficient decapping, such as the (L)Sm (Sm and Like-Sm) protein EDC3 (enhancer of decapping 3), 
the DEAD-box RNA helicase DDX6 (also known as RCK/Me31B/Dhh1) and PATL1 (Coller et al. 
2001, Harigaya et al. 2010, Marnef & Standart 2010). Decapping is an irreversible step that exposes 
bulk mRNA to complete degradation by the 5’-to-3’ exoribonuclease XRN1 (Chang et al. 2011, 
Jones et al. 2012, Arribas-Layton et al. 2013). Alternatively, deadenylated mRNAs can be degraded 
by the cytoplasmic RNA exosome in the 3’-to-5’ direction (Schmid & Jensen 2008). An illustration 
of eukaryotic mRNA turnover is shown in Figure 2. 
Deadenylation is often the rate-limiting step for mRNA decay and translational repression 
(Parker & Song 2004). There are three main deadenylases: the poly(A)-specific ribonuclease PARN 
(which is not present in budding yeast and Drosophila) (Harnisch et al. 2012, Virtanen et al. 2013), 
the PAN2-PAN3 complex (Wahle & Winkler 2013, Wolf & Passmore 2014) and the CCR4-NOT 
complex (Goldstrohm & Wickens 2008). PARN belongs to the DEDD (Asp-Glu-Asp-Asp) family 
of nucleases and is not involved in bulk mRNA deadenylation (Yoda et al. 2013) but rather acts on 
specific substrates and upon stress (Godwin et al. 2013). The PAN2-PAN3 complex, with PAN2 as 
a catalytic subunit, is stimulated by PABP proteins and is involved in general mRNA decay. It acts 
at the earliest stages of deadenylation in a distributive manner. Ultimately, the CCR4-NOT complex 
removes the remaining poly(A) tail in a processive manner (Yamashita et al. 2005, Chen et al. 
2017). Importantly, the CCR4-NOT complex deadenylates mRNAs even in the absence of the 
PAN2-PAN3 complex (Tucker et al. 2001). 
Introduction 
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2.3 The CCR4-NOT deadenylase complex 
2.3.1 CCR4-NOT architecture 
The CCR4-NOT complex was first discovered in budding yeast as a negative transcriptional 
regulator for TATA-less promoters, hence the name NOT – negative on TATA-less (Collart & 
Struhl 1994, Oberholzer & Collart 1998, Bai et al. 1999). However, further studies highlighted its 
central role as cytoplasmic deadenylase (Tucker et al. 2002). In yeast, the complex consists of nine 
subunits, the NOT1-5 proteins, CCR4 (carbon catabolite repressor 4), and three CCR4-associated 
factors, CAF1, CAF40, and CAF130. In metazoans, all of the nine subunits have orthologues apart 
from CAF130. Metazoans encode NOT3 as a functional homolog of both NOT5 and NOT3, and 
they have two orthologues for CAF1 known as CNOT7 and CNOT8 (also known as POP2) and two 
Figure 2: Mechanisms of eukaryotic mRNA turnover. mRNA decay is initiated by the removal 
of the poly(A) tail by the two major cytoplasmic deadenylases: the PAN2-PAN3 and CCR4-NOT 
complexes. Deadenylated mRNA can be decapped and degraded via the exonucleolityc activity of 
XRN1 from the 5’-to-3’ end. Alternatively, mRNA can be degraded 3’-to-5’ by the exosome. 
Additionally, derepression of mRNAs can occur through re-adenylation. 
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orthologues for CCR4 known as CNOT6 (or CCR4a) and CNOT6L (or CCR4b) that bind to the 
complex in a mutually exclusive manner. Additionally, metazoan NOT10 and NOT11 are absent in 
yeast (Albert et al. 2000, Bawankar et al. 2013, Mauxion et al. 2013). Finally, NOT4 does not 
appear to be stably associated with CCR4-NOT in metazoans, although it is an integral component 
of the complex in yeast (Albert et al. 2000, Wahle & Winkler 2013, Bhaskar et al. 2015). 
Within the CCR4-NOT deadenylase complex NOT1 is the largest protein and acts as a 
scaffold. Its depletion in cells induces cell death and impairs deadenylation activity, revealing the 
crucial role of NOT1 for the assembly and function of the complex (Ito et al. 2011). Multiple 
biochemical and structural studies have provided snapshots of subcomplexes of the CCR4-NOT 
complex (Basquin et al. 2012, Collart & Panasenko 2012, Petit et al. 2012, Bawankar et al. 2013, 
Boland et al. 2013, Bhandari et al. 2014, Mathys et al. 2014, Xu et al. 2014). The CCR4-NOT 
complex exhibits four distinct structural and functional modules that bind to the α-helical NOT1 
scaffold subunit, described below and shown in Figure 3. 
① First, the NOT11-NOT10 module comprises the NOT11 and NOT10 subunits that bind to 
the HEAT1 repeat of NOT1 (Bawankar et al. 2013, Mauxion et al. 2013). Structurally, NOT11 has 
a domain of unknown function DUF2363 in its C-terminal region and NOT10 has a TPR structure. 
This module is not conserved in all species and is not required for mRNA deadenylation (Bawankar 
et al. 2013). Currently, the function of the NOT11-NOT10 module remains unknown. ② Second, 
the catalytic module includes the MIF4G domain (structurally similar to the middle domain of 
eIF4G) of NOT1 and the two deadenylases CCR4 and CAF1. The exonuclease-endonuclease-
phosphatase (EEP) CCR4 uses its N-terminal LRR domain (leucine-rich repeat) to contact CAF1 (a 
member of the DEDD family of nucleases). CAF1, in turn, binds to the MIF4G domain of NOT1 
Figure 3: Architecture of the CCR4-NOT deadenylase complex in metazoans. Four distinct 
structural and functional modules assemble around the NOT1 scaffold protein and characterize the 
CCR4-NOT deadenylase complex. Adapted from Jonas & Izaurralde (2015). 
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(Dupressoir et al. 2001, Basquin et al. 2012, Petit et al. 2012). As the name suggests, this module is 
the catalytic region of the CCR4-NOT complex and its activity is essential for mRNA 
deadenylation (Tucker et al. 2002). However, it is unclear why the presence of two exonucleases is 
required. ③ Third, the CAF40 module consists of the armadillo repeat (ARM) of CAF40 (also 
known as Rcd1/RQCD1/CNOT9) bound to the three helix bundle CN9BD (CNOT9 binding 
domain) of NOT1 (Chen et al. 2014b, Mathys et al. 2014). The CAF40 concave surface is rich in 
positively charged residues that bind to nucleic acids in vitro (Garces et al. 2007). ④ Fourth, the 
NOT module is composed of the NOT2-NOT3 subunits that bind to the C-terminal superfamily 
homology domain (SHD) of NOT1 (Bhaskar et al. 2013, Boland et al. 2013). The C-terminal 
regions of NOT2 and NOT3 share conserved NOT-box domains that are involved in the interaction 
with the NOT1-SHD (Zwartjes et al. 2004). A schematic domain organization of the CCR4-NOT 
subunits is illustrated in Figure 4 and their binding sites on the NOT1 scaffold protein as well as 
their conservation between species are listed in Table 1. 
Importantly, some of the modules discussed above provide a versatile binding platform for 
the interaction with RNA-binding proteins that have been shown to bring the deadenylase complex 
in contact with their target mRNAs. An overview of the recruitment of the CCR4-NOT complex 
mediated by RNA-binding proteins will follow in section 2.4. 
Figure 4: Domain organization of the basic subunits of the CCR4-NOT deadenylase complex. 
Shown are the subunits of the CCR4-NOT complex as in Figure 3 including their domain 
organization. 
Introduction 
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2.3.2 CCR4-NOT functions 
Numerous studies have highlighted the role of CCR4-NOT as a multifunctional complex that 
controls gene expression at multiple levels within the cell.  
NOT proteins were originally identified as transcriptional repressors in yeast (Collart & 
Struhl 1994) and the CCR4-NOT complex has, since then, been shown to act at different levels of 
transcription. For example, several components of CCR4-NOT bind transcription factors and 
repress transcription initiation (Haas et al. 2004, Winkler et al. 2006). Additionally, the CCR4-NOT 
complex interacts with RNA polymerase II and was suggested to function in transcription 
elongation (Kruk et al. 2011). Nuclear functions of the yeast CCR4-NOT complex also include 
mRNA export and nuclear RNA quality control: Multiple subunits of the CCR4-NOT complex bind 
to nuclear pore complex proteins (Kerr et al. 2011) as well as to the nuclear exosome and the 
TRAMP complex (Azzouz et al. 2009). However, many of the above-mentioned functions were 
S. 
cerevisiae 
D. 
melanogaster 
H. sapiens 
Binding regions on 
NOT1 
NOT1 NOT1 CNOT1  
NOT2 NOT2 CNOT2 SHD 
NOT3 NOT3/5 CNOT3 SHD 
NOT4 (NOT4) (CNOT4)  
NOT5  - SHD 
CCR4 CCR4/TWIN 
CNOT6/CCR4a 
CNOT6L/CCR4b 
 
CAF1/POP2 CAF1 
CNOT7/CAF1a 
CNOT8/POP2/CAF1b 
MIF4G  
CAF40 CAF40 CNOT9/Rcd1/RQCD1 CN9BD 
CAF130 - - unknown 
- NOT10 CNOT10 
N-terminal region of 
NOT1 
- NOT11 CNOT11 (C2orf29) 
N-terminal region of 
NOT1 
Table 1: CCR4-NOT complex subunits. Note that NOT4 has been identified as a stable subunit 
of the CCR4-NOT complex only in yeast. Adapted from Collart & Panasenko (2017). 
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described only in yeast and are still controversial. Thus, their relevance in metazoans remains 
elusive. 
The most prominent and conserved function of the CCR4-NOT complex is deadenylation, the 
first step of mRNA decay that is performed by the CCR4 and CAF1 enzymes. The CCR4-NOT 
complex is widely conserved as a deadenylase for bulk mRNA turnover and it has also been shown 
to deadenylate aberrant transcripts that undergo nonsense-mediated decay (NMD) (Loh et al. 2013). 
Furthermore, targeted deadenyation by the CCR4-NOT complex is used to repress a plethora of 
target mRNAs by triggering their degradation in many physiological contexts such as immune 
response and germline stem cell (GSC) maintenance and differentiation. Targeting can occur via 
specific micro RNAs (miRNAs) or mRNA-binding proteins (see section 2.4). Indeed, the CCR4-
NOT complex is a central component of the miRNA-mediated mRNA decay pathway (Braun et al. 
2011, Chekulaeva et al. 2011, Zekri et al. 2013) and is recruited to miRNA by proteins of the 
TNRC6 family (GW182 in Dm). Importantly, the CCR4-NOT complex, independently of 
deadenylation, can also repress translation via the interaction with the translational repressor and 
decapping activator DDX6 (Kuzuoglu-Ozturk et al. 2016). However, the mechanisms underlying 
this process are yet unknown. 
In addition to its role in deadenylation and translational repression, the yeast CCR4-NOT 
complex can also ubiquitinate via the E3 ubiquitin ligase NOT4 (Albert et al. 2000). Ubiquitination 
by NOT4 was extensively studied in yeast, where NOT4 was shown to interact with the E2 enzyme 
UbcH5B (Albert et al. 2002, Winkler et al. 2004). Yeast NOT4 ubiquitinates a wide range of 
substrates, like the small ribosomal protein Rps7A (Collart & Panasenko 2012), the nascent 
polypeptide associated complex (NAC) (Panasenko et al. 2006) and the transcription factor YAP1 
(Gulshan et al. 2012). Even though the exact function of NOT4 is currently unknown, it is involved 
in the assembly of the proteasome and in co-translational quality control (Panasenko & Collart 
2011, Collart & Panasenko 2012, Panasenko 2014). These findings imply functions of the yeast 
CCR4-NOT complex also in protein degradation. 
Function of the CCR4-NOT complex in immune response 
A tight control of mRNA expression and thus protein levels in the immune system is 
fundamental for efficient immune and inflammatory responses. Via the interaction with RNA-
binding proteins (RBPs) the CCR4-NOT deadenylase complex is a crucial effector in regulating 
inflammatory mRNAs, such as tumor necrosis factor alpha (TNF-α), Interleukin-1 (IL-1), IL-6, 
IL-8, IL-10, cyclooxygenase-2, and interferon-γ (IFN-γ) (Sanduja et al. 2012, Leppek et al. 2013, 
Carpenter et al. 2014, Chapat & Corbo 2014). RBPs recognize multiple elements within the 
3’ untranslated region (UTR) of inflammatory mRNAs to ensure a fast and specific regulation of 
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the immune response. For example, the cytokine TNF-α mRNA contains both ARE (AU-rich 
element) and CDE (constitutive decay element) sequences in its 3’UTR. The posttranscriptional 
regulator tristetraproline (TTP, also known as TIS11 or ZFP36) binds ARE sequences and recruits 
the CCR4-NOT deadenylase complex (see section 2.4). This mechanism is fine-tuned via 
phosphorylation of TTP by the MAP-kinase pathway (Clement et al. 2011). Additionally, in 
macrophages, the CDE sequence is recognized by Roquin1, which can also recruit the CCR4-NOT 
complex (Leppek et al. 2013). Thus, the recruitment of the CCR4-NOT complex by multiple RBPs 
(here TTP and Roquin) to the same mRNA (e.g. TNF-α) provides a robust regulation of 
inflammatory mRNAs through its deadenylase activity. 
Function of the CCR4-NOT complex in GSC differentiation 
Deadenylation by the CCR4-NOT complex is also crucial for posttranscriptional regulation 
during oogenesis in Drosophila melanogaster (Dm) (Morris et al. 2005). NOT1 knockdown in germ 
cells, with consequently impaired deadenylation, results in a loss of GSCs (Fu et al. 2015). Among 
the subunits of the CCR4-NOT complex, several studies revealed that CCR4 is required in Dm 
germ cells and early Dm embryos (Joly et al. 2013, Fu et al. 2015). Concurrently, CCR4, which is 
encoded by the gene twin in Dm, has a strong phenotype: twin/CCR4 mutants show GSC loss. This 
is due to the role of CCR4 in regulating the poly(A) tail length of cyclin A and B in GSCs (Morris et 
al. 2005). Regulation of specific mRNAs in the context of GSCs is achieved by the recruitment of 
the CCR4-NOT complex via RBPs. To date, Nanos and Pumilio proteins have been reported to 
regulate specific targets such as cyclin B and mei-P26 in Dm germ cells through the CCR4-NOT 
complex (Joly et al. 2013). Additionally, Fu et al. (2015) showed that the CCR4 deadenylase 
controls Dm GSC self-renewal by maintaining E-cadherin accumulation in the niche cells and by 
interacting with the key differentiation factor Bag-of-marbles. 
2.4 Recruitment of the CCR4-NOT complex by mRNA-associated proteins 
In addition to its central role in bulk mRNA degradation, the CCR4-NOT complex controls 
the expression of specific mRNAs to which it is recruited via interactions with RBPs. RBPs directly 
or indirectly - through additional regulatory proteins - interact with the complex to determine 
mRNA fate in multiple biological processes. Transcript recognition by RBPs is determined by 
mRNA sequences and/or structures (Rissland 2017). 
DND1 (dead end homolog 1), TTP, GW182 (also known as TNRC6A-C in human), Smaug, 
Bicaudal-C, Pumilio, Nanos and Roquin1 are examples of RNA-associated proteins that have been 
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shown to bind to CCR4-NOT and to induce repression of target mRNAs. Their biological functions 
and interacting partners within the CCR4-NOT complex are described in Table 2. 
Table 2: Overview of the RNA-associated proteins that were known to interact with the 
CCR4-NOT complex (or its subunits) at the beginning of my PhD. Dm, Drosophila 
melanogaster; Hs, Homo sapiens; Mm, Mus musculus; Sc, Saccharomyces cerevisiae. The asterisk 
(*) highlights proteins that I investigated during my PhD. Adapted and extended from Chapat & 
Corbo (2014). 
 
  
RBPs/effectors 
CCR4-NOT 
interacting partner 
Species 
RNA 
recognition 
element 
Biological functions 
DND1 CNOT1 Mm URR 
Germ cell development 
and maintenance 
TTP CNOT1 Hs, Mm ARE Inflammation, immunity 
GW182 CNOT1/CAF40 Hs, Dm 
miRNA-
binding site 
miRNA-mediated gene 
silencing 
Smaug  Dm SRE Embryonic development 
Bicaudal-C NOT3 Dm  
Oogenesis 
Embryonic development 
Pumilio CAF1 Dm PRE 
Abdominal patterning 
Germline stem cell self-
renewal 
Nanos 
CNOT1 
CNOT1-CNOT3 
Hs, Mm, 
Dm 
 
Embryonic patterning 
Germ cell development 
Roquin1*  Hs CDE 
Inflammation, immunity 
Development 
NOT4* NOT1 Sc   
Bam* CCR4 Dm  
Germline stem cell 
differentiation 
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Recently Yamaji et al. revealed the RNA-binding protein DND1 as a putative binding partner 
for the N-terminal region of NOT1 in the mouse germ line. During embryogenesis in mice, DND1 
recruits the CCR4-NOT complex to mRNA targets thus regulating inflammation, apoptosis and 
stem cell pluripotency. Specifically, DND1 interacts with U-rich regions (URRs) in the 3’UTR of 
target mRNAs (Yamaji et al. 2017). 
Many proteins have also been characterized structurally in their binding to the CCR4-NOT 
complex. For example, TTP directly interacts with NOT1 and induces degradation of mRNA 
targets. TTP uses a tandem CCHC zinc finger (ZnF) domain to bind and destabilize mRNAs 
containing ARE sequences within their 3’UTR, such as TNF-α, cyclooxygenase-2 and IL-1, playing 
a crucial role in inflammation, as mentioned before (see section 2.3.2) (Sandler et al. 2011, Brooks 
& Blackshear 2013, Fabian et al. 2013). 
The CCR4-NOT complex can also be recruited by the RNA-induced silencing complex to 
control translation and stability of miRNA targets (Inada & Makino 2014). The interaction of the 
miRNA machinery with the CCR4-NOT complex is mediated by GW182 proteins. GW182 proteins 
directly interact with the PAN3 subunit of the PAN2-PAN3 deadenylase complex as well as with 
NOT1 and CAF40 of the CCR4-NOT complex to induce mRNA degradation and translational 
repression of miRNA-targets (Chen et al. 2014b, Mathys et al. 2014). 
Moreover, proteins functioning during Dm embryonic development have been shown to 
recruit the CCR4-NOT complex to specific mRNAs. Smaug, for example, regulates the decay of 
maternal mRNAs during maternal-to-zygotic transition by recruiting the CCR4-NOT complex to 
mRNAs containing Smaug recognition elements (SREs) (Semotok et al. 2005, Zaessinger et al. 
2006). 
During Dm oogenesis, Bicaudal-C binds to the NOT3 subunit of the CCR4-NOT complex to 
negatively regulate mRNAs involved in cytoskeletal regulation and oogenesis, including its own 
bicaudal-C mRNA (Chicoine et al. 2007). 
The RNA binding protein Pumilio binds to the Pumilio response element (PRE) of mRNA 
targets. The Pumilio/Nanos complex specifically represses hunchback mRNA to control Dm 
embryonic development (Wreden et al. 1997). This complex then recruits the CCR4-NOT 
machinery by binding to CAF1 via Pumilio, and NOT1-2-3 via Nanos (Van Etten et al. 2012, 
Raisch et al. 2016). 
In vertebrates and invertebrates, Nanos proteins contain a C-terminal CCHC-type ZnF that 
binds nucleic acids, and an unstructured, poorly conserved, N-terminal region. Human and Dm 
Nanos use different short motifs at their N-terminal regions to recruit the CCR4-NOT complex to 
mRNA targets. Human Nanos binds to the C-terminal end of NOT1, while Dm Nanos uses a 
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bipartite binding mode contacting the N-terminal part of NOT1 and NOT3 (Bhandari et al. 2014, 
Raisch et al. 2016). 
Recently, Roquin proteins have been shown to interact with conserved RNA stem-loop 
sequences, which are highly conserved and are found in more than 50 vertebrate mRNAs and code 
for regulators of inflammation, development and immunity. Additionally, Roquin1 was shown to 
recruit the CCR4-NOT complex, although the molecular details of the recruitment remain poorly 
characterized (Leppek et al. 2013).  
Furthermore, Bhaskar and colleagues revealed the Saccharomyces cerevisiae (Sc) NOT4 to 
bind to the NOT1 SHD via a short motif, which is not conserved in other species (Bhaskar et al. 
2015). Although human NOT4 was shown to interact with the C-terminal region of NOT1 in yeast-
two-hybrid assays (Albert et al. 2000), detailed molecular insights into this association with the 
CCR4-NOT complex are missing. It is also unclear whether NOT4 uses its RRM domains to recruit 
the CCR4-NOT complex to mRNA targets (Bhaskar et al. 2015). 
The fly-specific differentiation factor Bag-of-marbles (Bam) was recently shown to bind the 
CCR4-NOT deadenylase CCR4. However, Bam was proposed to do so independently of the CCR4-
NOT complex (Fu et al. 2015) and it its currently unknown if Bam can bind mRNAs in the context 
of a posttranscriptional repressor complex to regulate stem cell differentiation (Li et al. 2009, Shen 
et al. 2009, Insco et al. 2012). 
All of these examples indicate that the CCR4-NOT complex acts as a major regulator of 
mRNA stability during diverse cellular processes such as differentiation, immune response and 
proliferation. Below, I provide detailed information about two RNA-associated, regulatory proteins: 
the E3 ubiquitin ligase Roquin and the stem cell differentiation factor Bam, which are the major 
focus of my studies. 
2.5 RNA-binding E3 ubiquitin ligases 
Posttranslational modifications (PTMs) influence protein functions, and ubiquitination is a 
PTM that typically causes protein degradation (Varshavsky 2017). In addition, ubiquitination of 
RBPs can alter interactions, affinities and localization and thus influences mRNA translation and 
stability (Lee 2012). Ubiquitin is usually covalently attached to a lysine residue of the substrate 
proteins via an isopeptide bond. Ubiquitination requires three enzymatic reactions that include the 
ubiquitin-activating enzymes (E1), the ubiquitin conjugating enzymes (E2) and the ubiquitin ligases 
(E3) (Komander & Rape 2012). 
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The human genome encodes more than 600 potential E3 ligases and fifteen of these contain 
an additional RNA binding domain, implying another layer of complexity in posttranscriptional 
regulation (Deshaies & Joazeiro 2009, Cano et al. 2010, Hildebrandt et al. 2017). Little is known 
about the impact of ubiquitination on mRNA turnover. However, in the past few years several 
pieces of evidence suggested a link, as is the case for the MEX-family proteins. The human RNA-
binding proteins MEX-3A to -D are conserved phosphoproteins that contain two K homology (KH) 
domains and a C-terminal RING domain. Among the MEX-family proteins, MEX-3C has been 
associated with immune disease and cancer (Pereira et al. 2013, Cano et al. 2015). MEX-3C binds a 
consensus RNA motif in the 3’UTR of HLA-A2 (human leukocyte antigen A2) mRNA through its 
KH domains and with its RING domain interacts with and ubiquitinates the CAF1 subunit of the 
CCR4-NOT complex. Ubiquitination of CAF1 does not cause its proteolysis, but promotes its 
deadenylation activity, resulting in posttranscriptional regulation of specific transcripts (Cano et al. 
2015, Yang et al. 2017). This example implies a role for ubiquitin ligase activity in mRNA decay. 
However, the molecular mechanism of mRNA decay and translational repression mediated by 
MEX-3C lacks detailed characterization. 
Roquin and NOT4 are also RNA-binding E3 ubiquitin ligases that may connect ubiquitination 
to mRNA stability. Moreover, both proteins were shown to interact with the CCR4-NOT 
deadenylase complex (Leppek et al. 2013, Bhaskar et al. 2015), thus, they might regulate the 
activity of the complex by ubiquitination, similar to MEX-3C. 
2.6 Roquin proteins 
Roquin proteins are E3 ubiquitin ligases of the RING-type family with an important role in 
immune response. Roquin is an essential factor for preventing T-cell mediated autoimmune disease. 
It was identified in a mutagenesis screen for autoimmune regulators in mice where a point mutation 
in the Rc3h1 gene, encoding for Roquin1, caused autoimmunity in the sanroque mice (Vinuesa et 
al. 2005). The sanroque mice showed aberrant follicular helper T cell expansion, production of 
autoantibodies and resembled the human systemic lupus erythematosus (SLE) disease (Vinuesa et 
al. 2005). 
Roquin proteins are highly conserved in metazoans with only one homolog found in Dm and 
Caenorhabditis elegans (Ce) (Li et al. 2007). In vertebrates, there are two paralogs, Roquin1 and 
Roquin2 also called MNAB (membrane-associated nucleic-acid binding protein; Siess et al. 2000). 
The Ce and Dm homologs are RLE-1 (regulation of longevity by E3) and Roquin, respectively. The 
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N-terminal domain organization of all Roquin proteins is highly similar, whereas the C-terminal 
regions are unstructured and strongly divergent (see Figure 5 for Roquin domain organization). 
The presence of a RING domain suggests that Roquin may target proteins for ubiquitin-
dependent degradation, but until now, little is known about this activity. Previous studies have 
shown that Roquin2 ubiquitinates apoptosis signal-regulating kinase 1 (ASK1) for proteasomal 
degradation (Maruyama et al. 2014). Additionally, the Ce RLE-1 protein regulates the lifespan of 
the worm by ubiquitinating the transcriptional activator DAF-16 (homolog of mammalian Foxo3a) 
that regulates aging in Ce (Li et al. 2007). The ROQ domain is a highly conserved domain among 
Roquin proteins and mediates RNA binding. It recognizes a conserved stem-loop motif (CDE) in 
the 3’UTR of mRNA targets, such as the inducible costimulator Icos, the costimulatory receptor 
Ox40, neuropilin-1, IFN-γ, TNF-α and Roquin1 and 2 (Yu et al. 2007, Leppek et al. 2013, Vogel et 
al. 2013, Schlundt et al. 2014, Tan et al. 2014, Sakurai et al. 2015, Janowski et al. 2016). 
Figure 5: Domain organization of Roquin proteins. Roquin proteins share a conserved N-
terminal region containing a RING-finger E3 ubiquitin ligase domain, a ROQ RNA-binding domain 
flanked by helical HEPN (higher eukaryotes and prokaryotes nucleotide-binding) domains and a 
CCHC-type ZnF domain. The C-terminal half of Roquin proteins is not conserved and is predicted 
to be an intrinsically disordered region (shown in grey). Adapted from Sgromo et al. (2017). 
Importantly, human Roquin1 was shown to recruit the CCR4-NOT complex via its C-
terminal region, leading to a complete degradation of bound transcripts (Leppek et al. 2013). 
However, the molecular mechanism of this recruitment was still unknown when I started my PhD 
project. 
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2.7 Bag-of-marbles protein 
Dm Bag-of-marbles (Bam) is a master differentiation factor that determines the fate of 
germline stem cells. Loss of Bam results in uncontrolled stem cell proliferation and tumor 
formation, causing the tumorous bam mutant phenotype, where the germ cells resemble marbles in 
a bag (McKearin & Ohlstein 1995, Ohlstein & McKearin 1997). Bam lacks homology to other 
known proteins and it is only present in flies. Secondary structure prediction suggests Bam to be 
mainly α-helical (Figure 6). 
Figure 6: Schematic view of a secondary structure prediction of Bam. The Bam protein is 
predicted to be mainly α-helical (yellow) and to have a single β-strand (blue). Alignments indicate a 
possible separation into N- and C- fragments. Adapted from Sgromo et al. (2018). 
Dm gametogenesis is a common model to study stem cell behavior (Lin 2002). Bam is 
transcriptionally silent in GSCs and upregulated in cystoblasts (Chen & McKearin 2003). Via E-
cadherin, GSCs are anchored to neighboring niche cells that produce bone morphogenetic proteins 
(BMPs). In GSCs, the BMP ligands Decapentaplegic (Dpp) and Glass bottom boat (Gbb) activate 
the BMP receptor complex, consisting of type I serine/threonine kinase receptors Saxophone (Sax) 
and Thickveins (Tkv), as well as the type II receptor Punt (Xie & Spradling 1998). BMP signaling 
prevents differentiation by activating downstream transcriptional effectors (Mad, Medea and 
Schnurri) that silence bam transcription. Transcriptional repression of the bam gene is the major 
requirement to maintain GSC fate. Many additional factors have been identified as crucial 
regulators of GSC self-renewal. As an example, the repressor complex Pumilio/Nanos induces GSC 
fate within these cells via the CCR4-NOT complex (Kadyrova et al. 2007). In addition, microRNAs 
inhibit differentiation genes in GSCs (Neumuller et al. 2008). 
Following GSC division, one daughter cell migrates away from the niche to become a 
cystoblast. The absence of BMP signaling in cystoblasts leads to expression of Bam, which initiates 
the differentiation program (Spradling et al. 2011). Bam controls GSC differentiation by forming a 
protein complex with Benign gonial cell neoplasm (Bgcn; a putative DEXH RNA-helicase-like 
protein) (Lavoie et al. 1999, Li et al. 2009). This complex is thought to promote cystoblast 
formation by posttranscriptionally repressing the expression of stem cell maintaining factors like 
Nanos, Pumilio and E-cadherin (Li et al. 2009, Shen et al. 2009, Insco et al. 2012). Bam has also 
been found to cooperate with the proteins Tumorous testis (Tut; containing a tandem RRM) (Chen 
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et al. 2014a), Sex-lethal (Sxl) (Chau et al. 2012, Li et al. 2013) and Mei-P26 (Neumuller et al. 2008, 
Li et al. 2013) leading to differentiation. The process of germline stem cell differentiation in 
Drosophila is summarized in Figure 7. 
Despite the many protein-protein interactions identified for Bam, the mechanism by which it 
regulates mRNAs remains poorly understood. Currently it is unknown whether Bam can directly 
bind mRNAs or requires additional adaptor proteins. 
Recently, the CCR4 deadenylase subunit of the CCR4-NOT complex was shown to interact 
with Bam by immunoprecipitation in Dm S2 cells and germ cells (Fu et al. 2015). Fu et al. 
suggested a functional connection between Bam and CCR4 independent of the assembled CCR4-
NOT complex. However, it remained unclear which subunit of the CCR4-NOT complex is the 
direct interactor of Bam and if Bam requires an intact CCR4-NOT complex or isolated CCR4 to 
perform its repressive function. 
Figure 7: Schematic representation of Drosophila gametogenesis. Niche cells secrete BMP 
signals to maintain the nearby germline stem cell (GSC) identity by repressing bam expression. In 
the GSCs the repressor complex Pumilio/Nanos induces a self-renewal fate. After division, cells 
migrate away from the niche and the self-renewal signals. In the absence of BMP signaling, those 
cells differentiate into cystoblasts due to upregulation of bam expression. Here Bam, together with 
additional proteins such as Benign gonial cell neoplasm (Bgcn), Sex-lethal (Sxl), Mei-P26, 
Tumorous testis (Tut) and CCR4, regulates differentiation. 
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3. AIMS & OBJECTIVES 
To influence mRNA fate and ultimately protein production, a wide variety of biological 
processes rely on posttranscriptional regulation of mRNA (Vogel & Marcotte 2012). A versatile 
and widely acknowledged effector of mRNA regulation is the CCR4-NOT complex. The 
multisubunit complex deadenylates bulk mRNAs and specific transcripts, leading to their 
degradation. Recruitment of the CCR4-NOT complex to specific mRNA targets can be achieved by 
RBPs. Multiple RBPs and RNA-associated proteins are known to contact subunits or modules of 
the large CCR4-NOT complex (see section 2.4). Regulatory proteins that associate with RNA and 
recruit the CCR4-NOT complex to regulate mRNA expression are the central element of my PhD 
studies. 
In my work, I combined structural and biochemical approaches in order to elucidate how two 
Drosophila proteins, Roquin and Bam, regulate mRNA stability through their interaction with the 
CCR4-NOT complex, unveiling the molecular mechanisms of posttranscriptional regulation by 
Roquin and Bam. 
In the first part of my doctoral research, I investigated the regulatory mechanism underlying 
Roquin-mediated mRNA degradation. The human RBP Roquin1 has previously been shown to 
recruit the CCR4-NOT complex resulting in targeted mRNA decay (Leppek et al. 2013). Although 
human Roquin proteins have been studied for their important role in the immune system and 
inflammation, Dm Roquin was not yet characterized when I started my PhD. Therefore, it remained 
unclear whether and how Dm Roquin recruits the CCR4-NOT complex to degrade target mRNAs. 
My work aimed to investigate whether Roquin-mediated CCR4-NOT recruitment is conserved 
among species, given the poor conservation of the C-terminal region that binds to the CCR4-NOT 
complex in human Roquin1 (Leppek et al. 2013). 
In the second part of my doctoral research, I focused on the function of the fly-specific GSC 
differentiation factor Bam in mRNA decay. Fu et al. (2015) identified an interaction between Bam 
and CCR4, and proposed that Bam acts independently of the CCR4-NOT complex. In my studies, I 
wanted to test this model and fully characterize the binding of Bam to the CCR4-NOT complex to 
address how Bam posttranscriptionally regulates mRNA targets. Furthermore, I investigated the 
physical connection between Bam, Bgcn and Tut, the proposed repressor complex involved in GSC 
differentiation. Understanding how individual components of Bam’s network connect was expected 
to provide insights into the posttranscriptional regulation mechanisms behind GSC differentiation 
and the role of Bam in this process. 
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Finally, I also contributed to a collaborative project on the characterization of NOT4, which is 
an E3 ubiquitin ligase like Roquin. The presence of an E3 ubiquitin ligase domain together with an 
RNA-binding domain is a striking feature shared by other proteins associated with the CCR4-NOT 
complex, potentially linking protein turnover to posttranscriptional control. NOT4 carries an RRM 
domain, which suggests RNA binding and is a stable component of the CCR4-NOT complex in 
yeast. However, it remained unclear whether, in metazoans, NOT4 interacts with the CCR4-NOT 
complex.  
Deciphering the intricate binding network of the CCR4-NOT complex and associated RNA-
binding proteins in molecular detail is crucial for a thorough understanding of how cytoplasmic 
control of gene expression is achieved in a cell.  
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4. RESULTS 
4.1 Roquin-mediated mRNA degradation is conserved across species 
The work described in this chapter has been published in Sgromo et al. 2017. Detailed experimental 
data and methods are available in the attached publication (see chapter 9). 
4.1.1 Roquin proteins induce mRNA decay via their unstructured C-terminal regions 
The Roquin RNA-binding proteins are evolutionarily conserved (see Figure 5). Previous work 
identified the CCR4-NOT deadenylase complex as a major downstream factor for the repressive 
activity of Hs Roquin1 (Leppek et al. 2013) but the molecular details of this interaction were not 
investigated thoroughly. In addition, it remained unclear how Roquin proteins induce mRNA 
degradation and if they have maintained this activity throughout evolution. 
Hs Roquin1 was shown to recruit the CCR4-NOT complex via its unstructured C-terminal 
region (Leppek et al. 2013). The divergent nature of the C-terminal tails of Roquin proteins raised 
the question whether all Roquin proteins share a similar way to recruit the CCR4-NOT complex. In 
order to understand how Roquin proteins induce mRNA decay, I first cloned and expressed the Hs 
Roquin1 and Roquin2 proteins in the Human Embryonic Kidney 293T cell line (HEK293T) and the 
Dm Roquin protein in the Dm S2 cell line. To test the activity of Roquin proteins in mRNA decay 
and translational repression I performed tethering assays. The tethering assay is a powerful 
technique that allows to analyze the functional activity of a tethered protein on an artificial reporter 
mRNA, without knowing the natural mRNA target of the tethered protein. Different reporter 
systems have been developed, such as the λN/BoxB and MS2 systems. The protein of interest to be 
tethered is expressed with a tag of either λN or MS2 coat protein. This tag specifically binds to an 
RNA sequence, for example within the 3’UTR of the reporter, thereby recruiting the protein of 
interest to the reporter mRNA (Coller & Wickens 2007). The effect of the tethered protein on 
reporter levels can then be studied using several experimental techniques such as northern blots 
(revealing the effect on RNA levels) or luciferase assays (revealing the effect on protein levels). 
Using the tethering assay, I first tested the effect of Hs Roquin1 and 2 on a β-globin reporter 
mRNA containing 6xMS2 binding hairpins in the 3’UTR. The full-length proteins as well as the N- 
or C-terminal fragments (defined based on sequence alignments and analysis) were used with an N-
terminal MS2-tag. The N-terminal fragments include all conserved, structured domains (see Figure 
5), whereas the C-terminal fragments comprise the unstructured, non-conserved tails. Tethering of 
both full-length Hs Roquin1 and Hs Roquin2 induced reporter mRNA decay. Tethering of the C-
terminal fragment of Hs Roquin1 and Hs Roquin2 resulted in a comparable degradation of reporter 
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mRNA, whereas the N-terminal regions were inactive (Figure 8 A-D). These results confirmed 
previous experiments that linked the C-terminal region of Hs Roquin1 to mRNA decay (Leppek et 
al. 2013), and additionally showed that Hs Roquin2 can trigger mRNA degradation using the C-
terminal region which shares no sequence similarity with Hs Roquin1. Given that Hs Roquin1 and 2 
both induce mRNA decay through their C-terminal regions, I wanted to address whether this 
function is conserved, despite the C-terminal sequence divergence, also in Dm Roquin. 
Therefore, I performed similar experiments in S2 cells, using the λN/BoxB tethering system. 
N-terminally λN-tagged Dm Roquin fusion proteins (full-length, N- or C-terminal constructs) were 
tethered to the reporter encoding the firefly luciferase and carrying 5BoxB elements in the 3’UTR. 
Interestingly, also Dm Roquin induced degradation of the mRNA reporter via its C-terminal region 
(Figure 8 E,F), revealing that this feature is maintained across species. These results show that all 
Figure 8: Roquin proteins trigger mRNA decay via their C-terminal tails. Tethering assays 
using Hs Roquin1 and Hs Roquin2 in HEK293T cells and Dm Roquin in S2 cells. Full-length 
constructs or fragments (N- and C- terminal regions) of Roquin proteins were tethered. Panels A, C 
and E show the relative mRNA levels in three independent experiments. mRNA levels were 
normalized to those of the control (control or R-Luc) and set to 100% in cells expressing the tag 
peptide alone. Panels B, D and F show representative northern blots for each tethering assay. Figure 
modified from Sgromo et al. (2017). 
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tested Roquin proteins trigger decay of reporter mRNA via their C-terminal regions that are 
unstructured and are not conserved. 
4.1.2 Dm Roquin interacts directly with the CCR4-NOT complex to elicit mRNA decay 
The 5’-to-3’ mRNA decay pathway promotes deadenylation followed by decapping and rapid 
degradation (see chapter 2). To address whether Roquin proteins use this pathway to elicit mRNA 
decay, I overexpressed an inactive mutant of the catalytic subunit DCP2 of the decapping complex, 
which out-competes the endogenous protein, resulting in a dominant negative effect with inhibition 
of decapping activity and consequently inhibition of mRNA decay. In this condition, tethering of 
Roquin proteins to a reporter mRNA resulted in an accumulation of deadenylated mRNA, implying 
that Roquin proteins require 5’-to-3’ mRNA decay. 
Since the CCR4-NOT complex is the major deadenylase of the 5’-to-3’ decay pathway, it was 
of interest to study how it contributes to Roquin-mediated mRNA degradation. I therefore 
performed RNA interference (RNAi)-mediated knockdown experiments (Clemens et al. 2000, 
Zamore 2001), using double-stranded (dsRNA) RNA against the open reading frame (ORF) of 
NOT1 in S2 cells to deplete NOT1, the scaffold subunit of the CCR4-NOT complex. Tethering of 
Dm Roquin in cells depleted of NOT1 reduced Roquin-mediated mRNA decay activity, in 
comparison to a control knockdown, revealing that Roquin function requires the CCR4-NOT 
complex. 
To gain a mechanistic insight into the specificity of Roquin proteins in mRNA decay, I 
decided to biochemically characterize the interactions between Roquin proteins and the CCR4-NOT 
deadenylase complex first via co-immunoprecipitation (co-IP) assays in both Hs and Dm cells. The 
co-IP studies showed that Roquin proteins interact with the core subunits of the CCR4-NOT 
complex in vivo. In order to identify direct interactions, I then performed in vitro pulldown assays 
with purified proteins. I therefore expressed the Dm Roquin C-terminal region, which induced 
mRNA decay in the tethering assays, with an N-terminal MBP tag in Escherichia coli (E. coli). I 
performed pulldown assays of the MBP-tagged Dm Roquin C-terminal fragment with a purified 
subcomplex of the CCR4-NOT complex (consisting of the C-terminal fragments of NOT1, NOT2 
and NOT3, as well as the full-length NOT7 and the structured core of CAF40) and its purified 
distinct modules (the catalytic module, the CAF40 module and the NOT module) (see Figure 3). 
My results showed that Dm Roquin directly binds to the CAF40 subunit and to the NOT module. 
To map the minimal interacting regions in Dm Roquin, required to bind the CAF40 subunit and the 
NOT module, I performed in vitro pulldown assays with different overlapping fragments of the Dm 
Roquin C-terminal region. Using this approach, I identified two minimal binding peptides. One is 
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responsible for the binding to CAF40 (the CAF40 binding motif or CBMR, where the subscript R 
refers to Roquin) and one is responsible for the binding to the NOT module (the NOT module 
binding motif or NBM). 
To unravel the molecular details of the CBMR-CAF40 interaction, a crystal structure of the 
Dm Roquin CBMR peptide bound to the Hs CAF40 protein was solved in collaboration with a 
former PhD student in the lab, Tobias Raisch (note that Hs and Dm CAF40 share 75% of sequence 
identity). In the crystal structure, the CAF40 ARM domain folds into six armadillo repeats with a 
concave surface where the CBMR is bound. The CBMR uses an amphipathic helix to mediate 
binding to a conserved hydrophobic surface of CAF40 (see section 4.4.1). To validate the binding 
interface I tested several mutations, which were designed to disrupt the binding interface observed 
in the crystal structure, both in the context of Dm Roquin and in the context of CAF40. All of the 
mutations disrupted the interaction in vitro as well as in vivo (Figure 9 A,B). 
Interestingly, even though the Hs Roquin1 C-terminal region also directly contacts CAF40, 
the CAF40 mutations (Y134D + G141W and V181E) that disrupt the interaction with Dm Roquin 
did not disrupt the interaction with Hs Roquin1 (Figure 10). This result indicates that Hs Roquin1 
Figure 9: Validation of the CBMR-CAF40 interface. Anti-GFP in vivo co-IPs of GFP-tagged Dm 
Roquin proteins with the HA-tagged CAF40 module in the presence of RNaseA to exclude RNA-
mediated interactions. Panel A shows that wild type (wt) Dm Roquin immunoprecipitates the 
CAF40 module, whereas Dm Roquin mutants (M1, M2, M3 and M4; design based on the crystal 
structure) are not able to bind the CAF40 module anymore. Panel B shows that mutations in the 
concave CAF40 interface (Y139D + G146W and V186E; mutations based on the structure) disrupt 
the interaction with wt Dm Roquin. Protein size markers (kDa) are shown on the right in each panel. 
Figure modified from Sgromo et al. (2017). 
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has a more extended binding interface with CAF40 and/or that the interactions of Dm Roquin and 
Hs Roquin1 require different residues on CAF40. 
Regarding the interaction of Hs Roquin1 and Hs Roquin2 with the CCR4-NOT complex, I 
could not define a single fragment within their unstructured C-terminal regions, sufficient to 
mediate the interaction, but instead my results suggested the presence of multiple low-affinity 
binding sites that all contribute in an additive manner to bind CCR4-NOT. 
4.1.3 NBM and CBMR sequences in Dm Roquin act redundantly to mediate mRNA decay 
To investigate the role and the contribution of the CBMR and the NBM peptides in Dm 
Roquin to the interaction with the CCR4-NOT complex, I tested them in tethering assays. Single 
deletions of each of those peptides or combined deletions in Dm Roquin did not abolish its activity 
in tethering assays, suggesting the presence of other redundant and uncharacterized binding sites 
within the Dm Roquin C-terminal region involved in the regulation of mRNA targets. Therefore, 
both identified motifs contribute to the activity of Dm Roquin in S2 cells but they are not sufficient 
for its full activity. 
To test the impact of the CBMR on an endogenous Roquin target, I used Dm Roquin in a 
hybrid experiment in HEK293T cells. In this experiment, I modified the MS2-reporter system of the 
tethering assay by replacing the 6xMS2 binding hairpins in the 3’UTR of the β-globin reporter with 
Figure 10: Interaction of the Hs Roquin1 C-terminal region with CAF40. MBP pulldown assay 
of the MBP-tagged Hs Roquin1 C-terminal fragment and purified Hs CAF40 wt (lane 14) or 
mutants (Y134D + G141W and V181E, lanes 15 and 16, respectively). MBP alone served as a 
negative control (lanes 9 to 12). Protein size markers are shown on the left. Figure adapted from 
Sgromo et al. (2017). 
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the CDE of TNF-α. The CDE of TNF-α was previously shown to be directly bound by Hs Roquin1 
(Leppek et al. 2013; see Figure 11 A). Strikingly, wild type (wt) Dm Roquin promoted CDE-
mediated mRNA decay of this reporter, whereas the Dm Roquin with a mutated CBMR (M4), which 
is not able to bind CAF40, was strongly impaired in its mRNA decay activity in human cells 
(Figure 11 B,C). Thus, the CBMR provides a strong contribution to the interaction of Dm Roquin 
with the CCR4-NOT complex in human cells. Furthermore, the experiment implies that Dm Roquin 
has the capability to directly recognize the stem loop structure of the TNF-α CDE by the ROQ 
domain, which is conserved across species. However, endogenous Dm Roquin mRNA targets are 
still unknown. 
Overall, this study shows that all tested Roquin proteins elicit mRNA degradation by 
recruiting the CCR4-NOT complex. My results also shed light onto the evolution of Roquin 
proteins. It is evident that Roquin proteins have maintained the ability to recognize secondary 
structure elements in the 3’UTR of target mRNAs via their conserved ROQ domain. Moreover, the 
recruitment of the CCR4-NOT complex is conserved during evolution, although Hs Roquin proteins 
and Dm Roquin seem to rely on different motifs to mediate the interaction. 
  
Figure 11: Dm Roquin induces mRNA decay of a reporter containing the TNF-α CDE element 
in the 3’UTR. Panel A shows the secondary structure model of the human CDE of TNF-α (adapted 
from Leppek et al. 2013) that I cloned into the 3’UTR of the β-globin reporter. Panel B shows the 
relative mRNA levels of three independent experiments. mRNA levels were normalized to those of 
the control and set to 100% in cells expressing the MS2 tag. Dm Roquin induces degradation of an 
mRNA containing the CDE of TNF-α in its 3’UTR, in HEK293T cells. In contrast, a mutant 
version of Dm Roquin (M4), which is not able to interact with the CAF40 subunit of the CCR4-
NOT complex, retains the ability to induce degradation of the same reporter mRNA. Panel C shows 
a representative northern blot for the experiment shown in panel B. Figure modified from Sgromo 
et al. (2017).  
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4.2 Bam requires the assembled CCR4-NOT complex to induce decay of bound mRNA 
The work described in this chapter has been published in Sgromo et al. 2018. Detailed experimental 
data and methods are available in the attached publication (see chapter 9). 
4.2.1 Bam carries an N-terminal CBMB to recruit the CCR4-NOT complex 
This section describes my studies of Dm Bam, which is a crucial factor in germ line stem cell 
maintenance and has been proposed to interact with the CCR4 subunit of the CCR4-NOT complex 
(Fu et al. 2015). Fu et al. proposed a model in which Bam-mediated mRNA repression required the 
deadenylase CCR4 isolated from the CCR4-NOT complex. This model was based on the 
observation that mutations in the LRR domain of CCR4 disrupted both the binding to Bam and 
CAF1 (the other deadenylase of the CCR4-NOT complex that bridges CCR4 and NOT1, see Figure 
3). However, the mutations introduced by Fu et al. most likely destabilized the fold of the LRR 
domain of CCR4, as suggested by the available CCR4 structural information (Basquin et al. 2012). 
A misfolded CCR4 would explain why the mutant binds neither Bam nor CAF1 and cannot be 
incorporated into the CCR4-NOT complex anymore. Hence, it remained unclear whether Bam 
activity required isolated CCR4 or the assembled CCR4-NOT complex. 
To address this issue, I worked together with a master student in the lab, Charlotte Backhaus, 
to investigate the role of Bam in mRNA decay and translational repression. To assess whether Bam 
elicits mRNA degradation, I first performed tethering assays in the Dm S2 cell line. Different 
fragments of the Bam protein were tested (N- and C-terminal regions, as well as full-length protein; 
see Figure 6). Bam triggered reporter mRNA degradation via its N-terminal region, which does not 
include the previously proposed binding site for CCR4. Furthermore, overexpression of an inactive 
mutant of the catalytic subunit DCP2 blocked Bam-mediated mRNA decay, demonstrating that 
Bam acts via the 5’-to-3’ mRNA decay pathway, as I previously showed for Roquin (see section 
4.1). Moreover, depletion of NOT1 in S2 cells impaired Bam-mediated mRNA degradation, 
suggesting that the decay of a Bam-bound reporter mRNA requires the fully-assembled CCR4-NOT 
complex. 
To identify components of the CCR4-NOT complex that mediate Bam activity I performed 
co-IPs in S2 cells. HA-tagged Bam co-immunoprecipitated with multiple components of the CCR4-
NOT deadenylase complex, including NOT1, NOT2, NOT3, CCR4 (as previously shown) and 
CAF40 (Figure 12 A-E). Since these experiments were done in cell lysates, the observed 
interactions could be indirect and mediated by other proteins. To identify which of the interactions 
are direct, I performed in vitro pulldown assays using MBP-tagged full-length Bam and all of the 
purified modules of the CCR4-NOT complex, as previously shown for the experiments with Dm 
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Roquin (see section 4.1). Surprisingly, MBP-tagged Bam directly bound to the CAF40 module but 
not to the catalytic module, which contains CCR4. Further in vitro mapping of MBP-tagged, 
overlapping Bam fragments revealed the presence of a short motif (CBMB, where the subscript B 
refers to Bam) in the N-terminal region, responsible for the direct interaction with the CAF40 
module. This CBMB was necessary and sufficient to mediate the interaction with the CCR4-NOT 
complex both in vitro and in vivo. 
In collaboration with Tobias Raisch, two crystal structures were obtained for a detailed 
characterization of the Bam-CAF40 interaction: the Dm Bam peptide (CBMB) bound to the Hs 
CAF40 protein (see section 4.4.1) and the Dm Bam CBMB bound to the Hs CAF40-NOT1 
(CN9BD) complex. The latter clearly showed that Bam interacts with CAF40 via a different surface 
than NOT1; therefore, both interactions can occur simultaneously and do not interfere with each 
other. Strikingly, the structures revealed that the CBMB peptide binds to CAF40 in a similar manner 
as the CBMR peptide that I previously identified (see section 4.1). To validate the functional 
significance of the Bam-CAF40 binding interface, I tested single point mutations in both the Dm 
Figure 12: Dm Bam co-immunoprecipitates with several subunits of the CCR4-NOT complex. 
Western blots showing anti-GFP co-IPs of GFP-tagged CCR4-NOT subunits with HA-tagged Bam 
in Dm S2 cells, in presence of RNaseA. Bam interacts with NOT1 (A), NOT2 (B), NOT3 (C), 
CCR4 (D) and CAF40 (E, lane 5). Protein size markers (kDa) are shown on the right in each panel. 
Figure modified from Sgromo et al. (2018). 
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Bam full-length protein and on the CAF40 surface. All of the mutations were designed based on the 
structural information and they disrupted the interaction in vitro as well as in vivo (see Figure 12 E, 
lane 6 for the V186E). Additionally, tethering of these Bam mutants also impaired Bam-mediated 
mRNA decay. This confirmed that the CBMB is necessary and sufficient to promote degradation of 
bound mRNAs (Figure 13 A,B). 
4.2.2 The CBMB-CAF40 interaction is required for Bam-mediated mRNA decay 
My results clearly showed that Bam requires the interaction with CAF40 for the recruitment 
of the assembled CCR4-NOT complex and induces target mRNA degradation. To exclude that 
other factors facilitated Bam repressive activity, I depleted S2 cells of the CAF40 subunit of the 
CCR4-NOT complex using dsRNA against CAF40 mRNA. Tethering of Bam in cells depleted of 
CAF40 strongly impaired reporter repression. This effect could be rescued by overexpressing a 
dsRNA resistant version of wt CAF40 (where silent mutations impair dsRNA-mediated recognition 
without affecting the protein product) in a complementation assay shown in Figure 14. To support 
the idea that Bam-mediated repression depends entirely on CAF40, a dsRNA resistant version of 
the CAF40 mutant (V186E), that is unable to bind Bam or Roquin, was tested. Accordingly, the 
CAF40 mutant was not able to rescue Bam activity (Figure 14 A,B). 
Figure 13: Mutations in the Bam CBMB impair the repression of a reporter. Tethering assay 
using λN-HA-tagged Bam (full-length or mutant versions) and the F-Luc-5BoxB reporter in Dm S2 
cells. Bam induces decay of the reporter mRNA, whereas each of the tested Bam mutants with 
disrupted CAF40 binding fails to do so. An mRNA reporter expressing Renilla luciferase (R-Luc) 
served as transfection control. Panel A shows F-Luc activity (grey bars) and mRNA levels (black 
bars) normalized to those of the R-Luc control and set to 100% in cells expressing the λN-HA 
peptide. The bars represent mean values and error bars represent standard deviations from three 
independent experiments. Panel B shows a northern blot of representative RNA samples. Figure 
modified from Sgromo et al. (2018). 
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This new insight into the role of Bam reveals that Bam requires CAF40 and the assembled 
CCR4-NOT complex to elicit its activity in mRNA degradation. GSC differentiation requires a 
Bam repressor complex to regulate key transcripts and my work suggests how such repression 
could occur: Bam could posttranscriptionally repress specific GSC maintenance factors through the 
direct recruitment of the CCR4-NOT complex. However, it remains to be elucidated how the Bam 
repressor complex recognizes and targets the respective mRNA transcripts.  
  
Figure 14: Complementation assay in Dm S2 cells. Complementation assay using the F-Luc-
5BoxB reporter and λN-HA-tagged Bam in knockdown control S2 cells (control, gray bars) or in 
cells depleted of CAF40 (CAF40 KD, black bars). Panel A shows the relative mRNA levels from 
three independent experiments and panel B shows a representative northern blot. Panel C shows the 
efficiency of the CAF40 knockdown. Protein size markers (kDa) are shown on the right. Figure 
modified from Sgromo et al. (2018). 
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4.3 Bam forms a complex together with Bgcn and Tut 
The work described in this section is not published yet. Additional information regarding 
experimental procedures and methods are provided in section 8.3. 
4.3.1 Bgcn induces mRNA decay via its N-terminal region 
Bam was proposed to be part of a large repressor complex that regulates GSC differentiation 
in flies (Neumuller et al. 2008, Li et al. 2013, Chen et al. 2014a, Shan et al. 2017), however, the 
molecular details of Bam function remained poorly defined. To fully investigate the role of Bam in 
GSC differentiation, it is important to characterize Bam interactions with proposed co-factors (Shen 
et al. 2009, Chen et al. 2014a, Malik et al. 2017). Therefore, I started investigating the putative Bam 
binding partners Bgcn and Tut and their interaction with Bam. Bgcn was already shown to be an 
intimate binding partner of Bam (Ohlstein et al. 2000, Li et al. 2009) and to interact with the C-
terminal region of Bam (Pan et al. 2014). Tut is an interesting binding partner since it is an RBP and 
may represent the missing link between Bam and target mRNAs. Interestingly, tut and bgcn mutant 
flies show a similar phenotype as bam mutants, suggesting genetic interaction. Indeed, Bgcn and 
Bam were suggested to regulate germ cell differentiation (Li et al. 2009). To examine whether Bam 
and Bgcn share similar functions and repress target mRNAs, I performed a λN-based tethering 
assay in S2 cells together with a master student, Charlotte Backhaus. 
I expressed either full-length Bgcn or N- or C-terminal regions (Figure 15) with an N-
terminal λN-HA tag that binds to a co-transfected firefly luciferase mRNA reporter, containing 
5BoxB hairpins (which are λN-binding sites) in the 3’UTR (for detailed experimental procedures 
see Supplemental information in section 8.3). Tethering of Bgcn to the F-Luc-5BoxB reporter 
mRNA decreased the F-Luc reporter levels to approximately 20% relative to the negative control 
(tethering of λN-HA fusion protein). Importantly, Bgcn activity resided in the Bgcn-N fragment, 
Figure 15: Domain organization of Dm Bgcn and Dm Tut proteins. Bgcn is a DExH-box RNA 
helicase but it lacks ATP-binding and RNA unwinding motifs (Ohlstein et al., 2000). It contains 
two ankyrin repeats (yellow). Tut is a fly-specific RNA-binding protein that contains two RRM 
domains (purple). Protein domain organizations and N- and C- fragments are indicated. 
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while the Bgcn-C fragment was not active (Figure 16 A). The decrease in F-Luc activity 
corresponds to a decrease in the mRNA levels (Figure 16 B), thereby showing that similarly to 
Bam, Bgcn (in particular the N-terminal region; Bgcn-N) also induces mRNA decay in S2 cells. 
This seems to be independent of the presence of Bam, since endogenous Bam levels are very low in 
S2 cells (Shen et al. 2009). 
Bgcn-mediated mRNA decay could depend on the interaction with the CCR4-NOT 
deadenylase complex. I therefore used co-IPs to identify several interacting subunits within the 
CCR4-NOT complex (NOT1, NOT2, NOT11 and CCR4) that bind to Bgcn in vivo (Figure 17 A-
D). However, a precise mapping of the interaction in vitro is currently missing due to difficulties in 
expressing and purifying Bgcn protein fragments from E.coli. 
Figure 16: The Bgcn N-terminal region induces degradation of the F-Luc-5BoxB mRNA 
reporter. Tethering assay using λN-HA-tagged Bgcn (full-length, N-terminal and C-terminal 
regions) to the F-Luc-5BoxB reporter in Dm S2 cells. Bgcn induces decay of the reporter mRNA 
via its N-terminal region. An mRNA reporter expressing Renilla luciferase (R-Luc) served as 
transfection control. Panel A shows F-Luc activity (grey bars) and mRNA levels (black bars) 
normalized to those of the R-Luc control and set to 100% in cells expressing the λN-HA peptide. 
The bars represent mean values and error bars represent standard deviations from three independent 
experiments. Panel B shows a representative northern blot of the experiment in panel A. 
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4.3.2 Tut recruits the CCR4-NOT complex via Bam 
Recently it was shown that Tut interacts with the N-terminal region of Bam in yeast two-
hybrid assays (Chen et al. 2014a). A detailed mapping of this interaction was however still missing. 
In collaboration with two former students in the lab, Kevin Sabath and Andreas Blaha, I determined 
the minimal regions in Bam and Tut required for their direct interaction, combining in vivo co-IPs 
and in vitro pulldown assays. Bam uses a TBM (Tut binding motif; residues 79-103) in its N-
terminal region to interact directly with the Tut N-terminal region (which includes the two RRMs) 
(result obtained by Kevin Sabath). This peptide is distinct from the CBMB (residues 17-36) used to 
bind to CAF40. These data, together with the already known interaction between Bam and Bgcn, 
suggested the formation of a trimeric Bam-Bgcn-Tut complex. 
To gain molecular insights into the repressive activity of the Bam-Tut complex I performed 
luciferase assays using a λN-based tethering approach in S2 cells. I tethered λN-HA-tagged Tut to 
the F-Luc-5BoxB mRNA reporter, while co-expressing GFP-tagged Bam constructs. I used either 
full-length Bam, N-terminal or C-terminal Bam fragments, the Bam mutant (4xMut) that does not 
bind to CAF40 as shown previously (Sgromo et al. 2018) or GFP alone (as a control). Under control 
conditions, λN-HA-tagged Tut did not cause mRNA decay but rather increased reporter levels 
(Figure 18 A,B; lanes 1,2). In contrast, tethering of λN-HA-tagged Tut decreased the F-Luc 
expression levels to 30% relative to the negative control (λN-HA fusion protein) when co-
transfected with GFP-Bam full-length or the GFP-Bam N-terminal fragment that both carry the 
CBMB and the TBM (Figure 18 A,B; lanes 4 and 6). Notably, tethered Tut requires Bam to repress 
bound mRNA, most likely via Bam-mediated recruitment of the CCR4-NOT complex. Thus, Tut 
Figure 17: Dm Bgcn co-immunoprecipitates several subunits of the CCR4-NOT complex. 
Western blots showing anti-GFP co-IPs of GFP-tagged Bgcn with HA-tagged subunits of the 
CCR4-NOT complex in Dm S2 cells, in presence of RNaseA. Bgcn interacts with NOT1 (A), 
NOT2 (B), NOT11 (C) and CCR4 (D). GFP-F-Luc served as negative control. Inputs (1% for the 
HA-tagged proteins and 3% for the GFP-tagged proteins) and immunoprecipitates (30% for the 
HA-tagged proteins and 10% for the GFP-tagged proteins) were analyzed by western blotting. 
Protein size markers (kDa) are shown on the right in each panel. 
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triggered mRNA degradation only when co-expressed with functional Bam in S2 cells. Importantly, 
tethering of λN-HA-Tut did not decrease the reporter mRNA levels when co-expressed with the 
GFP-Bam C-terminal fragment or the GFP-Bam mutant (4xMut) (Figure 18 A,B; lanes 8 and 10). 
Thus, Tut and Bam were functional only when Bam was able to directly recruit the CCR4-NOT 
complex via its N-terminal region where the CBMB is located (Figure 18 A,B). These experiments 
revealed that Tut is a direct binding partner of Bam and requires Bam to degrade bound mRNAs. 
Moreover, Tut may provide RNA-binding to the Bam-Bgcn-Tut repressor complex, since it 
contains a tandem RRM domain. To validate this hypothesis, I performed a similar experiment to 
the one shown in Figure 18, using a modified reporter system, where I replaced the 5BoxB elements 
Figure 18: Tut degrades bound mRNAs when expressed together with Bam. Tethering assay of 
λN-HA-Tut onto an F-Luc-5BoxB reporter in the presence of Bam. Panel A shows F-Luc activity 
and mRNA levels normalized to those of the R-Luc control and set to 100% in cells expressing the 
λN-HA peptide. The bars represent mean values ± standard deviations from three independent 
experiments. Panel B shows a northern blot of representative RNA samples. Panel C shows the 
equivalent expression of proteins used in the experiments shown in panels A and B. Protein size 
markers (kDa) are shown on the right.  
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with the 3’UTR of mei-P26 (F-Luc-mei-P26), a proposed endogenous mRNA target of the Bam-
Bgcn-Tut complex (Chen et al. 2014a). This reporter assay does not rely on the artificial tethering 
of Tut, but rather on its intrinsic RNA binding ability. Unexpectedly, Tut did not affect the 
expression of this reporter. Figure 19 A shows protein levels of the firefly luciferase reporter 
carrying the mei-P26 3’UTR when Bam (either wt protein, the N- or C- terminal regions or the 
mutant version) and Bgcn were overexpressed. This finding is in conflict with previous data (Chen 
et al. 2014a) and suggests that the complex might require additional co-factors to modulate and/or 
bind the RNA. 
Overall, these results identified for the first time the minimal regions required for a direct 
interaction between Bam and Tut. The data suggest the formation of a trimeric Bam-Bgcn-Tut 
complex with Tut acting as an RNA-binding protein, possibly for the direct recognition of specific 
mRNAs via its tandem RRM domains. Unexpectedly, I could not confirm previous findings that 
Tut binds to the mei-P26 3’UTR (Chen et al. 2014a). Thus, it would be of great interest to further 
characterize at the molecular and structural level the architecture of this trimeric complex as well as 
its recruitment to target mRNAs. This will help to elucidate the complete mechanism by which 
Bam, Bgcn and Tut act through the CCR4-NOT complex to regulate GSC differentiation. 
Figure 19: Bam, Bgcn and Tut do not affect the expression of a reporter containing the mei-
P26 3’UTR, when co-expressed. Panel A shows F-Luc activity normalized to the R-Luc control 
and set to 100% in cells expressing the λN-HA peptide alone. Panel B shows the equivalent 
expression of proteins used in the experiment shown in panel A. Protein size markers (kDa) are 
shown on the right. 
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4.4 CAF40 is an important hub for the recruitment of the CCR4-NOT complex 
My two publications (Sgromo et al. 2017 and Sgromo et al. 2018) contain parts of the work 
summarized in this section. The papers including detailed experimental data and methods are 
attached. The work involving NOT4 is described in the attached manuscript in preparation Keskeny 
et al. (see chapter 9). 
4.4.1 Dm NOT4 also carries a CBM that directly binds the CCR4-NOT complex 
The identification of two distinct CBMs in Roquin and Bam targeting the same surface on the 
CAF40 subunit of the CCR4-NOT complex raised the question whether there are yet other RNA-
binding proteins containing a CBM. Indeed, in collaboration with the PhD students Csilla Keskeny 
and Tobias Raisch, we identified, by in vitro pulldown assays, metazoan NOT4 as another protein 
that carries a CBM (CBMN, where the subscript N refers to NOT4). 
The CBMN sequence resides in the C-terminal region of Dm NOT4 and binds to the same concave 
surface of CAF40 as the two previously identified CBMs, CBMR and CBMB. In contrast to the Dm 
CBMR, the Dm CBMN is conserved in metazoan NOT4 proteins and functional in Hs NOT4, which 
Figure 20: Crystal structures of the CBMs bound to CAF40. Dm Roquin (green), Dm Bam (red)  
and Dm NOT4 (blue) CBMs bound to Hs CAF40 are illustrated. Hs CAF40 consists of six ARM 
repeats (gray). All CBMs fold into an α-helix and bind to the concave surface of CAF40. The 
bottom of the figure shows a superimposition of all CBM structures. Figure adapted from Sgromo et 
al. (2017), Sgromo et al. (2018) and the Keskeny et al. NOT4 manuscript.  
Results 
40 
 
additionally contains a NOT module binding motif (NBM) that shares no sequence homology with 
the Dm Roquin NBM. 
Interestingly, the crystal structure of the Dm CBMN in complex with CAF40 determined by 
Tobias Raisch, showed that the Dm NOT4 CBMN peptide also forms an α-helix, but that it binds to 
CAF40 in an N-to-C inverted orientation, when compared to the CBMs of Roquin and Bam. Even 
though all CBMs lack sequence similarity, they all fold into an amphipathic helix to interact with 
the same hydrophobic surface on CAF40 (Figure 20). These findings imply that the same binding 
surface within the CCR4-NOT complex (the concave CAF40 interface) can be bound by multiple 
motifs (CBMs) that evolved independently of each other by convergent evolution to bind CAF40 
and recruit the CCR4-NOT complex. 
To assess the role of the three CAF40-CBM interactions, I first validated the structures both 
in vivo and in vitro (the in vitro validation of the CAF40-CBMN interaction was performed by 
Tobias Raisch). Similar to Roquin and Bam (see sections 4.1 and 4.2) NOT4 can induce decay of 
bound mRNAs via the direct interaction with the CCR4-NOT complex, through a CMBN and an 
NBM. 
4.4.2 CBMs show common properties but differences in binding CAF40 
Even though the CBMs of Roquin, Bam and NOT4 bind to the CAF40 subunit of the CCR4-
NOT complex in a very similar way, they contribute differently to the recruitment of the CCR4-
NOT complex and to the resulting mRNA decay activity. While the Dm CBMB is necessary and 
sufficient to trigger Bam-mediated mRNA degradation (section 4.2), the Dm CBMR and Dm CBMN 
alone only trigger partial target mRNA decay in the tethering assay (section 4.1 and Keskeny et al. 
manuscript in preparation). This reflects the fact that NOT4 and Roquin rely on additional 
interactions outside of their CBMs for the recruitment of the CCR4-NOT deadenylase complex.  
The requirement for additional interactions in the recruitment of the CCR4-NOT complex 
could be explained by a low-affinity binding of the CBMR and CBMN to CAF40. It was thus 
interesting to determine the binding affinities of the different CBMs for the purified CAF40 
module. To measure the respective dissociation constants, I performed isothermal titration 
calorimetry (ITC) measurements together with Tobias Raisch. We were able to determine the 
binding affinity between the CBMB peptide and the CAF40 module (dissociation constant of ~180 
nM). However, measuring the Roquin and NOT4 CBM binding affinities was not possible because 
the elevated protein concentrations required for the measurements led to protein precipitation. The 
need for high CBMR and CBMN peptide concentrations implies a rather low-affinity interaction of 
these peptides with the CAF40 module in comparison to the CBMB peptide. Assuming that Roquin, 
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Bam and NOT4 all recruit the CCR4-NOT complex with comparable efficiency, a low-affinity 
binding of the CBMR and CBMN peptides would explain why additional binding sites (leading to 
avidity effects) are needed within Roquin and NOT4 to recruit the CCR4-NOT complex. 
The presence of a CBM in Roquin, Bam and NOT4 raises the question whether these three 
proteins compete in vivo for the binding to CAF40. Currently it is unknown if the three identified 
CBM-containing proteins are present at the same time in a cell which is a prerequisite for a 
competitive binding scenario. It is thus possible that Roquin, Bam and NOT4 compete for binding 
to CAF40 under specific cellular conditions. 
In conclusion, my results reveal for the first time that the highly conserved CAF40 subunit of 
the CCR4-NOT complex is an important hub since it is not only bound by TNRC6 proteins (Chen 
et al. 2014b, Mathys et al. 2014), which contact the CAF40 convex surface, but also by Roquin, 
Bam and NOT4, which contact the CAF40 concave surface via their CBMs. However, the 
identification of new CBMs in other proteins remains challenging, since all three CBMs identified 
here lack sequence conservation. 
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5. DISCUSSION 
The CCR4-NOT complex regulates mRNA metabolism from transcription to decay. In 
addition to its role in bulk mRNA turnover, it is required for deadenylation and translational 
repression of a plethora of mRNAs to which it is recruited via its interaction with RNA-associated 
proteins. My doctoral work, together with other studies, highlights the CCR4-NOT complex as a 
major effector for mRNA repression mediated by specific binding partners, such as Roquin and 
Bam. My findings not only reveal the structural and molecular basis for the recruitment of the 
CCR4-NOT deadenylase complex by these two proteins, but they also show how Roquin and Bam 
trigger mRNA decay. Importantly, I uncover a previously unknown binding surface in CAF40 as a 
contact site within the CCR4-NOT complex that is shared by these two proteins, and by NOT4. 
This is the first time that functionally distinct proteins are found to contact an overlapping interface 
within the CCR4-NOT complex, using a short α-helical motif. The discovery of a common CBM-
binding surface on CAF40 identifies CAF40 as a common hub for mRNA-associated proteins to 
recruit the CCR4-NOT complex. A cartoon summary of the recruitment of the CCR4-NOT 
complex by the mRNA-associated proteins characterized in my studies is shown in Figure 21. 
5.1 Roquin-mediated mRNA decay is conserved through evolution 
In my PhD work, I first investigated the role of Dm Roquin, a previously uncharacterized 
protein, in the recruitment of the CCR4-NOT complex. My results showed that Roquin proteins 
induce mRNA degradation via the direct interaction with the CCR4-NOT deadenylase complex in 
both human and fly. In Drosophila, Roquin interacts with the CCR4-NOT complex through two 
distinct motifs in its unstructured C-terminal region that contact the CAF40 module (CBMR) and 
the NOT module (NBM) to mediate deadenylation and to target mRNAs for decay. 
Interestingly, both motifs (CBMR and NBM) are not conserved between Dm and Hs Roquin 
proteins, suggesting that the proteins have maintained the ability to recruit the CCR4-NOT complex 
to mRNA targets even though the precise mode of binding has changed during evolution. Previous 
studies on Hs Roquin1 showed that it recruits the CCR4-NOT complex via its unstructured C-
terminal tail (Leppek et al. 2013). I could confirm this interaction and additionally show that also 
Hs Roquin2 recruits the CCR4-NOT complex via its C-terminal tail (see section 4.1). Since the C-
terminal tails of Roquin proteins are divergent (also between Hs Roquin1 and 2), this supports the 
concept that the recruitment of the CCR4-NOT complex is functionally conserved but differs at the 
molecular level. 
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Another feature that appears to be maintained through evolution is the recognition of specific 
RNA elements by the ROQ domain. This characteristic RNA binding domain is highly conserved 
between all Roquin proteins. My results showed that Dm Roquin is capable of using its ROQ 
domain to recognize the CDE of TNF-α, a known target of the Hs Roquin1 ROQ domain, but it is 
unknown whether the Dm Roquin ROQ domain has the same mRNA targets in the fly. Even though 
the Drosophila immune system differs largely from the vertebrate immune system (Govind 2008), 
Drosophila has a TNF-α homolog called Eiger. Eiger induces cell-death and is involved in the 
immune response (Perez-Garijo et al. 2013, Igaki & Miura 2014). However, the Dm eiger 3’UTR 
lacks evident CDEs, suggesting that Dm Roquin could have other target mRNAs than its human 
counterpart. To date, the identity of endogenous Dm Roquin targets remains unknown, raising the 
question whether they also regulate inflammation and immunity. Since Dm Roquin binds the CDE 
of Hs TNF-α, it would be interesting to screen the Drosophila transcriptome for consensus CDEs, 
as has been previously done for the mouse transcriptome (Leppek et al. 2013). This would reveal 
endogenous Dm CDE-containing mRNAs as potential Dm Roquin targets. To identify mRNAs that 
are bound by Roquin in Drosophila, endogenous Roquin immunoprecipitation followed by RNA 
sequencing could be used in future experiments. Alternatively, RNA sequencing experiments in 
combination with Dm Roquin knockdown will provide a general picture of mRNAs that are 
affected by Dm Roquin. It will be interesting to discover the biological context in which Dm Roquin 
recruits the CCR4-NOT complex, considering the existing evidence that roquin is essential for fly 
development (Smibert et al., abstract for the 48th Annual Drosophila Research Conference, 2007). 
5.2 Bam and NOT4 use a CBM to recruit the CCR4-NOT complex 
From simple sequence analysis of Bam, the second protein that I investigated as a putative 
CCR4-NOT interactor, the presence of a CBM was not obvious. Thus, it was surprising to discover 
that Bam carries a CBMB and that the CBMB-CAF40 interaction is highly similar to the CBMR-
CAF40 interaction identified previously. Bam is a GSC differentiation factor in Dm and the 
identified CBMB is crucial for the direct interaction with CAF40 within the CCR4-NOT 
deadenylase complex. Importantly, my results shed light on the function of Dm Bam and show that 
Bam requires the integrity of the CCR4-NOT complex for mRNA repression, in contrast to the 
previous work of Fu et al. (2015). The model proposed by Fu et al. was based on an interaction 
between Bam and CCR4. They proposed a mutually exclusive binding of either Bam or CAF1 to 
CCR4. The authors based their observation on mutations in the LRR domain of CCR4 that 
disrupted both the binding to Bam and CAF1. However, the mutations introduced most likely 
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destabilized the fold of the LRR domain of CCR4, as suggested by the available CCR4 structural 
information (Basquin et al. 2012), thus impairing its incorporation into the CCR4-NOT complex. 
Fu et al. showed that the CCR4 LRR mutants cannot rescue twin mutant flies, which is consistent 
with their model where the LRR mutations disrupt a common binding interface for CAF1 and Bam 
(Fu et al. 2015). However, Fu et al. did not prove the functional integrity of these CCR4 LRR 
mutants, raising the possibility that the mutants are misfolded and bind neither Bam nor CAF1. 
Thus, it remained unclear whether Bam acts by recruiting the CCR4-NOT complex or by binding to 
CCR4 independently of the complex. My results confirmed the binding between Bam and CCR4, 
but also demonstrated that this interaction is actually indirect. Moreover, my studies revealed that 
Bam directly interacts with CAF40 to recruit the whole CCR4-NOT complex to target mRNAs (see 
section 4.2). Bam requires the CCR4-NOT complex for its activity since depletion of the scaffold 
subunit NOT1, which disrupts the assembly of the complex, abolishes Bam-mediated mRNA 
degradation. 
While Bam is a known GSC differentiation factor that represses GSC maintenance (McKearin 
& Ohlstein 1995), a function of CAF40 in GSC differentiation has not been described yet. A role 
for CAF40 in this process seems likely, considering that the Bam-CAF40 interaction is necessary 
for the direct recruitment of the CCR4-NOT complex, a major deadenylase. Thus, it  is possible that 
Bam triggers deadenylation, translational repression and degradation of yet unknown GSC-
maintaining target mRNAs, via CAF40. Bam might act as an adaptor between specific transcripts 
and the mRNA decay machinery in differentiating germ cells. In this light, it will be crucial to study 
the physiological importance of the observed CAF40-CBMB interaction, which is sufficient to 
recruit the CCR4-NOT complex in S2 cells. Future experiments could address this question by 
assessing the impact of Bam point mutations in fly GSCs. 
Unexpectedly, a CBMN that directly binds CAF40 within the CCR4-NOT complex was also 
identified in the Hs and Dm NOT4 proteins, in a collaborative project with my colleagues Csilla 
Keskeny and Tobias Raisch. In contrast to the CBMR, the Dm CBMN sequence is conserved in 
metazoans. Interestingly, Hs and Dm NOT4 both carry additional motifs to interact with the CCR4-
NOT complex. The presence of additional binding sites within NOT4 indicates a possible 
redundancy in the recruitment of the CCR4-NOT complex, similar to Roquin proteins. The fact that 
also yeast NOT4 interacts with the CCR4-NOT complex suggests that NOT4 proteins have evolved 
to maintain the interaction with the CCR4-NOT complex. There are however, two striking 
differences between Hs/Dm NOT4 and the yeast NOT4. First, yeast NOT4 is a stable component of 
the CCR4-NOT complex, whereas the interaction in Hs and Dm appears to be transient or regulated 
(Lau et al. 2009, Temme et al. 2010). Second, yeast NOT4 recruits the CCR4-NOT complex via the 
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NOT module (Bhaskar et al. 2015), whereas Hs and Dm NOT4 additionally bind to CAF40. It is 
clear that the interaction of NOT4 proteins with the CCR4-NOT complex is important, however it is 
currently unknown if Hs and Dm NOT4 have additional functions other than binding the CCR4-
NOT complex. Furthermore, it remains elusive, whether NOT4 uses its RRM domain to recruit the 
CCR4-NOT complex to specific mRNA targets or whether the CCR4-NOT complex recruits the E3 
ubiquitin ligase NOT4 for independent functions. Finally, it is conceivable that the main function of 
Hs and Dm NOT4 is independent of the CCR4-NOT complex and requires a transient interaction 
with the CCR4-NOT machinery. 
Figure 21: Models for the recruitment of the CCR4-NOT deadenylase complex by Dm Roquin, 
Dm Bam and Dm NOT4 proteins. A) Dm Roquin with its ROQ domain directly recognizes stem 
loop-structured elements in the 3’UTR of target mRNAs and with the CBMR and NBM directly 
recruits the CCR4-NOT complex. B) Dm Bam directly interacts with the CAF40 subunit of the 
CCR4-NOT complex via a CBMB. Additionally, Bam forms a complex together with Bgcn and Tut 
proteins. It is still unknown if Bam or Tut directly contact target RNAs or require binding to 
additional RBPs. C) Dm NOT4 might contact target mRNAs with its N-terminal RRM domain and 
it directly binds to CAF40 (via a CBMN) and carries additional yet unidentified binding sites to 
contact the CCR4-NOT complex. In all of the proposed models, the recruitment of the CCR4-NOT 
complex leads to deadenylation followed by decapping and degradation, as well as translational 
repression of target mRNAs. 
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5.3 The Bam-Bgcn-Tut repressor complex 
The identification of the Bam CBMB indicates that the recruitment of the CCR4-NOT 
complex is important for Bam’s function in GSC differentiation. However, it is not clear whether 
Bam requires other binding partners such as Bgcn or Tut to elicit its function in posttranscriptional 
regulation. My preliminary results indicate that Bam and Bgcn can both induce mRNA degradation 
independently of each other, via the CCR4-NOT effector complex. However, it remains unclear 
whether Bgcn can directly recruit the CCR4-NOT complex or requires additional proteins. In the 
context of a trimeric Bam-Bgcn-Tut repressor complex (Chen et al. 2014a), the finding that both 
Bam and Bgcn execute a similar function is surprising. Further studies are required to understand 
whether Bam and Bgcn act redundantly or cooperate to recruit the CCR4-NOT complex via 
multiple contacts. Additionally, it remains unknown whether Bam can directly bind mRNA by 
itself, or requires other RBPs such as Tut. 
Bam, Bgcn and Tut form a trimeric complex that represses GSC maintenance (Chen et al. 
2014a), however, a detailed characterization of the interactions within the complex is currently 
missing. Tut is an especially interesting protein within this complex, because it contains two RRMs 
(section 4.3) which might explain how Bam associates with RNAs in vivo. It can be speculated that 
within the Bam-Bgcn-Tut complex functions such as RNA binding and CCR4-NOT recruitment are 
distributed among the different proteins, rather than coming from a single polypeptide chain as it is 
the case for Roquin. 
Work done by Kevin Sabath demonstrated that Bam directly contacts Tut and identified the 
minimal regions for this interaction. Moreover, my results showed that Tut requires the interaction 
with Bam to elicit repression of an mRNA reporter via the CCR4-NOT complex in tethering assays. 
Thus, Tut may confer RNA-binding activity to the Bam-Bgcn-Tut complex, which in turn recruits 
the CCR4-NOT complex via Bam. However, Tut does not mediate the degradation of an mRNA 
reporter carrying the mei-P26 3’UTR, even in the presence of Bam and Bgcn (see section 4.3). 
Previous work showed by RNA immunoprecipitations that Tut can bind a long and a short isoform 
of the mei-P26 3’UTR (Chen et al. 2014a). Interestingly, binding seems to be weaker for the short, 
wild type isoform of the mei-P26 3’UTR (Chen et al. 2014a) which I used in my reporter construct. 
This could explain my result, where Tut did not reduce the levels of this reporter mRNA. Thus, it 
would be interesting to identify additional endogenous Tut target mRNAs to test their regulation by 
the Bam-Bgcn-Tut complex in reporter binding assays. Photoactivatable ribonucleoside-enhanced 
crosslinking and immunoprecipitation (PAR-CLIP) experiments of Tut (in the presence or absence 
of Bam/Bgcn) could be used to identify direct targets of the complex. 
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The CCR4-NOT complex has critical roles in the germline, where it regulates Nanos mRNA 
targets in GSCs. My finding that the GSC master differentiation factor Bam directly recruits CAF40 
indicates that the CCR4-NOT complex also regulates stem cell differentiation. However, the 
functional relevance of the proposed Bam-Bgcn-Tut repressor complex and its connection to the 
CCR4-NOT complex in vivo remain to be elucidated.  
5.4 CAF40 as a common binding platform for RNA-associated proteins 
An important and unexpected common feature of Roquin, Bam and NOT4 is the interaction 
with a previously unknown binding surface on CAF40. Binding interfaces on the CCR4-NOT 
complex are known for other RNA-associated proteins, such as for GW182 (which binds CAF40 on 
its convex surface; Chen et al. 2014b, Mathys et al. 2014), as well as for Hs and Dm Nanos (which 
contact the NOT module on distinct surfaces; Bhandari et al. 2014, Raisch et al. 2016). In general, 
these proteins use distinct interaction modes to bind the CCR4-NOT complex. It is thus surprising 
that the sequence-wise unrelated CBMs of Roquin, Bam and NOT4 all fold into an amphipathic α-
helix to contact the same site on the concave surface of CAF40. Importantly, the concave CAF40 
surface is highly conserved, even in species where CBMs where not identified so far, for example 
in yeast. Thus, it is likely that CBM-containing proteins are also present in these species, but remain 
to be discovered. 
Notably, even though all of the CBM-containing proteins that I identified in my studies fold 
into an amphipathic α-helix to contact CAF40, they share no sequence conservation. This strongly 
suggests that the CBMs arose from convergent evolution, a characteristic feature of short linear 
motifs (SLiMs) (Tompa 2012, Van Roey et al. 2014). Moreover, the presence of a CBM in Roquin, 
Bam and NOT4 indicates that their binding to CAF40 is mutually exclusive. Thus, it is possible that 
the CBMs compete for the same binding site under certain cellular conditions. Competition for 
CAF40 binding might provide a stringent posttranscriptional mRNA regulation to coordinate 
different biological processes that depend on CCR4-NOT activity. However, to date, there is no 
information regarding the simultaneous expression of these proteins within a cell. Since Bam is 
exclusively expressed in the germline (Brown et al. 2014), competition is more likely to occur 
between the two E3 ubiquitin ligases Roquin and NOT4 that are broadly expressed in Dm. 
Several non-catalytic modules of the CCR4-NOT complex have regulatory functions and are 
now known to be bound by mRNA-associated proteins. For example, proteins like Hs and Dm 
Nanos and yeast NOT4 have been shown to interact with the NOT module on distinct surfaces 
(Bhaskar et al. 2015). With the present work however, the CAF40 module emerges as a major hub 
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within the CCR4-NOT complex that is competitively targeted by several mRNA-associated 
proteins, whereas proteins of the TNRC6/GW182 family can probably still contact CAF40 on the 
convex surface and recruit the CCR4-NOT complex to miRNA targets (Chen et al. 2014b, Mathys 
et al. 2014). The fact that the CBM-containing proteins bind CAF40 implies that CAF40 plays a 
general role beyond miRNA-mediated gene silencing and represents a central contact site in the 
CCR4-NOT complex for mRNA-associated proteins. 
5.5 An evolutionary perspective on CBMs in the recruitment of the CCR4-NOT complex 
Multiple motifs carry out CCR4-NOT recruitment in proteins like TNRC6/GW182 (Chen et 
al. 2014b, Mathys et al. 2014), TTP (Fabian et al. 2013), Roquin (see section 4.1), Nanos (Bhandari 
et al. 2014, Raisch et al. 2016), Bam (see section 4.2) and NOT4 (Bhaskar et al. 2015 and 
unpublished work by Keskeny et al.). Typically, such proteins use SLiMs (Tompa 2012, Van Roey 
et al. 2014) located in intrinsically disordered regions to bind directly and specifically to the CCR4-
NOT complex, consequently triggering translational repression and mRNA degradation. These 
motifs are linear, meaning that their secondary structure is often induced upon binding. SLiMs 
mediate transient low-affinity interactions that generally act cooperatively to promote a more stable 
binding. They are subject to high evolutionary plasticity, meaning that they evolve rapidly and 
typically show convergent evolution, which hampers their identification. A clear example of this 
plasticity is found in Roquin and NOT4 proteins. The Roquin CBM and NBM are not conserved in 
orthologous proteins across species and represent an example of how multiple low affinity motifs 
can result in high avidity interactions. At least two redundant motifs are also found in the Hs NOT4 
protein, however, the NOT4 CBM is conserved between Hs and Dm. 
In contrast to Roquin and NOT4, Bam relies entirely on the interaction between the CBMB 
and CAF40 to recruit the CCR4-NOT complex and elicit its repressive activity. This might explain 
the relatively high binding affinity of Bam for CAF40 measured by ITC. The crucial role of Bam in 
GSC differentiation might require a single, defined interaction with the CCR4-NOT deadenylase 
complex rather than a modulated interaction via multiple redundant binding motifs to strictly 
regulate target mRNAs.  
In general, SLiMs appear to be a common feature of the above-described mRNA-associated 
proteins that recruit the CCR4-NOT complex. SLiMs have been proposed to mediate binding 
interactions of dynamic processes (Davey et al. 2015). This is possibly also the case for the CBM-
containing proteins, where in all of the cases, the recruitment of the CCR4-NOT complex leads to a 
common repressive mechanism. The removal of the poly(A) tail from target mRNAs, their 
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translational repression and, in a cell context-dependent manner, their full degradation are all highly 
regulated processes that certainly benefit from a dynamic interaction with the CCR4-NOT complex. 
5.6 A general view on posttranscriptional mRNA regulation  
To date, multiple interactions of RNA-associated proteins with the CCR4-NOT complex have 
been characterized. Based on these findings it is possible to draw a general picture of the 
recruitment of the CCR4-NOT complex to mRNA targets (Figure 22). Typically, RNA-associated 
proteins contain an RNA-binding domain recognizing specific mRNA targets, for example the ROQ 
domain in Roquin (Leppek et al. 2013) or the ZnF in Nanos proteins (Curtis et al. 1997, Hashimoto 
et al. 2010). This RNA-binding domain is phyiscally distinct from the motifs required to bind the 
CCR4-NOT complex. RNA-associated proteins have evolved versatile binding modes to recruit the 
CCR4-NOT complex: i) by using distinct motifs, which usually are not conserved between species 
and ii) by contacting different modules within the complex. 
The context-specific expression of mRNA-associated proteins allows a fine-tuned regulation 
of numerous mRNA targets. Moreover, PTMs of either the RNA-associated proteins (as is the case 
for TTP phosphorylation; Clement et al. 2011) or of subunits of the CCR4-NOT complex (as is the 
case for CAF1 ubiquitination by MEX-3C; Cano et al. 2015) play a key role in posttranscriptional 
regulation. mRNAs can also be modified, for example by methylation or uridylation (Lee et al. 
Figure 22: Overview of the complexity of posttranscriptional mRNA regulation. General 
determinants of mRNA stability are the poly(A) tail and the 5’-cap structure. Specific mRNAs are 
often recognized by RBPs (red and orange) that recruit effector complexes (grey) to regulate 
mRNA stability. The complexity of this network is increased by PTMs of RBPs and effector 
complexes. Furthermore, RNA modifications (here methylation and uridylation are shown as 
examples) have an impact on mRNA stability. 
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2014), thus affecting their stability, activity and localization. This overwhelming complexity is 
additionally increased by the cooperativity of multiple regulatory proteins binding to a single 
mRNA. It will be interesting, but also challenging considering the level of complexity, to fully 
understand the molecular mechanisms behind the function and specificity of RNA-associated 
proteins in posttranscriptional mRNA regulation. 
My studies on Roquin proteins and Bam highlight the plasticity in the recruitment of the 
CCR4-NOT complex to posttranscriptionally regulate mRNAs. Here CAF40 acts as regulatory hub 
that is contacted by multiple RNA-associated proteins. This emphasizes the importance of mRNA 
regulation in diverse biological contexts ranging from regulation of autoimmunity to GSC 
differentiation. 
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7. ABBREVIATIONS 
ARE Au-rich element 
ARM Armadillo repeat 
ASK1 Apoptosis signal-regulating kinase 1 
Bam Bag-of-marbles 
Bgcn Benign gonial cell neoplasm 
BMP Bone morphogenetic protein 
CAF CCR4-associated factor 
CBM CAF40-binding motif 
CC Coiled-coil 
CCR4 Carbone catabolite repressor 4 
CDE Constitutive decay element 
Ce Caenorhabditis elegans 
CN9BD CAF40/CNOT9 binding domain 
co-IP Co-immunoprecipitation 
DAF-16 Abnormal dauer formation 16 
DCP1/DCP2 Decapping enzyme subunit 1/2 
DDX6 DEAD box protein 6 
DEDD Asp-Glu-Asp-Asp 
DExH Asp-Glu-X-His 
Dpp Decapentaplegic 
Dm Drosophila melanogaster 
DNA Deoxyribonucleic acid 
DND1 Dead end homolog 1 
ds Double stranded 
DUF Domain of unknown function 
EDC3 Enhancer of decapping 3 
E.coli Escherichia coli 
EEP Endonuclease-exonuclease-phosphatase domain 
eIF Eukaryotic translation initiation factor 
F-Luc Firefly luciferase 
Foxo Forkhead box protein O 
Gbb Glass bottom boat 
Abbreviations 
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GFP Green fluorescent protein  
GSC Germline stem cell 
GW182 Glycine-tryptophan repeat containing protein of 182 kDa size, Gawky 
HEK293T Human embryonic kidney 293T cell line 
HEPN Higher eukaryotes and prokaryotes nucleotide-binding 
HLA-A2 Human leukocyte antigen 2 
Hs Homo sapiens 
Icos Inducible costimulatory 
IFN- γ Interferon γ 
IL-1 Interleukin-1 
ITC Isothermal titration calorimetry 
KD Knockdown 
KH K homology 
LRR Leucine rich repeat 
MAPK Mitogen-activated protein kinases 
MBP Maltose binding protein 
MIF4G Middle domain of eukaryotic initiation factor 4G 
miRNA MicroRNA 
Mm Mus musculus 
MNAB Membrane-associated nucleic-acid binding protein 
mRNA Messenger RNA 
mRNP Messenger ribonucleoprotein 
NAC Nascent polypeptide associated complex 
NBM NOT module-binding motif 
NMD Nonsense-mediated decay 
NOT Negative on TATA less 
ORF Open reading frame 
Ox40 Ox40 receptor 
PABP Poly(A) binding protein 
PAN2-PAN3 Poly(A) nuclease 2-3 
PAR-CLIP Photo-activable ribonucleoside-enhanced crosslinking and immunoprecipitation 
PARN Poly(A) ribonuclease 
PATL1 Protein PAT1 homolog 1 
Poly(A) Poly adenosine 
Abbreviations 
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POP2 PGK promoter directed over production 2 
PRE Pumilio response element 
pre-mRNA Precursor messenger RNA 
PTM Posttranslational modification 
RBP RNA-binding protein 
Rcd-1 Required for cell differentiation-1 
RING Really interesting new gene 
RLE-1 Regulation of longevity by E3 
R-Luc Renilla luciferase 
RNA Ribonucleic acid 
RNAi RNA interference 
Rps7A 40S ribosomal protein s7-A 
RQCD1 Required for cell differentiation 1 
RRM RNA recognition motif 
rRNA Ribosomal RNA 
S2 Schneider 2 cell line 
Sax Saxophone 
Sc Saccharomyces cerevisiae 
SHD NOT1 superfamily homology domain 
SLE systemic lupus erythematosus 
SLiMs  Short linear motifs 
snRNA Small nuclear RNA 
SRE Smaug recognition element 
Sxl Sex-lethal 
TBM Tut binding motif 
TNF-α Tumor necrosis factor alpha 
TNRC6 Trinucleotide repeat containing gene protein 6 
Tkv Thickveins 
TRAMP Trf4/Air2/Mtr4p polyadenylation 
tRNA Transfer RNA 
TTP Tristetraproline 
TPR Tetratricopeptide repeat  
Tut Tumorous testis 
URR U-rich repeat 
Abbreviations 
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UTR Untranslated region 
wt wild type 
XRN1 5’-3’ exoribonuclease 1 
YAP1 Yes-associated protein 1 
ZnF Zinc-finger
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8. APPENDIX 
8.1 List of publications 
In this section, I describe my contribution as author for the publications discussed in this thesis. 
 
Sgromo A, Raisch T, Bawankar P, Bhandari D, Chen Y, Kuzuoğlu-Öztürk D, Weichenrieder O, 
Izaurralde E (2017) A CAF40-binding motif facilitates recruitment of the CCR4-NOT complex to 
mRNAs targeted by Drosophila Roquin. Nat Commun 8: 14307 
 
My contribution: I designed and cloned all constructs for expression in Dm S2 cells and E.coli. 
Together with Praveen Bawankar, I designed and cloned all constructs for expression in human 
cells. I performed all of the tethering assays and knockdown experiments both in human and Dm S2 
cells and co-IP assays in Dm S2 cells. I identified both CBM and NBM motifs involved in the direct 
interaction between Roquin and the CCR4-NOT complex via in vitro pulldown assays. Together 
with Tobias Raisch, I crystalized the Roquin CBMR bound to CAF40. I contributed to writing the 
manuscript and prepared all of the figures. 
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My contribution: I designed and cloned all constructs for expression in human and Dm S2 cells as 
well as E.coli. Together with Charlotte Backhaus, I performed tethering assays and co-IP assays in 
Dm S2 cells. I performed all overexpression experiments and knockdown experiments in Dm S2 
cells. I performed all of the tethering assays and pulldown experiments in human cells. Together 
with Charlotte Backhaus and Tobias Raisch, I identified the Bam CBM involved in the direct 
interaction with CAF40 via in vitro pulldown assays. I contributed to writing the manuscript and 
prepared all of the figures. 
8.2 Manuscript in preparation 
This section describes my contribution as author for the manuscript discussed in this thesis. 
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Keskeny C, Raisch T, Sgromo A, , Bhandari D, Igreja C, Weichenrieder O, Izaurralde E (in 
preparation) Metazoan NOT4 associates with the CCR4-NOT complex via interactions with CAF40 
and NOT1.  
 
My contribution: I designed and cloned all constructs for expression in Dm S2 cells. I performed all 
of the tethering assays and western blots in Dm S2 cells. Together with Tobias Raisch, I identified 
the NOT4 CBM bound to CAF40. I contributed to writing the manuscript.  
8.3 Supplemental information 
Table 3. Constructs used in section 4.3. 
 
Name Bag-of-marbles 
(Uniprot P22745) 
Comment 
Bam GFP-Bam 1–442  
Bam-N GFP-Bam 1–140 
Contains the CBM and 
the TBM 
Bam-C GFP-Bam 141–442 Interacts with Bgcn 
Bam-4xMut 
GFP-Bam L17E, M24E, L28E, 
V32E 
Disrupts CAF40 
binding 
 
Name Benign gonial cell neoplasm 
(Uniprot Q9W1I2) 
Comment 
Bgcn HA- Bgcn 1-1215  
 GFP- Bgcn 1-1215  
Bgcn-N HA- Bgcn 1-950  
Bgcn-C HA- Bgcn 951-1215  
 
Name Tumorous testis 
(Uniprot Q8IQA2) 
Comment 
Tut HA-Tut 1-230  
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Table 4. Antibodies used in section 4.3. 
Antibody Source Catalog number Dilution 
Monoclonal/ 
Polyclonal 
Anti-HA-HRP Roche 12 013 819 001 1:5,000 Monoclonal 
Anti-GFP 
(for 
immunoprecipitation) 
In house   
Rabbit 
Polyclonal 
Anti-V5 
AbD 
Serotec 
MCA1360GA 1:5,000 Monoclonal 
Anti-mouse-HRP 
GE 
Healthcare 
NA931V 1:10,000 Monoclonal 
Anti-GFP 
(for western blotting) 
Roche 11 814 460 001 1:2,000 
Mouse 
Monoclonal 
 
Material and Methods of section 4.3 
DNA constructs 
The DNA constructs used are listed in Table 3 and were confirmed by sequencing. For 
expression of Bgcn (full-length and fragments) in Dm S2 cells, the corresponding cDNA was 
amplified from total Dm oocyte cDNA and cloned between the HindIII and XhoI restriction sites of 
the pAc5.1-λN-HA and pAc5.1-GFP vectors (Rehwinkel et al. 2005, Tritschler et al. 2008). For 
expression of Tut in Dm S2 cells, the corresponding cDNA was amplified from total Dm oocyte 
cDNA and cloned between the KpnI and XhoI restriction sites of the pAc5.1-λN-HA vector. The 
plasmids used for the expression of Dm Bam constructs and for the expression of the subunits of the 
CCR4-NOT complex in S2 cells have been previously described (Sgromo et al. 2017, Sgromo et al. 
2018). 
Co-immunoprecipitation assays 
All co-immunoprecipitation assays in Dm S2 cell lysates were performed in the presence of 
RNaseA as previously described (Sgromo et al. 2017). All western blots were developed using an 
ECL western blotting detection system (GE Healthcare). The antibodies used are listed in Table 4. 
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2.5 × 106 of S2 cells were seeded per well in six-well plates and transfected using Effectene 
transfection reagent (Qiagen). The transfection mixtures contained plasmids expressing GFP-tagged 
Bgcn (2 μg) and HA-tagged subunits of the CCR4-NOT complex (1.5 µg for NOT1, 1 µg for 
NOT2, NOT11 and CCR4). GFP-F-Luc (0.015 µg) served as a negative control. Cells were 
harvested 3 days after transfection, and co-immunoprecipitation assays were performed using NET 
buffer (50 mM Tris [pH 7.4], 150 mM NaCl, 1 mM EDTA, 0.1% Triton X-100 supplemented with 
protease inhibitors [Complete protease inhibitor mix, Roche]) as previously described (Braun et al. 
2011). 
Tethering assays 
For the λN-tethering assays in Dm S2 cells, 2.5 × 106 cells per well were seeded in six-well 
plates and transfected using Effectene transfection reagent (Qiagen). For the experiment shown in 
Figure 16 the transfection mixtures contained the following plasmids: 0.1 µg of firefly luciferase 
reporter F-Luc-5BoxB, 0.4 µg of the R-Luc transfection control and various amounts of plasmids 
expressing λN-HA-tagged full-length Bgcn or Bgcn fragments (0.005 µg for full-length, 0.025 µg 
for Bgcn-N, 0.01 µg for Bgcn-C). In the experiment shown in Figure 18, cells were transfected with 
0.01 µg of plasmid expressing λN-HA-tagged Tut. Cells were also transfected with plasmids 
expressing GFP (0.05 µg) or GFP-tagged Bam either wild type (0.1 µg) or fragments or the mutant 
(0.05 µg for Bam-N, 0.2 µg for Bam-C and 0.15 µg for Bam-4xMut). For the experiment shown in 
Figure 19 the transfection mixtures contained the following plasmids: 0.1 µg of firefly luciferase 
reporter F-Luc-mei-P26, 0.4 µg of the R-Luc transfection control and 0.01 µg of plasmids 
expressing λN-HA-tagged Tut. Cells were also co-transfected with 0.2 µg of GFP-tagged full-
length Bgcn. 
To generate F-Luc-mei-P26 the 3’UTR of mei-P26 was amplified from wt ovary cDNA using 
the oligos AGCCgctagcTTGCAAATCAAAGCGCGCAAC and 
CGAActcgagAGTAGTAGCGCTAATTG and cloned into the 3’UTR of the F-Luc reporter using 
the NheI and XhoI restriction sites. 
Cells were harvested 3 days after transfection. Firefly and Renilla luciferase activities were 
measured by using a Dual-Luciferase Reporter Assay System (Promega). The total RNA was 
isolated using Trifast Reagent (Peqlab) and analyzed by northern blotting, as previously described 
(Braun et al. 2011).  
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A CAF40-binding motif facilitates recruitment
of the CCR4-NOT complex to mRNAs targeted
by Drosophila Roquin
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Human (Hs) Roquin1 and Roquin2 are RNA-binding proteins that promote mRNA target
degradation through the recruitment of the CCR4-NOT deadenylase complex and are
implicated in the prevention of autoimmunity. Roquin1 recruits CCR4-NOT via a C-terminal
region that is not conserved in Roquin2 or in invertebrate Roquin. Here we show that Roquin2
and Drosophila melanogaster (Dm) Roquin also interact with the CCR4-NOT complex through
their C-terminal regions. The C-terminal region of Dm Roquin contains multiple motifs that
mediate CCR4-NOT binding. One motif binds to the CAF40 subunit of the CCR4-NOT
complex. The crystal structure of the Dm Roquin CAF40-binding motif (CBM) bound to
CAF40 reveals that the CBM adopts an a-helical conformation upon binding to a conserved
surface of CAF40. Thus, despite the lack of sequence conservation, the C-terminal regions of
Roquin proteins act as an effector domain that represses the expression of mRNA targets via
recruitment of the CCR4-NOT complex.
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T
he CCR4-NOT deadenylase complex plays a central role in
bulk mRNA degradation by catalysing the removal of
mRNA poly(A) tails, which is the first step in general
mRNA decay1. In addition to its role in global mRNA
degradation, the CCR4-NOT complex regulates the expression
of a large number of specific mRNAs, to which it is recruited
via interactions with RNA-associated proteins. Consequently,
CCR4-NOT functions as a major downstream effector complex in
posttranscriptional mRNA regulation in eukaryotes.
The CCR4-NOT complex consists of several structurally and
functionally distinct modules, which assemble around the NOT1
scaffold subunit1. NOT1 contains several a-helical domains that
provide binding surfaces for the individual modules. A central
domain of NOT1 that is structurally related to the middle portion
of eIF4G (termed the NOT1 MIF4G domain) provides a binding
site for the catalytic module, which comprises two deadenylases,
namely CAF1 or its paralogue POP2 (also known as CNOT7 and
CNOT8, respectively, in humans), and CCR4a or its paralogue
CCR4b (also known as CNOT6 and CNOT6L, respectively, in
humans). The NOT1 MIF4G domain also serves as a binding
platform for the DEAD-box protein DDX6 (also known as RCK),
which functions as a translational repressor and decapping
activator2,3. C-terminal to the MIF4G domain, NOT1, contains a
CAF40/NOT9-binding domain, CN9BD, that binds to the highly
conserved CAF40 subunit, which is also known as CNOT9
(refs 2,3), followed by a NOT1 superfamily homology domain
SHD, which interacts with NOT2-NOT3 heterodimers to form
the NOT module4,5.
The CAF40 and NOT modules have no catalytic activity
and have been implicated in mediating interactions with
RNA-associated proteins that recruit the CCR4-NOT complex
to their targets2–10. These proteins include the GW182 family,
which is involved in miRNA-mediated gene silencing in
animals2,3, tristetraprolin (TTP), a protein required for the
degradation of mRNAs containing AU-rich elements6, the
germline determinant Nanos7–9 and the human Roquin1 and
Roquin2 proteins10.
The vertebrate Roquin proteins are negative regulators of
T follicular helper cell differentiation and autoimmunity in
vertebrates11,12. There are two partially redundant paralogues,
Roquin1 and Roquin2 (initially named membrane-associated
nucleic acid-binding protein), in vertebrates and only one family
member in invertebrate species11,12. The proteins feature an
N-terminal folded region followed by a C-terminal extension of
variable length and low sequence complexity that is predicted to
be predominantly unstructured13,14 (Fig. 1a). The N-terminal
region contains a RING finger E3 ubiquitin ligase domain, a ROQ
RNA-binding domain flanked by a bilobed HEPN domain and a
CCCH-type zinc finger domain, all of which are highly conserved
in metazoans and define the protein family14–20. The
RING domains of Hs Roquin2 and the Caenorhabditis elegans
homologue of Roquin1, RLE-1, (regulation of longevity by E3)
exhibit E3 ubiquitin ligase activity21,22.
The ROQ domain of Hs Roquin1 and Roquin2 recognizes
specific stem-loop structures in the 30-untranslated region (UTR)
of target mRNAs. These targets include mRNAs encoding
regulators of inflammation such as the inducible T-cell
costimulator, the costimulatory receptor Ox40, neuropilin-1,
interleukin-6, interferon g (IFN-g) and the tumor necrosis
factor-a (TNF-a)10,14,16,23–31. Hs Roquin1 and Roquin2
downregulate these mRNA targets through interactions with the
CCR4-NOT deadenylase complex and decapping factors10,32.
For Hs Roquin1, it has been shown that the interaction with
the CCR4-NOT complex is mediated by the C-terminal region of
the protein that is conserved only among vertebrate Roquin1
orthologues10. However, it is not known how Roquin2 recruits
the CCR4-NOT complex, because its C-terminal region shows no
similarity with that of Roquin1. In addition, the C-terminal
regions of the invertebrate Roquin proteins are highly
divergent18,20–22, and it is unclear whether Roquin proteins
recruit the CCR4-NOT complex in invertebrates. However, the
conservation of the ROQ domain indicates that Roquin proteins
also bind RNA in invertebrates, although their specific RNA
targets are currently unknown.
Despite extensive information regarding the mode of RNA
recognition by Roquin proteins15–19, a detailed molecular
understanding of how the proteins interact with the CCR4-
NOT complex is lacking, and it is not even known whether the
interactions are direct. Here we investigate the molecular details
of how Roquin proteins recruit the CCR4-NOT complex. First,
we show that Hs Roquin2 and Dm Roquin interact with the
CCR4-NOT complex and promote target mRNA degradation
via their C-terminal regions, suggesting conserved functional
principles among all Roquin proteins. Furthermore, we find that
the Dm Roquin C-terminal region contains multiple binding sites
for the CCR4-NOT complex and that these sites act redundantly
to promote mRNA degradation. Among these sites, we identify a
short linear motif (SLiM) that is necessary and sufficient to
mediate direct binding to the CAF40 subunit of the CCR4-NOT
complex. This motif is termed the CAF40-binding motif (CBM),
and we determine its crystal structure bound to CAF40.
Structure-based mutations of the CAF40-CBM interface prevent
binding of Dm Roquin to CAF40 and reduce the ability of the
protein to degrade mRNA targets, indicating that CAF40 is an
important mediator of the recruitment of the CCR4-NOT
complex. Together with previous studies10, our results reveal a
common role of the Roquin C-terminal region as an effector
domain that regulates mRNA target expression through the
recruitment of the CCR4-NOT complex despite the lack of
sequence conservation.
Results
Roquin C-terminal regions recruit the CCR4-NOT complex.
Hs Roquin1 interacts with the CCR4-NOT deadenylase complex
through a C-terminal region that shows very low sequence
similarity to the C-terminal regions of the corresponding
vertebrate Roquin2 paralogues and invertebrate Roquin10
(Fig. 1a). We therefore asked whether the C-terminal regions
of Hs Roquin2 and Dm Roquin have the ability to interact with
the CCR4-NOT complex. Hs Roquin2 and Dm Roquin expressed
with a tag consisting of the V5 epitope followed by the
streptavidin-binding peptide (V5-SBP) pulled down the
endogenous CCR4-NOT complex in human HEK293T cells
to a similar extent as Hs Roquin1 (Fig. 1b). Moreover, the
C-terminal regions of Hs Roquin2 and Dm Roquin were
necessary and sufficient for the interaction, as observed for Hs
Roquin1 (Fig. 1c,d; Supplementary Fig. 1a)10. The observation
that Dm Roquin interacts with the CCR4-NOT complex in
human cells further suggests that the protein recognizes surfaces
on the CCR4-NOT complex that are conserved across species.
Roquin C-terminal regions mediate mRNA degradation. We
next investigated whether the C-terminal regions of Hs Roquin2
and Dm Roquin elicit the degradation of mRNA targets. To this
end, we used an MS2-based tethering assay in human HEK293T
cells. The full-length proteins and the corresponding N- and
C-terminal fragments (Hs Roq2-N, Hs Roq2-C, Dm Roq-N and
Dm Roq-C, respectively; Fig. 1a, Supplementary Table 1) were
expressed with an MS2-HA tag that mediates binding to a
b-globin reporter mRNA containing six MS2-binding sites in its
30-UTR (b-globin-6xMS2bs)33. Tethered Hs Roquin2 and Dm
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Roquin reduced the level of the b-globin-6xMS2bs mRNA
relative to the MS2-HA fusion protein, which was used as a
negative control (Fig. 1e–j). Furthermore, the C-terminal
fragments retained the mRNA degradation activity of the full-
length proteins, whereas the N-terminal fragments were inactive
(Fig. 1e–j). Similar results were obtained for Hs Roquin1
(Supplementary Fig. 1b–d). The N- and C-terminal fragments
were expressed at levels comparable to those of the full-length
proteins (Fig. 1g,j), and none of the proteins affected the
expression of the control b-globin mRNA lacking MS2-binding
sites (Fig. 1f,i; control). Thus we conclude that, despite the lack of
sequence conservation, the C-terminal regions of Roquin proteins
interact with the CCR4-NOT complex and promote the
degradation of bound mRNAs.
As shown for Hs Roquin1 and Roquin2, Dm Roquin regulates
the expression of a b-globin mRNA reporter containing the
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constitutive decay element (CDE) from the TNF-a mRNA in its
30-UTR (CDE-37; ref. 10) in human HEK293T cells (Fig. 1k,l),
consistent with the conservation of the ROQ domain15,16,23.
Regulation of the b-globin-TNF-a reporter by Dm Roquin was
abolished by mutations in the CDE that disrupt the binding of the
ROQ domain (Supplementary Fig. 1e,f; mutant MUT16; ref. 10).
Furthermore, in contrast to the results obtained in the tethering
assay, degradation of the b-globin-TNF-a reporter required both
the N- and the C-terminal regions of Dm Roquin (Fig. 1k,l).
Indeed, the C-terminal region alone was not sufficient to cause
degradation of the b-globin-TNF-a reporter (Fig. 1k,l), most
likely because it does not bind RNA.
Roquin proteins direct mRNAs to the 50-to-30 decay pathway.
Given that Roquin proteins interact with the CCR4-NOT
complex, we next investigated whether the proteins elicit
degradation of mRNA targets via the 50-to-30 decay pathway,
in which deadenylation is followed by decapping and 50-to-30
exonucleolytic degradation of the mRNA body. To this end,
we performed tethering assays in HEK293T cells overexpressing
a catalytically inactive DCP2 mutant (DCP2 E148Q), which
inhibits decapping in a dominant-negative manner34. We
observed that degradation of the b-globin-6xMS2bs mRNA by
tethered Hs Roquin1, Hs Roquin2 and Dm Roquin was impaired
in cells expressing the DCP2 mutant; in these cells, the reporter
accumulated in a shorter deadenylated form (Fig. 2a,b, lanes 6–8).
The expression of the tethered proteins was not affected by the
expression of DCP2 mutant (Fig. 2c). Our results indicate that the
three Roquin proteins direct mRNA targets to the 50-to-30 decay
pathway.
Dm Roquin degrades bound mRNAs in Drosophila cells. To
investigate whether the Dm Roquin protein has the ability to
repress and degrade bound mRNAs in Dm cells, we used a
lN-based tethering assay in Drosophila melanogaster Schneider
S2 cells35. Tethered Dm Roquin caused 10-fold repression of a
firefly luciferase (F-Luc) reporter containing five binding sites for
the lN-tag (BoxB hairpins) in its 30-UTR (Fig. 3a–c). The
reduction in F-Luc activity was accompanied by a corresponding
decrease in mRNA abundance (Fig. 3a–c) and a decrease in the
half-life of the mRNA (Fig. 3d,e), indicating that Dm Roquin
induces mRNA degradation in S2 cells. Dm Roquin did not affect
the expression of an F-Luc reporter that lacked the BoxB hairpins
(Supplementary Fig. 1g,h).
As observed in human cells, the Roq-C fragment retained the
repressive activity of the full-length protein in the tethering
assay and accelerated the degradation of the mRNA reporter
(Fig. 3a–e), whereas the Roq-N fragment was inactive (Fig. 3a,b).
Furthermore, the full-length Dm Roquin and the Roq-C fragment
repressed the translation of a F-Luc mRNA reporter with a
30-end generated by a self-cleaving hammerhead ribozyme
(F-Luc-5BoxB-A95C7-HhR; Fig. 3f,g). This reporter is resistant
to deadenylation and is therefore not degraded in S2 cells36.
Similar results have been reported for other RNA-associated
proteins that recruit the CCR4-NOT complex8,9,36, although the
involvement of other factors cannot be excluded.
To confirm that mRNA degradation caused by Dm Roquin is
dependent on the CCR4-NOT complex, we depleted NOT1 in S2
cells. The ability of Dm Roquin to elicit the degradation of the
F-Luc-5BoxB mRNA was partially suppressed in NOT1-depleted
cells (Fig. 3h,i). Western blotting analysis indicated that the
NOT1 levels were reduced to o25% of their control levels in
depleted cells (Supplementary Fig. 1i). Thus Dm Roquin
promotes mRNA degradation by recruiting the CCR4-NOT
complex in Drosophila cells.
Dm Roquin interacts directly with CAF40 and the NOT module.
To identify the subunits of the CCR4-NOT complex that interact
with Dm Roquin, we expressed the GFP-tagged protein in S2 cells
and determined whether it interacts with HA-tagged sub-
units of the CCR4-NOT complex using co-immunoprecipitation
assays. We also tested for interactions of the protein with the
PAN2-PAN3 deadenylase complex and with decapping factors.
Dm Roquin interacted with NOT1, NOT2, NOT3, CAF40,
NOT10, CAF1 and PAN3 (Supplementary Fig. 2a–j). These
interactions were observed in the presence of RNase A, suggesting
that they are not mediated by RNA. Dm Roquin also interacted
with the decapping factor HPat in an RNA-independent manner
but not with other decapping factors (Supplementary Fig. 2k–o).
In particular, and in contrast to Hs Roquin1 (ref. 32), we observe
no interaction of Dm Roquin with Dm EDC4 or Me31B, which is
the Dm orthologue of DDX6/RCK (Supplementary Fig. 2n,o).
To discriminate between direct and indirect interactions with
subunits of the CCR4-NOT complex, we performed pulldown
assays in vitro using purified recombinant proteins expressed in
Escherichia coli. Because Dm NOT1 is not expressed in a soluble
form in bacteria, we expressed the human proteins, which interact
with Dm Roquin (as shown in Fig. 1b) and tested them for
interaction with Dm Roquin in vitro.
Initially, we used a purified human pentameric complex
consisting of a NOT1 fragment comprising residues 1093–2376,
CAF1, CAF40 and the C-terminal domains of NOT2 and NOT3
(Fig. 4a). The Dm Roq-C fragment carrying an N-terminal
maltose-binding protein (MBP) tag pulled down the purified
pentameric complex (Fig. 4b, lane 20), thus demonstrating its
direct interaction with the complex.
Figure 1 | The C-terminal regions of Roquin proteins interact with the CCR4-NOT complex and induce degradation of bound mRNA. (a) Roquin proteins
consist of a conserved N-terminal region containing a RING-finger E3 ubiquitin ligase domain, a ROQ RNA-binding domain flanked by a bilobed HEPN
domain and a CCCH-type zinc-finger (ZnF) domain. The N-terminal region is followed by a variable C-terminal extension (shown in grey) that often
contains proline-rich sequences (P-rich). The positions of the CBM and the NBM in Dm Roquin are indicated. The numbers above the protein outline
indicate the residues at domain/motif boundaries. (b–d) SBP pulldown assays in HEK293T cells expressing V5-SBP-tagged Hs Roquin1, Hs Roquin2 and Dm
Roquin (full-length or N- and C-terminal fragments). A V5-SBP-tagged GFP-MBP fusion served as a negative control. The presence of endogenous NOT1,
NOT2 and NOT3 in the bound fractions was analysed by western blotting using specific antibodies. The inputs (1.5% for the V5-SBP tagged proteins and
1% for NOT1, NOT2 and NOT3) and bound fractions (10% for the V5-SBP tagged proteins and 30% for NOT1, NOT2 and NOT3) were analysed by western
blotting. (e–j) Tethering assays using the b-globin-6xMS2bs reporter and MS2-HA-tagged Hs Roquin2 and Dm Roquin (full-length or the indicated
fragments) in human HEK293T cells. A plasmid expressing a b-globin mRNA reporter lacking MS2-binding sites (Control) served as a transfection control.
The b-globin-6xMS2bs mRNA level was normalized to that of the control mRNA and set to 100% in cells expressing MS2-HA. The mean values±s.d. from
three independent experiments are shown in e,h. (f,i) show representative northern blottings. (g,j) show the equivalent expression of the MS2-HA-tagged
proteins used in the corresponding tethering assays. (k,l) Effect of Dm Roquin on the expression of the b-globin-TNF-a mRNA reporter analysed as
described in e–j. Protein size markers (kDa) are shown on the right of the western blotting panels. Error bars represent s.d. from three independent
experiments. Full images of western and northern blottings are shown in Supplementary Fig. 10.
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To map the binding site more precisely, we tested interactions
with individual CCR4-NOT subcomplexes, including the NOT1
MIF4G domain bound to CAF1, the NOT1 CN9BD bound to
CAF40, a C-terminal connector domain of unknown function
(CD) and the NOT module (comprising the NOT1 SHD and the
C-terminal regions of NOT2 and NOT3). MBP-tagged Dm
Roq-C pulled down the CN9BD-CAF40 complex as well as the
NOT module but not the NOT1 MIF4G-CAF1 complex or the
CD (Fig. 4b, lanes 21–24).
Further analysis indicated that Dm Roq-C interacted directly
with both Hs and Dm CAF40 in the absence of the NOT1
CN9BD (Fig. 4c, lanes 11 and 12). We also investigated whether
the interaction of Dm Roq-C with the NOT module was mediated
by the NOT1 C-terminal SHD domain or by the NOT2-NOT3
dimer. However, splitting the NOT module resulted in severely
reduced binding to both NOT1 and the NOT2-NOT3 dimer,
demonstrating that only the assembled module is recognized
efficiently (Supplementary Fig. 3a). In summary, the Dm Roq-C
fragment contains at least two distinct binding sites for the
CCR4-NOT complex, one site that contacts CAF40 and a second
site that contacts the NOT module.
Redundancy of CCR4-NOT-binding motifs in Dm Roq-C. To
define more precisely how Dm Roq-C interacts with CAF40 and
the NOT module, we sought to identify conserved motifs within
the primary sequence. Using only sequences from Drosophila
species, it was possible to align the Dm Roq-C sequences across
their entire length (Supplementary Fig. 4). The alignment
revealed clusters of conserved residues dispersed throughout the
sequence with a higher level of conservation evident at the
C-terminal end of Roq-C (Supplementary Fig. 4). We therefore
generated two fragments, which we termed Roq-CN and Roq-CC
(Fig. 1a, Supplementary Fig. 4). Remarkably, each of these
fragments in isolation exhibited repressive activity in tethering
assays, indicating functional redundancy (Supplementary
Fig. 3b–h). However, only the Roq-CC fragment, comprising
residues 702–819, bound to the purified CAF40 protein in vitro as
efficiently as the entire Roq-C fragment, whereas binding of the
Roq-CN fragment (residues 501–702) was strongly impaired
(Fig. 4d, lanes 23 and 20 versus lane 17). In contrast, both
Roq-CN and Roq-CC retained binding activity for the NOT
module, although their binding was reduced compared with that
of the full Roq-C fragment (Fig. 4d, lanes 21 and 24 versus
lane 18). These results indicate the presence of multiple binding
sites for the NOT module within Roq-C.
Through a deletion analysis combined with binding, we then
identified a motif comprising residues 790–812 within Roq-CC
that is necessary and sufficient for binding to the CAF40
armadillo repeat (ARM) domain (Figs 1a and 4e). Indeed,
deletion of the CBM in Roq-CC abolished its binding to CAF40
(Figs 4e, lane 14). Conversely, the CBM is sufficient for binding to
CAF40 (Fig. 4e, lane 16 versus lane 12). We also identified
Figure 2 | Roquin proteins degrade mRNAs through the 50-to-30 mRNA
decay pathway. (a,b) A tethering assay was performed in HEK293T cells
using the b-globin-6xMS2bs reporter as described in Fig. 1e–j, except that
different amounts of plasmid were transfected (see Methods section). The
transfection mixture included plasmids expressing either GFP or a
GFP-tagged catalytically inactive DCP2 mutant (E148Q). The
b-globin-6xMS2bs mRNA levels were normalized to those of the control
mRNA and set to 100% in the presence of MS2-HA for each condition. The
mean values±s.d. from three independent experiments are shown in a. The
white and black bars represent the normalized b-globin-6xMS2bs mRNA
values in cells expressing GFP and the GFP-DCP2 mutant, respectively.
(b) shows a representative northern blotting. The positions of the
polyadenylated (An) and deadenylated (A0, dashed red line) mRNA
reporter are indicated on the right. (c) Western blotting analysis showing
equivalent expression of MS2-HA-tagged proteins in cells expressing GFP
or the DCP2 mutant. Error bars represent s.d. from three independent
experiments. Full images of western and northern blottings are shown in
Supplementary Fig. 11.
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residues 725–755 as being required for binding to the NOT
module in the context of Roq-CC (this region was termed the
NOT-module binding motif (NBM); Fig. 1a, Supplementary
Fig. 5a, lane 14); however, in isolation the NBM was not sufficient
for binding, indicating a more complicated binding mode
(Supplementary Fig. 5a, lane 16).
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Figure 3 | Dm Roquin degrades bound mRNAs. (a,b) Results of tethering assays using the F-Luc-5BoxB reporter and lN-HA-tagged Dm Roquin (full-
length or the indicated fragments) in Dm S2 cells. A plasmid expressing R-Luc served as a transfection control. F-Luc activity and mRNA levels were
normalized to those of the R-Luc transfection control and set to 100% in cells expressing the lN-HA peptide. The mean values±s.d. from three
independent experiments are shown in a. (b) shows a representative northern blotting. The corresponding control experiment with a F-Luc reporter lacking
the BoxB sites is shown in Supplementary Fig. 1g,h. (c) Western blotting showing the equivalent expression of the lN-HA-tagged proteins used in a,b.
(d,e) Representative northern blotting showing the decay of the F-Luc-5BoxB mRNA in S2 cells expressing lN-HA or lN-HA-tagged Dm Roquin or the
Roq-C fragment after inhibition of transcription by actinomycin D. F-Luc mRNA levels were normalized to those of the rp49 mRNA and plotted against time.
The mRNA half-life (t1/2)±s.d. was calculated from the decay curve shown in e. (f,g) Results of the tethering assays using the F-Luc-5BoxB-A95-C7-HhR
reporter and lN-HA-tagged Dm Roquin (full-length or the indicated fragments) in Dm S2 cells. The samples were analysed as described in a,b.
(h,i) Tethering assay using the F-Luc-5BoxB reporter and lN-HA-tagged Dm Roquin in Dm S2 cells depleted of NOT1 or in control cells (treated with a
dsRNA targeting GST). The samples were analysed as described in a,b. The efficacy of the depletion is shown in Supplementary Fig. 1i. Error bars represent
s.d. from three independent experiments. Full images of western and northern blottings are shown in Supplementary Fig. 12.
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a three-helix bundle domain (CN9BD, yellow), a connector domain (CD, light blue) and a NOT1 superfamily homology domain (SHD, grey), which also
consists of HEAT repeats. The positions of the other subunits indicate their binding sites on NOT1. (b) MBP pulldown assay showing the interaction of
MBP-tagged Dm Roq-C with purified pentameric NOT1-2-3-7-9 complex, the indicated NOT1 domains and CCR4-NOT subcomplexes. MBP served as a
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images of protein gels are shown in Supplementary Fig. 13.
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We next tested whether the interaction with CAF40 is also
observed for the human Roquin proteins. We observed that
Hs CAF40 interacts directly with the C-terminal region of
Hs Roquin1 (Supplementary Fig. 5b); however, more detailed
mapping to identify a single CBM was unsuccessful, thus
suggesting the presence of multiple binding sites.
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The CBM contributes to the activity of Dm Roquin. To assess
the relative contribution of the CBM and the NBM to the binding
of Dm Roquin to the CCR4-NOT complex and to the repressive
activity of Dm Roquin, we deleted these motifs from the protein
and performed co-immunoprecipitations and tethering assays in
Dm S2 cells and human HEK293T cells. Deletion of the CBM
abolished the interaction of full-length Dm Roquin with the Dm
CAF40-CN9BD module in S2 cells (Fig. 5a, lane 8). However, this
deletion did not affect the binding of Dm Roquin to NOT2 or
NOT3 (Fig. 5b,c, lane 8). Deletion of the NBM had no effect on
CAF40, NOT2 or NOT3 binding (Fig. 5a–c, lane 9), consistent
with the observation that Dm Roquin harbours multiple binding
sites for the NOT module. Accordingly, deletion of the CBM and
NBM in the context of Roq-C reduced but did not abolish the
activity of this fragment in tethering assays (Fig. 5d,e,
Supplementary Fig. 5c–e).
Similarly, in human cells, deletion of the CBM abolished the
interaction of full-length Dm Roquin with the CAF40-CN9BD
module (Fig. 5f, lane 8), indicating that the CBM represents the
only binding site for CAF40 in Dm Roquin. Importantly, deletion
of the CBM also abolished the interaction of full-length Dm
Roquin with the endogenous CCR4-NOT complex in human cells
(Fig. 5g, lane 8). In agreement with these results, deletion of the
CBM reduced the ability of Dm Roquin to degrade b-globin-
6xMS2bs and b-globin-TNF-a mRNAs (Fig. 5h–l). Furthermore,
depletion of CAF40 partially suppressed the activity of Hs
Roquin1, Hs Roquin2 and Dm Roquin in tethering assays
(Supplementary Fig. 6a–c), indicating that CAF40 is indeed an
important recruitment factor, but other, redundant interactions
compensate for the lack of CAF40 in Dm and human cells.
In summary, the interaction of the CBM with CAF40
contributes to the recruitment of the CCR4-NOT complex by
Dm Roquin. However, the observation that deletion of the NBM
and CBM have little effect on the activity of full-length Dm
Roquin in S2 cells probably indicates that Dm Roquin establishes
additional uncharacterized interactions with the CCR4-NOT
complex or additional binding partners to regulate mRNA
targets.
Crystal structure of the Dm Roquin CBM bound to CAF40. To
elucidate the molecular principles underlying the recruitment of
CAF40 by Dm Roquin, we sought to determine the crystal
structure of the CBM peptide bound to the Dm and Hs CAF40
ARM domains, which exhibit 81% identity (Supplementary
Fig. 7). However, only the complex containing Hs CAF40
yielded well-diffracting crystals, from which we obtained a
structure at 2.15 Å resolution (Table 1). Two copies of the
complex, which are structurally highly similar, are present in the
crystal asymmetric unit (Supplementary Fig. 8a,b; root-mean-
square deviation (r.m.s.d.) 0.24 Å over 254 Ca atoms).
As previously described, the CAF40 ARM domain consists of
17 a-helices arranged into six armadillo (ARM) repeats. These
repeats adopt the typical crescent-like shape of ARM domains
(Fig. 6a–c)2,3,37, with the concave surface that accommodates the
CBM peptide (residues 790–810). The CBM peptide folds into an
amphipathic helix (residues 795–810) that runs centrally across
the concave surface of CAF40 and binds to a conserved
hydrophobic patch close to the previously postulated nucleic
acid-binding groove (Fig. 6d–f)37.
Table 1 | Data collection and refinement statistics.
CAF40–DmCBM
Data collection
Space group P21
No. of reflections 34,975
Cell dimensions
a, b, c (Å) 56.9, 103.7, 60.8
a, b, g () 90.0, 113.0, 90.0
Wavelength (Å) 1.00001
Resolution (Å) 46.8–2.15 (2.20–2.15)*
Rsym 0.048 (0.52)
I/sI 13.6 (2.2)
Completeness (%) 98.7 (98.8)
Redundancy 2.9 (2.7)
Refinement
Resolution (Å) 46.7–2.15
No. of reflections 34,964
Rwork/Rfree 18.4%/22.6%
No. of atoms 4,905
Protein 4,678
Water 191
Other solvent molecules 36
B-factors (Å2) 60.0
Protein 60.0
Water 52.4
Other solvent molecules 102.5
Ramachandran plot
Favoured regions (%) 98.8
Disallowed regions (%) 0.0
r.m.s. deviations
Bond lengths (Å) 0.004
Bond angles () 0.597
*Values in parentheses are for the highest-resolution shell.
Figure 5 | The CBM contributes to the mRNA degradation activity of Dm Roquin. (a–c) Immunoprecipitation assays showing the interaction of
GFP-tagged Dm Roquin (wild-type or the indicated deletion mutants) with HA-tagged CAF40, NOT2 and NOT3 in Dm S2 cells. In (a) the interaction was
tested in the presence of HA-tagged CN9BD. GFP-tagged firefly luciferase (F-Luc) served as a negative control. Input and immunoprecipitates were
analysed using anti-GFP and anti-HA antibodies. For the GFP-tagged proteins, 3% of the input and 10% of the immunoprecipitates were loaded. For the
HA-tagged proteins, 1% of the input and 30% of the immunoprecipitates were analysed. In all panels, the cell lysates were treated with RNase A prior to
immunoprecipitation. (d,e) Tethering assay using the F-Luc-5BoxB reporter and lN-HA-tagged Dm Roq-C or the indicated deletion mutants in Dm S2 cells.
The samples were analysed as described in Fig. 3a,b. The corresponding control experiment with a F-Luc reporter lacking the BoxB sites and a western
blotting showing the equivalent expression of the tethered proteins are shown in Supplementary Fig. 5c–e. (f,g) Interaction of V5-SBP-tagged Dm Roquin
(full-length or the indicated deletion mutants) with HA-tagged CAF40 (in the presence of the HA-tagged CN9BD) and with endogenous NOT1, NOT2 and
NOT3 in HEK293T cells. A V5-SBP-tagged MBP-F-Luc-GFP fusion served as a negative control. The inputs (0.75% for V5-SBP-tagged proteins and 1% for
NOT1, 2, 3) and bound fractions (5% for SBP-V5-tagged proteins and 30% for NOT1, NOT2 and NOT3) were analysed by western blotting. (h,i) Tethering
assay using the b-globin-6xMS2bs reporter and the indicated MS2-HA-tagged proteins in HEK293T cells. The samples were analysed as described in
Fig. 1e–j. (j,k) The effect of full-length Dm Roquin or the indicated deletion mutants on the expression of the b-globin-TNF-a mRNA reporter was analysed
as described in Fig. 1k,l. (l) Western blotting analysis showing comparable expression of the MS2-HA-tagged proteins used in h–k. The asterisk indicates
cross-reactivity with the anti-HA antibody. Error bars represent s.d. from three independent experiments. Full images of western and northern blottings are
shown in Supplementary Fig. 14.
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Superposition of the CAF40-CBM complex with the structure
of the CAF40 dimer37 (r.m.s.d. of 0.87 Å over 260 Ca atoms;
PDB 2FV2) or with that of CAF40 bound to the NOT1
CN9BD (r.m.s.d. of 0.59 Å over 254 Ca atoms, PDB 4CRV)2
shows that binding of the CBM peptide does not induce
major conformational changes in the CAF40 ARM domain
(Supplementary Fig. 8c,d). Importantly, binding of the CBM does
not interfere with NOT1 binding (Fig. 6c), suggesting that Dm
Roquin can interact with CAF40 in the context of the CCR4-NOT
complex. Finally, binding of the CBM does not block access to the
tryptophan-binding pockets on the convex surface of CAF40 that
serve as binding sites for the GW182/TNRC6 proteins involved in
miRNA-mediated gene silencing (Fig. 6c)2,3.
The amphipathic helix of the CBM peptide lies almost parallel
to helices a5, a8 and a11 and it uses residues M798, L801, L805,
I808 and V809 on its hydrophobic side to interact with CAF40
residues Y134, L137, G141, G144 and A145 (helix a8) and L177,
T180, V181 and F184 (helix a11; Fig. 6g,h and Supplementary
Fig. 8e,f). Furthermore, I793 anchors the N-terminal extension of
the CBM helix between CAF40 residues A84, R130, P131 and
Y134, resulting in a total buried surface of 1903 Å2 that does not
include any water molecules (Fig. 6h). Finally, the CBM peptide is
fixed by two hydrogen bonds between N804 and the CAF40
residue Q98 (helix a5) and by a hydrogen bond from CAF40 N88
(helix a5) to the carbonyl oxygen of G791 (Fig. 6g). The CAF40
residues R130 and K148 may have additional roles in anchoring
the CBM peptide, but they have distinct orientations in the two
copies of the complex.
CCR4-NOT is recruited via the concave surface of CAF40. To
validate the interfaces determined from the crystal structure,
we introduced mutations in CBM and CAF40 and tested them
in MBP pulldown assays in vitro. Substitution of Dm Roquin
interface residues L805 and V809 by glutamic acid (mutant M2)
and the further introduction of I793E and L801E substitutions to
create a quadruple mutant (mutant M4) abolished the interaction
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of the MBP-tagged Roq-CC with purified Hs CAF40 in vitro
(Fig. 7a, Supplementary Table 1). Conversely, a single V181E
substitution in Hs CAF40 or substitution of residues Y134 and
G141 by aspartic acid and tryptophan, respectively, abolished the
interaction of Hs CAF40 with MBP-Roq-CC (Fig. 7b,
Supplementary Table 1). In contrast, mutation of the concave
surface of CAF40 was not sufficient to disrupt the interaction
with Hs Roq1-C (Supplementary Fig. 5b). Thus, although Hs
Roq1-C binds to CAF40 directly, it must contact additional
and/or alternative CAF40-binding surfaces.
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Figure 7 | The CBM is the only CAF40-binding site in Dm Roquin. (a) In vitro MBP pulldown assay showing the interaction of MBP-tagged Dm Roq-CC
and the indicated mutants (M2 and M4; see Supplementary Table 1) with the purified Hs CAF40-ARM domain. MBP served as a negative control.
(b) In vitro MBP pulldown assay showing the interaction of MBP-tagged Dm Roq-CC with the Hs CAF40-ARM domain (wild-type or the indicated mutants).
(c) Interaction of GFP-tagged Dm Roquin (wild-type or the M1, M2, M3 and M4 mutants; see Supplementary Table 1) with HA-tagged CAF40 in the
presence of the HA-tagged CN9BD in Dm S2 cells. F-Luc-GFP served as a negative control. (d) Interaction of GFP-tagged Dm Roquin wild-type with
HA-tagged CAF40 (wild-type or the indicated mutants) in the presence of the HA-tagged CN9BD in Dm S2 cells. (e) Interaction of GFP-tagged Dm CAF40
(wild-type or mutants) with HA-tagged CN9BD in Dm S2 cells. (f,g) A tethering assay using the F-Luc-5BoxB reporter and lN-HA-tagged Dm Roquin,
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shown in f. Error bars represent s.d. from three independent experiments. Full images of western and northern blottings are shown in Supplementary Fig. 15.
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The residues in CAF40 that interact with the Dm Roquin CBM
peptide are conserved in Hs and Dm (Fig. 6d, Supplementary
Fig. 7), suggesting that the CBM interacts with Dm CAF40 via a
similar binding mode. Nevertheless, it was important to test
whether Dm Roquin binds to the concave surface of Dm
CAF40. All tested mutations in the CBM (M1, M2, M3 and
M4; Supplementary Table 1) were sufficient to disrupt the
interaction of full-length Dm Roquin with Dm CAF40 in
co-immunoprecipitation assays in Dm S2 cells (Fig. 7c,
lanes 9–12), confirming that the CBM is the only motif in
Dm Roquin that mediates binding to CAF40. Conversely,
substitutions in Dm CAF40 corresponding to the mutations of
Hs CAF40 shown in Fig. 7b abolished the interaction of
full-length Dm CAF40 with full-length Dm Roquin (Fig. 7d).
The mutations in CAF40 did not abolish its binding to NOT1
CN9BD, indicating that they do not disrupt the CAF40 fold
(Fig. 7e).
Notably, mutations in the CBM did not disrupt the interaction
of full-length Dm Roquin with NOT2 or NOT3 in Dm S2 cells
(Supplementary Fig. 9a,b), in agreement with the observation that
Dm Roquin contains multiple sequences that mediate binding to
the CCR4-NOT complex in a redundant manner. Consistent with
this redundancy, mutations in the CBM abolished the activity of
the Roq-CC fragment in tethering assays in Dm S2 cells but
impaired the activity of full-length Dm Roquin only slightly
(Fig. 7f,g, Supplementary Fig. 9c–e). In contrast, when it was
tested in human cells, mutations in the Dm Roquin CBM not only
abolished interaction with CAF40 but strongly reduced the
interaction with the endogenous CCR4-NOT complex (Fig. 8a,b)
indicating that the CBM provides a major contribution to the
interaction of Dm Roquin with the CCR4-NOT complex in
human cells. Accordingly, the CBM mutants strongly reduced the
ability of Dm Roquin to degrade the b-globin-TNF-a reporter
containing the CDE-37 element in the 30-UTR in human
HEK293T cells (Fig. 8c–e).
Discussion
In this study, we show that Roquin proteins (Hs Roquin1,
Hs Roquin2, Dm Roquin) use their C-terminal extensions to
directly recruit the CCR4-NOT complex to mRNA targets,
promoting the degradation of these mRNAs. We show that this
function is conserved among Roquin proteins despite the fact that
the sequences of the unstructured C-terminal regions of these
proteins are highly divergent and do not share similar motifs.
In Dm Roquin, the interaction with the CCR4-NOT complex is
mediated by multiple and partially redundant motifs that include
a CBM. We further elucidated the structural basis of the
interaction of the CBM with CAF40 and identified the concave
surface of CAF40 as a target for amphipathic helices to recruit the
CCR4-NOT complex.
The finding that Roquin proteins use a combination of SLiMs
(or eukaryotic linear motifs)38 to recruit the CCR4-NOT complex
has important functional implications. First, although SLiMs
mediate relatively low-affinity interactions, these interactions can
be highly specific, and stable binding can be achieved through
avidity effects generated by contributions from the flanking
disordered regions that extend the interaction interface38,39. In
the case of Dm Roquin, the sequences flanking the CBM provide
binding sites for the NOT module, indicating that the C-terminal
region of Dm Roquin contacts multiple subunits within the
CCR4-NOT complex.
A second consequence of the nature of SLiMs is their
evolutionary plasticity38,39. Owing to their short length and lack
of sequence constraints in the absence of a protein fold, even
single point mutations can render an existing motif nonfunctional
or generate a new motif in another location of the same protein.
In particular, the CBM is present in Drosophila species, but
sequence analysis of Roquin proteins from other insects, worms
and vertebrates does not reveal a detectable CBM. Nevertheless,
Hs Roquin1 and Roquin2 also interact with the CCR4-NOT
complex via their unstructured C-terminal regions (ref. 10 and
this study), indicating that the overall principle of CCR4-NOT
complex recruitment and mRNA target repression is
evolutionarily conserved even though the interaction details
have diverged across species.
In addition to the previously identified tryptophan-binding
pockets on the CAF40 convex surface2,3, our crystal structure
demonstrates that the concave surface of CAF40 is also used to
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Figure 8 | The CBM mediates the activity of Dm Roquin in human cells.
(a) SBP pulldown assays in HEK293T cell lysates showing the interaction
of V5-SBP-tagged Dm Roquin (full-length or the M4 mutant) with
HA-tagged CAF40-MBP in the presence of CN9BD-HA. A V5-SBP-tagged
MBP-F-Luc-GFP fusion served as a negative control. The presence of the
HA-tagged proteins in the bound fractions was tested by western blotting
using anti-HA antibodies. The samples were analysed by western blotting
as described in Fig. 5f. (b) SBP pulldown assays in HEK293T cell lysates
showing the interaction of V5-SBP-tagged Dm Roquin (full-length or the
M4 mutant) with endogenous NOT1, NOT2 and NOT3. A V5-SBP-tagged
MBP-F-Luc-GFP fusion served as a negative control. The samples were
analysed by western blotting as described in Fig. 1b–d. (c,d) The effect
of Dm Roquin full-length or the M4 mutant on the expression of the
b-globin-TNF-a mRNA reporter was analysed in HEK293T cells as
described in Fig. 1k,l. Error bars represent s.d. from three independent
experiments. (e) Western blotting analysis showing the equivalent
expression of the proteins used in the tethering assays shown in c,d.
Full images of western and northern blottings are shown in Supplementary
Fig. 16.
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recruit the CCR4-NOT complex by RNA-associated proteins.
The hydrophobic properties of the concave surface are highly
conserved, making it an ideal partner for amphipathic helices or
disordered, short hydrophobic peptides that are frequently
present in RNA-binding proteins.
Therefore, the C-terminal regions of Hs Roquin1 and Roquin2
may also target this surface of CAF40, although no clear CBM
motifs are detectable by sequence analysis. However, the proteins
may contain ‘cryptic’ CBMs that are likely discontinuous and
probably also target neighbouring surfaces on CAF40 because
mutations affecting the concave surface of Hs CAF40 did not
disrupt its interaction with the Hs Roquin1 C-terminal fragment.
In addition to the Roquin proteins, a large number of
RNA-associated proteins have been shown to recruit the
CCR4-NOT complex to their mRNA targets, thereby repressing
translation and/or promoting mRNA degradation. These include
GW182 proteins, TTP, Nanos and the Dm proteins CUP,
Bicaudal C, Smaug and Pumilio2,3,6,8,9,40–44. For most of these
proteins, it has been shown that interaction with the CCR4-NOT
complex is mediated by SLiMs embedded in peptide regions of
predicted disorder. However, detailed characterization of the
binding mode on the structural level is only available for TTP,
GW182, vertebrate and Dm Nanos and Dm Roquin (refs 2,3,6,8,9
and this study). Similar to Roquin, Dm Nanos, GW182 proteins
and TTP all contain multiple binding sites for different subunits
of the CCR4-NOT complex that act redundantly to recruit the
complex to mRNA targets. This modular recruitment mode likely
enhances the binding affinity and confers redundancy and
robustness to the repression mechanism.
As observed for Roquin, the motifs in TTP and vertebrate and
Dm Nanos, which have been structurally characterized, adopt an
a-helical conformation that possibly forms only upon binding
(refs 6,8,9 and this study). In contrast, GW182 peptides likely
bind to the CCR4-NOT complex in an extended conformation
and insert tryptophan residues into tandem hydrophobic pockets
exposed at the convex surface of CAF40 and into additional
pockets in NOT1 that remain to be identified2,3.
Because Dm Roquin and GW182 proteins can bind CAF40
simultaneously (Fig. 6c), it is possible that the proteins cooperate
to recruit the CCR4-NOT complex to mRNAs. The presence of
multiple CCR4-NOT-binding partners on an mRNA likely
enhances the efficiency of recruitment and the extent of the
regulation.
In summary, together with previous studies2,3,6,8,9, our results
indicate that SLiMs in unstructured and poorly conserved regions
of RNA-associated proteins represent a common and widespread
mode of recruitment of the CCR4-NOT complex to mRNA
targets, resulting in a common downstream repressive
mechanism that has a major role in posttranscriptional mRNA
regulation in eukaryotic cells.
Methods
DNA constructs. Luciferase reporters and plasmids for the expression of
GFP- and HA-tagged subunits of the CCR4-NOT and PAN2-PAN3 deadenylase
complexes and decapping factors in S2 cells were previously described35,45,46.
Dm Roquin cDNA was purchased from the Drosophila Genomics Resource Center,
amplified by PCR and inserted into the HindIII and NotI restriction sites of the
pAc5.1-lN-HA or pAc5.1-GFP vectors. For expression in HEK293T cells, the
cDNA encoding Dm Roquin was inserted into the NotI and ApaI restriction sites of
the pcDNA3.1-MS2-HA vector33 and between the HindIII and KpnI sites of the
pT7-V5-SBP-C1 vector47.
A cDNA sequence encoding Hs Roquin1 open-reading frame was amplified by
PCR from human HEK293T cell total cDNA and inserted between the EcoRI and
SacII sites of the pT7-V5-SBP-C1 vector and between the NotI and ApaI sites of
the pcDNA3.1-MS2-HA vector. A cDNA encoding Hs Roquin2 open-reading
frame was amplified by PCR from human HeLa cell total cDNA and inserted
between the BamHI and NotI restriction sites of the pcDNA3.1-MS2-HA vector
and between the SalI and BamHI restriction sites of the pT7-V5-SBP-C1 vector.
b-Globin reporters containing the wild-type or mutant (MUT16) TNF-a CDE
were obtained by replacing the 6xMS2-binding sites in vector b-globin-6xMS2bs33
with the CDE-37 (TTGGCTCAGACATGTTTTCCGTGAAAACGGAGCTGAA)
or CDE-37-MUT16 (TTGGCTCAGACATGTTTTCCGTGAAATGGGAGCT
GAA) sequences10.
For expression of recombinant proteins in E.coli, cDNAs encoding Hs Roq1-C
and Dm Roquin fragments were inserted between the AflII and AvrII and the AflII
and XbaI restriction sites of the pnYC-pM plasmid48, respectively, resulting in
Roquin fusion proteins carrying N-terminal MBP tags that are cleavable by
HRV3C protease. The Roq-C and Roq-CC cDNAs and all of the constructs derived
from them also contain a C-terminal GB1 tag49 followed by a MGSS linker and a
6xHis tag.
A cDNA encoding Dm CAF40 was inserted between the NdeI and XbaI
restriction sites of the pnEA-pM plasmid48, generating a fusion protein containing
an N-terminal MBP tag cleavable by the HRV3C protease.
For purification of the pentameric NOT1-2-3-7-9 complex, a cDNA encoding
human NOT1 (residues 1093–2371) was inserted between the XhoI and BamHI
restriction sites of the pnYC-pM vector, resulting in a fusion protein containing an
N-terminal MBP-tag. A multicistronic plasmid was generated by inserting an
expression cassette containing 6xHis-NOT3-C, MBP-NOT2-C, 6xHis-CAF40-
ARM and GST-NOT7 (all tags except the CNOT3 6xHis tag are cleavable by
HRV3C protease) into the pnEA vector.
A cDNA encoding NOT1-CD (residues 1607–1815) was inserted between the
XhoI and BamHI restriction sites of the pnYC-pM plasmid48, generating a fusion
protein containing an N-terminal MBP tag cleavable by HRV3C protease.
Plasmids for the expression of NOT1-MIF4G, NOT1-CN9BD, NOT1-SHD,
NOT2-C, NOT3-C, NOT7 and CAF40-ARM have been previously described2,5,50.
The DNA constructs used in this study are listed in Supplementary Table 1.
Co-immunoprecipitation and SBP-pulldown assays. For co-immunoprecipita-
tion assays in S2 cells (ATCC), 2.5 106 cells were seeded per well in six-well plates
and transfected using Effectene transfection reagent (Qiagen). The transfection
mixtures contained 1 mg of plasmid expressing HA-tagged deadenylase or
decapping factors and 1.5 mg of GFP-tagged Roquin (either full length or
fragments). S2 cells were harvested 3 days after transfection and co-immunopre-
cipitation assays were performed as previously described51.
For SBP pulldown assays in human cells, HEK293T cells (ATCC) were grown in
10-cm dishes and transfected using TurboFect transfection reagent (Thermo Fisher
Scientific). The transfection mixtures contained 6, 30 and 2 mg of plasmids
expressing Hs Roquin1, Hs Roquin2 and Dm Roquin, respectively. In the
experiment shown in Fig. 1c, the transfection mixture contained 25 mg of plasmids
expressing Hs Roquin2 and Roq2-N and 12 mg of a plasmid expressing Roq2-C.
In the experiment shown in Fig. 1d, the transfection mixtures contained 15, 20 and
25 mg of plasmids expressing Dm Roquin, Roq-N and Roq-C, respectively. In the
experiments shown in Fig. 5f,g, 10mg of plasmids expressing Dm Roquin, DCBM
and DNBM and 15 mg of plasmid expressing Dm Roquin DCBMþNBM were
included. In the experiments shown in Fig. 8a,b, 10 mg of the Dm Roquin and
Dm Roquin M4 plasmids was transfected. In the experiments shown in Figs 5f
and 8a, the transfection mixtures contained 7.5 mg of a plasmid expressing
CAF40-HA-MBP and 5mg of a plasmid expressing CN9BD-HA. In the
experiments shown in Supplementary Fig. 1a, the transfection mixtures contained
1 mg of plasmids expressing Hs Roquin1 and Roq1-C and 10mg of a plasmid
expressing Roq1-N. Human cells were harvested 2 days after transfection, and
co-immunoprecipitation assays were performed as previously described8. Western
blottings were developed using the ECL Western Blotting Detection System
(GE Healthcare) according to the manufacturer’s recommendations. The
antibodies used in this study are listed in Supplementary Table 2.
Tethering assays in human and S2 cells and RNA interference. Tethering
assays in human HEK293T cells using the b-globin reporter containing six
MS2-binding sites (6xMS2bs)33 were performed as previously described8. Briefly,
cells were seeded in six-well plates (0.8 106 cells per well) and transfected using
Lipofectamine 2000 (Thermo Fisher Scientific).
The transfection mixtures contained 0.5 mg of the control plasmid (containing
the b-globin gene fused to a fragment of the GAPDH gene but lacking
MS2-binding sites)33, 0.5 mg of the b-globin-6xMS2bs reporter and varying
amounts of pcDNA3.1-MS2-HA plasmids expressing MS2-HA-tagged proteins.
The plasmid amounts were as follows: for Hs Roquin1, 0.6 mg full length and 0.5 mg
each Roq1-N and Roq1-C; for Hs Roquin2, 1.5 mg full length, 0.6 mg Roq2-N and
0.3 mg Roq2-C; for Dm Roquin, 0.3 mg full length, 0.1 mg each Roq-N and Roq-C,
0.2 mg each Roq-DCBM and DNBM and 0.3 mg Roq-DCBMþNBM. In the
experiment shown in Fig. 2a,b, 0.175 mg of Dm Roquin, 0.4 mg of Hs Roquin1 and
1 mg of Hs Roquin2 were transfected. The transfection mixtures also contained
plasmids expressing GFP (0.2 mg) or a GFP-tagged catalytically inactive DCP2
mutant (1.5 mg), as indicated.
When the b-globin-TNF-a reporter was used, cells were co-transfected with
0.5 mg b-globin-TNF-a reporter (CDE37 wild-type or MUT16; ref. 10) and
plasmids expressing the HA-MS2 tagged proteins (Hs Roquin1: 0.5 mg full-length,
0.4 mg each Roq1-N and Roq1-C; Dm Roquin: 0.2 mg full-length, 0.1 mg each
Roq-N, Roq-C, DCBM and DNBM and 0.2 mg DCBMþDNBM). In the
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experiments shown in Fig. 8c–e, the cells were transfected with 0.05 mg of Dm
Roquin and Dm Roquin M4. Cells were harvested 2 days after transfection.
For the lN-tethering assay in Dm S2 cells, 2.5 106 cells per well were seeded
in six-well plates and transfected using Effectene (Qiagen). The transfection
mixtures contained 0.1 mg firefly luciferase reporter (F-Luc-5BoxB, F-Luc-V5 or
F-Luc-5BoxB-A95C7-HhR), 0.4 mg Renilla luciferase transfection control and
various amounts of plasmids expressing lN-HA-tagged Dm Roquin constructs
(0.01 mg full-length, 0.003 mg Roq-N, 0.025 mg Roq-C, 0.05 mg GST-Roq-CN, and
0.02 mg GST-Roq-CC). In the experiment described in Fig. 7f,g and Supplementary
Fig. 9c–e, half of these amounts were transfected. In the experiment described in
Supplementary Fig. 3g,h, the GST tags were replaced by GFP tags and 0.02 mg
GFP-Roq-CN, and 0.005 mg GFP-Roq-CC were transfected. Cells were harvested
3 days after transfection.
NOT1 knockdowns using dsRNA were performed as previously described35.
To measure the mRNA half-life, cells were treated with actinomycin D (5 mg ml 1
final concentration) 3 days after transfection and collected at the indicated time
points. RNA samples were analysed by northern blotting. The level of reporter
mRNA was normalized to the levels of endogenous rp49 mRNA in three
independent experiments, averaged and plotted against time. The data were fitted
to a double exponential decay function prior to averaging. The reported half-lives
(t1/2) correspond to 50% decay with respect to the initial amount of reporter RNA.
Half-life errors are calculated from the standard fitting error.
Knockdowns in HeLa cells (provided by O. Mühlemann) were performed as
described previously2. The 19 nt target sequences are as follows: control 50-ATT
CTCCGAACGTGTCACG-30 , CAF40 50-GATCTATCAGTGGATCAAT-30 . Cells
were transfected in six-well plates using Lipofectamine 2000 according to the
manufacturer’s protocol. Transfection mixtures contained 0.2 mg of Dm Roq-C;
0.3 mg of Hs Roq1-C and 0.4 mg of Hs Roq2-C.
Firefly and Renilla luciferase activities were measured using a Dual-Luciferase
Reporter Assay system (Promega). Northern blotting was performed as previously
described35.
Protein expression and purification. All recombinant proteins were expressed in
E. coli BL21 (DE3) Star cells (Invitrogen) in LB medium at 20 C overnight. Dm
Roquin fragments were expressed as fusion proteins containing N-terminal MBP
tags cleavable by HRV3C protease48. In addition, the Dm Roq-C, -CN and -CC
fragments carried an HRV3C-cleavable C-terminal GB1-6xHis tag49. The cells were
lysed using an Avestin Emulsiflex-C3 homogenizer in lysis buffer (50 mM HEPES-
NaOH (pH 7.5), 200 mM NaCl, 20 mM imidazole and 2 mM b-mercaptoethanol)
supplemented with complete EDTA-free protease inhibitors (Roche), 5 mg ml 1
DNaseI and 1 mg ml 1 lysozyme. The proteins were separated from the crude
lysate using amylose resin (New England Biolabs) and subsequently eluted from
the resin in lysis buffer containing 25 mM D-(þ )-maltose. The proteins containing
a GB1-6xHis tag were further purified by nickel affinity chromatography using a
HiTrap IMAC column (GE Healthcare). Proteins without GB1-6xHis tags were
further purified by anion exchange chromatography using a HiTrapQ column
(GE Healthcare). The final purification step for all proteins was size exclusion
chromatography using a Superdex 200 16/600 column (GE Healthcare) in a buffer
containing 10 mM HEPES-NaOH (pH 7.5), 200 mM NaCl and 2 mM DTT.
Hs CAF40 (residues 19–285) was expressed with a 6xHis tag cleavable by the
HRV3C protease. Lysis was carried out in lysis buffer containing 50 mM potassium
phosphate (pH 7.5), 500 mM NaCl, 10% glycerol, 20 mM imidazole and 2 mM
b-mercaptoethanol supplemented with complete EDTA-free protease inhibitors,
DNaseI and lysozyme. The Hs 6xHis-CAF40 ARM domain was isolated from the
lysate using a HiTrap IMAC column (GE Healthcare). The 6xHis tag was removed
by cleavage using HRV3C protease during dialysis in low salt buffer containing
50 mM Tris-HCl (pH 7.5), 150 mM NaCl and 1 mM DTT. Subsequently, Hs
CAF40 was further purified using a HiTrap Heparin column (GE Healthcare)
followed by gel filtration on a Superdex 200 26/600 column (GE Healthcare) in
gel filtration buffer containing 20 mM Tris-HCl (pH 7.5), 150 mM NaCl and
1 mM DTT.
Dm CAF40 (residues 25–291) was expressed with an N-terminal MBP tag. The
cells were lysed in a buffer containing 50 mM HEPES-NaOH (pH 7.5), 500 mM
NaCl and 2 mM DTT supplemented with complete EDTA-free protease inhibitors,
DNaseI and lysozyme. The protein was isolated from the crude lysate using
amylose resin followed by anion exchange chromatography using a HiTrapQ
column (GE Healthcare). The MBP tag was removed by cleavage with HRV3C
protease during dialysis in a buffer containing 10 mM potassium phosphate
(pH 8.0), 400 mM NaCl, 10% glycerol, 50 mM ammonium sulfate and 2 mM DTT.
The final purification step was size exclusion chromatography using a Superdex
200 26/600 column equilibrated with the same buffer.
The pentameric human NOT1-2-3-7-9 complex was obtained by co-expression
of MBP-NOT1 (residues 1093–2371), MBP-NOT2-C, 6xHis-NOT3-C, GST-NOT7
and 6xHis-CAF40-ARM. The cells were lysed in buffer containing 50 mM
potassium phosphate (pH 7.5), 300 mM NaCl and 2 mM DTT supplemented with
complete EDTA-free protease inhibitors, DNaseI and lysozyme. The complex was
purified using amylose resin, and the tags were removed by cleavage with HRV3C
protease during dialysis in buffer containing 20 mM HEPES-NaOH (pH 7.5),
100 mM NaCl, 5% glycerol and 2 mM DTT. The complex was further purified
using a HiTrap Heparin column (GE Healthcare) followed by size exclusion
chromatography on a Superdex 200 26/600 column equilibrated in 20 mM
HEPES-NaOH (pH 7.5), 300 mM NaCl, 5% glycerol and 2 mM DTT.
To purify the complex containing 6xHis-NOT1-MIF4G (residues 1093–1317)
bound to MBP-CAF1, cells coexpressing the proteins were lysed in a buffer
containing 50 mM HEPES-NaOH (pH 7.5), 300 mM NaCl, 20 mM imidazole and
2 mM b-mercaptoethanol supplemented with complete EDTA-free protease
inhibitors, DNaseI and lysozyme. The complex was isolated from the crude lysate
using amylose resin followed by chromatography on a HiTrap IMAC column. The
affinity tags were removed by cleavage using the HRV3C protease, followed by final
size exclusion chromatography on a Superdex 200 26/600 column in a buffer
containing 10 mM HEPES-NaOH (pH 7.5), 200 mM NaCl and 2 mM DTT.
The NOT1 CD (residues 1607–1815) was expressed with an N-terminal MBP
tag. The cells were lysed in a buffer containing 50 mM HEPES (pH 7.5), 300 mM
NaCl and 2 mM DTT supplemented with complete EDTA-free protease inhibitors,
DNaseI and lysozyme. The protein was isolated from the lysate using amylose resin
followed by a HiTrapQ column. The MBP tag was removed by cleavage with
HRV3C protease, followed by final size exclusion chromatography on a Superdex
200 26/600 column using a buffer containing 10 mM HEPES-NaOH (pH 7.5),
200 mM NaCl and 2 mM DTT.
Purification of the Hs NOT module comprising NOT1-SHD (residues
1833–2361), NOT2-C (residues 350–540) and NOT3-C (residues 607–748) and
the complex comprising NOT1-CN9BD (residues 1356–1588) bound to the
CAF40-ARM has been previously described2,9.
The Dm Roquin CBM peptide (residues 790–810) used for crystallization was
synthesized by EMC Microcollections. The peptide was dissolved in 20 mM
Tris-HCl (pH 7.5), 150 mM NaCl and 1 mM DTT.
Crystallization. Dm Roquin CBM was mixed with the purified Hs CAF40 ARM
domain in an equimolar ratio. Initial crystallization screens were carried out
using the sitting drop vapor diffusion method at 22 C by mixing 200 nl of the
CAF40-Roquin complex solution (at 6.75 mg ml 1) with 200 nl of reservoir
solution. Crystals appeared within 1 day under several conditions. Optimized
crystals grew at 18 C after 1 day using hanging drops after mixing 0.8 ml of the
CAF40-Roquin complex solution (at 2.25 mg ml 1) with 0.8 ml of reservoir
solution containing 0.1 M NaOAC (pH 5.0), 17.5% (w v 1) PEG 4000 and 0.1 M
AmSO4. Crystals were cryoprotected using reservoir solution supplemented with
15% glycerol and flash-frozen in liquid nitrogen.
Data collection and structure determination. Diffraction data were collected on
a PILATUS 6M detector (Dectris) at the PXII beamline of the Swiss Light Source.
The best data set extending to a resolution of 2.15 Å was recorded at a wavelength
of 1.000 Å and processed in space group P21 using XDS and XSCALE52. Two
copies of the CAF40 ARM domain (PDB-ID 2FV2, chain A) were found in the
asymmetric unit by molecular replacement using PHASER53 from the CCP4
package54. This initial model was improved by iterative cycles of model building in
COOT55 and refinement using PHENIX56. As the final step, two Roquin CBM
peptides were modeled into the density and improved by further refinement cycles.
The final model was refined with excellent stereochemistry to Rwork¼ 18.4%
and Rfree¼ 22.6% and includes all residues of the two CAF40 molecules (residues
19–285 plus six residues from the HRV3C cleavage site and linker sequences;
chains A and C) and all residues (790–810) of the Roquin peptides for both chains
(B and D). For the C-terminal two pairs of a-helices in CAF40, the final atomic
B-factors are clearly above average, pointing to an elevated mobility and/or
statistical disorder in this part of the molecule, which is not involved in binding
the CBM.
In vitro MBP-pulldown assays. Purified MBP (20 mg) or MBP-tagged Roquin
fragments (40 mg) were incubated with equimolar amounts of purified CCR4-NOT
subcomplexes and 50 ml of the amylose resin slurry (New England Biolabs) in 1 ml
of pulldown buffer (50 mM HEPES-NaOH (pH 7.5), 200 mM NaCl, 2 mM DTT).
After a 1-h incubation, the beads were washed five times with pulldown buffer and
the proteins were eluted with pulldown buffer supplemented with 25 mM
D-(þ )-maltose. The eluted proteins were precipitated with trichloroacetic acid
and analysed by SDS-PAGE followed by Coomassie blue staining.
Data availability. The coordinates for the structure of the Dm Roquin CBM
peptide bound to CAF40 were deposited in the Protein Data Bank (PDB) under ID
code 5LSW. The authors declare that the data supporting the findings of this study
and relevant source data are available within the article and its Supplementary
Information file. Other data and materials are available from the authors upon
request.
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Supplementary Figure 1 | The C-terminal regions of Roquin proteins recruit the 
CCR4-NOT complex and trigger degradation of bound mRNA. (a) SBP pulldown 
assays in HEK293T cell lysates showing the interaction of V5-SBP-tagged Hs Roquin1 
(full-length or the indicated fragments) with endogenous NOT1, NOT2 and NOT3. 
Input and immunoprecipitates were analyzed as described in Fig. 1b–d. (b,c) Tethering 
assays using the β-globin-6xMS2bs reporter and MS2-HA-tagged Hs Roquin1 (full-
length or the indicated fragments) in human HEK293T cells. A plasmid expressing a β-
globin mRNA reporter lacking MS2-binding sites (Control) served as a transfection 
control. The β-globin-6xMS2bs mRNA levels were normalized to those of the control 
mRNA and set to 100% in the presence of MS2-HA. The mean values ± s.d. from three 
independent experiments are shown in panel (b). Panel (c) shows a representative 
	   2	  
northern blot. (d) Western blot showing the equivalent expression of the MS2-HA-
tagged proteins used in the tethering assay shown in panels (b,c). (e,f) Effect of Hs 
Roquin1 and Dm Roquin on the expression of the β-globin-TNFα-MUT16 mRNA 
reporter carrying a mutated CDE (MUT16; ref. 10) analyzed as described in Fig. 1k,l. 
(g,h) A tethering assay using the F-Luc-V5 (lacking the 5BoxB sites) reporter in Dm S2 
cells co-expressing λN-HA-Dm Roquin (full-length or the indicated fragments) was 
performed as described in Fig. 3a,b. (g) Mean values ± s.d. from three independent 
experiments. (h) Northern blot of representative RNA samples. (i) Western blot analysis 
of S2 cells depleted of NOT1 corresponding to the experiment shown in Fig. 3h,i. 
Dilutions of control cell lysates were loaded in lanes (1–4) to estimate the efficacy of 
the depletion. Tubulin served as a loading control. KD: knockdown. 
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Supplementary Figure 2 | Dm Roquin interacts with subunits of the deadenylase 
and decapping complexes. (a–o) Co-immunoprecipitation assays showing the 
interaction of GFP-tagged Dm Roquin with the indicated HA-tagged proteins in Dm S2 
cell lysates treated with RNase A. In panels (n) and (o), GFP-tagged DCP1 and HPat, 
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respectively, served as positive controls. In all panels, F-Luc-GFP served as a negative 
control. Protein size markers (kDa) are shown on the right in each panel. 
 
 
Supplementary Figure 3 | The Dm Roquin C-terminal region binds to CAF40 and 
to the NOT-module. (a) In vitro MBP pulldown assay showing the interaction of the 
MBP-tagged Dm Roq-C with the assembled NOT module (NOT1-2-3), the isolated 
NOT1-SHD (NOT1) and the NOT2-NOT3 dimers (NOT2-3). MBP served as a negative 
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control. (b–e) Tethering assays using the F-Luc-5BoxB or the F-Luc-V5 (lacking the 
5BoxB sites) reporters and λN-HA-tagged Dm Roquin (full-length or the indicated 
fragments) were performed in Dm S2 cells as described in Fig. 3a,b. A plasmid 
expressing R-Luc served as a transfection control. F-Luc activity and mRNA levels 
were normalized to those of the R-Luc transfection control and set to 100% in cells 
expressing the λN-HA peptide. Panels (b,d) show mean values ± s.d. of the normalized 
F-Luc activities and mRNA levels from three independent experiments. Panels (c,e) 
show northern blots of representative RNA samples. (f) Western blot analysis showing 
the equivalent expression of the λN-HA-tagged proteins used in panels (b–e). (g) A 
tethering assay using the F-Luc-5BoxB reporter and λN-HA-tagged Dm Roquin (full-
length or the indicated fragments) was performed in Dm S2 cells as described in Fig. 
3a,b. The Dm Roq-CC and Roq-CN contained in addition either a GST or a GFP tag, 
with the purpose of visualization. A plasmid expressing R-Luc served as the 
transfection control. F-Luc activity was normalized to that of the R-Luc transfection 
control and set to 100% in cells expressing the λN-HA peptide. The panel shows mean 
values ± s.d. of the normalized F-Luc activities from three independent experiments. 
The GST or GFP tags do not interfere with the activity of the fragments. (h) Western 
blot analysis showing the equivalent expression of the λN-HA-tagged proteins used in 
the tethering assays shown in panel (g).  
Error bars represent s. d. from three independent experiments. 
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Supplementary Figure 4 | Sequence alignment of the Drosophila Roquin C-
terminal regions. The CBM helix as determined from the crystal structure is indicated 
in red above the sequences. The secondary structure elements as predicted by PSIPRED 
(http://bioinf.cs.ucl.ac.uk/psipred/) are indicated in black. Residues conserved in all of 
the  aligned  sequences  are  shown  with  a  dark green background,  and residues  with 
>70% similarity are highlighted in light green; conservation scores were calculated 
using the SCORECONS webserver1. The sequences required for binding to the NOT 
module (NBM) and the CAF40-binding motif (CBM) are indicated. Residues in the 
CBM that directly contact CAF40 are marked by brown diamonds. Residues that were 
mutated in this study are indicated by red asterisks. The boundary between the CN and 
CC fragments is indicated below the alignment. 
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Supplementary Figure 5 | The CBM contributes to the activity of Dm Roquin. (a) 
In vitro MBP pulldown assay showing the interaction of MBP-tagged Dm Roq-CC, 
Roq-CC-ΔNBM or the NBM alone with the assembled NOT module (NOT1-2-3). MBP 
served as a negative control. (b) MPB pulldown assay showing the interaction of MPB-
tagged Hs Roq1-C with the purified Hs CAF40-ARM domain (wild-type and the 
indicated mutants). MBP served as a negative control. (c,d) A tethering assay using the 
F-Luc-V5 reporter lacking λN binding sites and the indicated λN-HA-tagged Dm 
Roquin fragments was performed in Dm S2 cells as described in Fig. 3a,b. The 
corresponding experiment using the F-Luc-5BoxB reporter is shown in Fig. 5d,e. Error 
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bars represent s.d. from three independent experiments. (e) Western blot showing the 
equivalent expression of the λN-HA-tagged proteins used in panels (c,d) and in Fig. 
5d,e. Protein size markers (kDa) are shown on the right of the panels. 
 
 
Supplementary Figure 6 | Depletion of CAF40 partially suppresses Roquin activity 
in HeLa cells. A tethering assay using the R-Luc-6xMS2bs was performed in HeLa 
cells depleted of CAF40 or treated with a control shRNA (Control). A plasmid 
expressing F-Luc served as a transfection control. For each condition, Renilla luciferase 
activity was measured, normalized to that of the F-Luc transfection control and set to 
100% in cells expressing MS2-HA. (a) Mean values ± s.d. of the normalized R-Luc 
activities from three independent experiments. (b) Western blot analysis showing the 
equivalent expression of the MS2-HA-tagged proteins used in the tethering assay shown 
in panel (a). (c) Western blot showing the efficiency of the CAF40 knockdown. 
Dilutions of control cell lysates were loaded in lanes 1–4 to estimate the efficacy of the 
depletion. Tubulin served as a loading control.  
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Supplementary Figure 7 | Structure-based sequence alignment of CAF40. 
Secondary structure elements as determined by the Hs CAF40-Dm Roquin structure are 
shown above the alignment. Residues conserved in all aligned species are highlighted 
by a brown background, and residues that show conservation of at least 70% are shown 
with an orange background. Conservation scores were calculated using the 
SCORECONS webserver1. Residues that directly contact the Dm Roquin CBM peptide 
are marked by green diamonds. The residues that were mutated in this study are 
indicated by red asterisks. Species abbreviations are as follows:  Hs, Homo sapiens; Dm, 
Drosophila melanogaster; Dr, Danio rerio; Ce, Caenorhabditis elegans; Sc, 
Saccharomyces cerevisiae; At, Arabidopsis thaliana. 
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Supplementary Figure 8 | Structure of CAF40 bound to the Dm Roquin CBM 
peptide. (a) Crystal packing of the CAF40-Roquin CBM complex. CAF40 (chain A) 
and Dm Roquin CBM (chain B) from complex 1 are colored in light brown and green, 
respectively, whereas the molecules from complex 2 are colored in cyan (CAF40, chain 
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C) and red (CBM, chain D). (b) Superposition of the two CAF40-Roquin complexes 
from the asymmetric unit of the crystal. The colors are as described in (a). The 
structures superpose with an RMSD of 0.24 Å over 254 Cα atoms. (c) Superposition of 
the structure of the CAF40 ARM domain bound to the CBM (light brown, this study) 
with the structure of the isolated CAF40 ARM domain (blue, PDB 2FV2; ref. 37). (d) 
Superposition of the structure of the CAF40 ARM domain bound to the CBM (light 
brown, this study) with that of the CAF40 ARM domain bound to the NOT1 CN9BD 
(red, PDB 4CRU; ref. 2). (e) Stereo view showing the Fo-Fc difference electron density 
for the CBM peptide. The Roquin CBM peptide is shown in stick representation bound 
to CAF40 in cartoon representation. The difference electron density of the CBM peptide 
is shown as a grey mesh. The Fo-Fc-type map, which is contoured at 2.0 σ, was 
calculated using a refined CAF40 model before the CBM peptide was modelled. (f) 
Stereo view showing the 2Fo-Fc simulated annealing composite omit map surrounding 
the CBM peptide. This 2Fo-Fc map (which is largely devoid of model bias2), is shown 
around the CBM and contoured at 1.0 σ. It was generated with Phenix.Autobuild3 using 
the final refined CAF40-Roquin model. 
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Supplementary Figure 9 | The CBM of Dm Roquin contributes to the recruitment 
of the CCR4-NOT complex. (a,b) Interaction of GFP-tagged Dm Roquin (wild-type 
and the M1, M2, M3 and M4 mutants; see Supplementary Table 1) with HA-tagged 
NOT2 and NOT3 in Dm S2 cells. F-Luc-GFP served as negative control. (c,d) A 
tethering assay using the F-Luc-V5 reporter lacking λN binding sites and the indicated 
λN-HA-tagged Dm Roquin mutants was performed in Dm S2 cells as described in Fig. 
3a,b. The corresponding experiment using the F-Luc-5BoxB reporter is shown in Fig. 
7f,g. Error bars represent s.d. from three independent experiments. (e) Western blot 
showing the equivalent expression of the λN-HA-tagged proteins used in panels (c,d) 
and Fig. 7f,g. 
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Supplementary Figure 10 | Original images of western and northern blots used in the 
corresponding panels in Fig. 1. The estimated sizes of the mRNA reporters without 
poly(A) and protein size markers (kDa) are shown on the right of the Northern and 
Western blots, respectively.  
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Supplementary Figure 11 | Original images of western and northern blots used in the 
corresponding panels in Fig. 2. The estimated sizes of the mRNA reporters without 
poly(A) and protein size markers (kDa) are shown on the right of the Northern and 
Western blots, respectively.  
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Supplementary Figure 12 | Original images of western and northern blots used in the 
corresponding panels in Fig. 3. The estimated sizes of the mRNA reporters without 
poly(A) and protein size markers (kDa) are indicated. 
 
 
Supplementary Figure 13 | Original images of protein gels used in the corresponding 
panels in Fig. 4. Protein size markers (kDa) are shown on the right of the panels. 
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Supplementary Figure 14 | Original images of western and northern blots used in the 
corresponding panels in Fig. 5. The estimated sizes of the mRNA reporters without 
poly(A) and protein size markers (kDa) are indicated. 
 
	   19	  
 
Supplementary Figure 15 | Original images of protein gels, western and northern blots 
used in the corresponding panels in Fig. 7. The estimated sizes of the mRNA reporters 
without poly(A) and protein size markers (kDa) are indicated 
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Supplementary Figure 16 | Original images of western and northern blots used in the 
corresponding panels in Fig. 8. The estimated sizes of the mRNA reporters without 
poly(A) and protein size markers (kDa) are indicated. 
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Supplementary Table 1. Constructs and mutants used in this study. 
 
Dm Roquin (1-819) (Uniprot Q9VV48) Comment 
Roquin λN-HA-Roquin 1-819  
 GFP-Roquin 1-819  
 MS2-HA-Roquin 1-819  
 V5-SBP-Roquin 1-819  
Roq-N λN-HA-Roquin 1-500  
 MS2-HA Roquin 1-500  
 V5-SBP-Roquin 1-500  
Roq-C λN-HA-Roquin 501-819  
 MS2-HA-Roquin 501-819  
 V5-SBP-Roquin 501-819  
 MBP-Roquin 501-819-GB1-6xHis  
Roq-CN λN-HA-GST-Roquin 501-702  
 λN-HA-GFP-Roquin 501-702  
 MBP-Roquin 501-702-GB1-6xHis  
Roq-CC λN-HA-GST-Roquin 702-819  
 λN-HA-GFP-Roquin 702-819  
 MBP-Roquin 702-819-GB1-6xHis  
NBM MBP-Roquin 725-755 NOT module-binding region 
CBM MBP-Roquin 790-812 CAF40-binding region 
ΔNBM MS2-HA-Roquin Δ725-755 NOT module-binding region 
 GFP-Roquin Δ725-755 NOT module-binding region 
 V5-SBP-Roquin Δ725-755 NOT module-binding region 
Roq-C-ΔNBM λN-HA-Roquin 501-819 Δ725-755 NOT module-binding region 
Roq-CC-ΔNBM 
MBP-Roquin 702-819 
Δ725-755-GB1-6xHis 
NOT module-binding region 
ΔCBM MS2-HA-Roquin Δ790-812 CAF40-binding region 
 GFP-Roquin Δ790-812 CAF40-binding region 
 V5-SBP-Roquin Δ790-812 CAF40-binding region 
Roq-C-ΔCBM λN-HA-Roquin 501-819 Δ790-812 CAF40-binding region 
Roq-CC-ΔCBM 
MBP-Roquin 702-819 
Δ790-812-GB1-6xHis 
CAF40-binding region 
ΔCBM+NBM MS2-HA-Roquin Δ725-755-Δ790-812 CAF40-binding region, NOT module-binding region 
 GFP-Roquin Δ725-755-Δ790-812 CAF40-binding region, NOT module-binding region 
 V5-SBP-Roquin Δ725-755-Δ790-812 CAF40-binding region, NOT module-binding region 
Roq-C-
ΔCBM+NBM 
λN-HA-Roquin 702-819 
Δ725-755-Δ790-812 
CAF40-binding region, 
NOT module-binding region 
Roq-CC 
ΔCBM+NBM 
MBP-Roquin 702-819 
Δ725-755-Δ790-812-GB1-6xHis 
CAF40-binding region, 
NOT module-binding region 
M1 GFP-Roquin I793E-L801E CAF40-binding region 
M2 GFP-Roquin L805E-V809E CAF40-binding region 
Roq-CC M2 MBP-Roquin 702-819 L805E-V809E-GB1-6xHis 
CAF40-binding region 
M3 GFP-Roquin L801E-L805E CAF40-binding region 
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M4 GFP-Roquin I793E-L801E-L805E-V809E 
CAF40-binding region 
 λN-HA-Roquin I793E-L801E-L805E-V809E 
CAF40-binding region 
 MS2-HA-Roquin I793E-L801E-L805E-V809E 
CAF40-binding region 
 V5-SBP-Roquin I793E-L801E-L805E-V809E 
CAF40-binding region 
Roq-C M4 λN-HA-Roquin 501-819 I793E-L801E-L805E-V809E 
CAF40-binding region 
Roq-CC M4 λN-HA-GST-Roquin 702-819 I793E-L801E-L805E-V809E 
CAF40-binding region 
 
MBP-Roquin 702-819 
I793E-L801E-L805E-V809E-GB1-
6xHis 
CAF40-binding region 
 
Hs Roquin1 (1-1133) (Uniprot Q5TC82) 
Roquin1 MS2-HA-Roquin1 1-1133  
 V5-SBP-Roquin1 1-1133  
Roq1-N MS2-HA-Roquin1 1-500  
 V5-SBP-Roquin1 1-500  
Roq1-C MS2-HA-Roquin1 501-1133  
 V5-SBP-Roquin1 501-1133  
 MBP-Roq1 501-1133  
 
Hs Roquin2 (1-1191) (Uniprot Q9HBD1) 
Roquin2 MS2-HA-Roquin2 1-1191  
 V5-SBP-Roquin2 1-1191  
Roq2-N MS2-HA-Roquin2 1-500  
 V5-SBP-Roquin2 1-500  
Roq2-C MS2-HA-Roquin2 501-1191  
 V5-SBP-Roquin2 501-1191  
 
Hs CNOT1 (Uniprot A5YKK6) 
CNOT1-MID+C MBP-Hs CNOT1 1093-2371 Includes MIF4G, CN9BD, CD and SHD 
CNOT1-MIF4G 6xHis-Hs CNOT1 1093-1317 MIF4G-like domain 
CNOT1-CN9BD MBP-Hs CNOT1 1351-1588 CNOT9-binding domain 
CNOT1-CD MBP-Hs CNOT1 1607-1815 Connector domain 
CNOT1-SHD MBP-Hs CNOT1 1833-2361 Superfamily homology domain 
 
Hs CNOT2 (Uniprot Q9NZN8) 
CNOT2-C MBP-Hs CNOT2 350-540  
 
Hs CNOT3 (Uniprot O75175) 
CNOT3-C 6xHis-Hs CNOT3 607-748  
 
Hs CNOT7 (Uniprot Q9UIV1) 
CNOT7 MBP-Hs CNOT7  
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Hs CNOT9 (Uniprot Q92600) 
CNOT9-ARM 6xHis-HsCNOT9 19-285  
CNOT9-ARM 
V181E 6xHis-HsCNOT9 19-285-V181E 
Disrupts Roquin binding 
CNOT9-ARM 
2xMut 
6xHis-HsCNOT9 19-285-Y134D-
G141W 
Disrupts Roquin binding 
 
Dm NOT9 (1-304) (Uniprot Q7JVP2) 
CAF40 λN-HA-CAF40 1-304  
 GFP-CAF40 1-304  
CAF40 V186E GFP-CAF40 V186E Roquin-binding region 
CAF40 2xMut GFP-CAF40 Y139D-G146E Roquin-binding region 
CAF40-ARM MBP-CAF40 25-291 Roquin-binding region 
 
Dm NOT1 (Uniprot  A8DY81) 
NOT1 λN-HA-NOT1  
CN9BD λN-HA-CN9BD 1468-1717 CAF40-binding domain 
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 Supplementary Table 2. Antibodies used in this study. 
Antibody Source Catalog Number Dilution Monoclonal/ 
Polyclonal 
Anti-HA-HRP Roche 12 013 819 001 1:5,000 Monoclonal 
Anti-GFP (for western 
blotting) 
Roche 11 814 460 001 1:2,000 Monoclonal 
Anti-GFP (for 
immunoprecipitations) 
In house   Rabbit 
Polyclonal 
Anti-Dm NOT1 Kind gift from 
E. Wahle 
T6199 1:1,000 Rabbit 
Polyclonal 
Anti-tubulin Sigma-Aldrich T6199 1:10,000 Monoclonal 
Anti-V5 AbD Serotec MCA1360GA 1:5,000 Monoclonal 
Anti-mouse-HRP GE Healthcare NA931V 1:10,000 Monoclonal 
Anti-Hs NOT1 In house  1:2,000 Rabbit 
polyclonal 
Anti-Hs NOT2 Bethyl A302-562A 1:2,000 Rabbit 
Polyclonal 
Anti-Hs NOT3 Abcam Ab55681 1:2,000 Monoclonal 
Anti-Hs CAF40 (RQCD1) Proteintech 22503-1-AP 1:1,000 Rabbit 
Polyclonal 
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Drosophila Bag-of-marbles directly interacts with the
CAF40 subunit of the CCR4–NOT complex to elicit
repression of mRNA targets
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ABSTRACT
Drosophila melanogaster Bag-of-marbles (Bam) promotes germline stem cell (GSC) differentiation by repressing the expression of
mRNAs encoding stem cell maintenance factors. Bam interacts with Benign gonial cell neoplasm (Bgcn) and the CCR4
deadenylase, a catalytic subunit of the CCR4–NOT complex. Bam has been proposed to bind CCR4 and displace it from the
CCR4–NOT complex. Here, we investigated the interaction of Bam with the CCR4–NOT complex by using purified
recombinant proteins. Unexpectedly, we found that Bam does not interact with CCR4 directly but instead binds to the CAF40
subunit of the complex in a manner mediated by a conserved N-terminal CAF40-binding motif (CBM). The crystal structure of
the Bam CBM bound to CAF40 reveals that the CBM peptide adopts an α-helical conformation after binding to the concave
surface of the crescent-shaped CAF40 protein. We further show that Bam-mediated mRNA decay and translational repression
depend entirely on Bam’s interaction with CAF40. Thus, Bam regulates the expression of its mRNA targets by recruiting the
CCR4–NOT complex through interaction with CAF40.
Keywords: deadenylation; mRNA decay; translational repression; germ cell differentiation
INTRODUCTION
The CCR4–NOT deadenylase complex is a major down-
stream effector complex in post-transcriptional mRNA regu-
lation in eukaryotes (Wahle and Winkler 2013). Beyond its
role in global mRNA degradation, the complex regulates
the expression of a large number of specific mRNAs, to which
it is recruited via interactions with RNA-associated proteins.
These proteins include the GW182 family, which is involved
in miRNA-mediated gene silencing in animals (Chen et al.
2014a; Mathys et al. 2014); tristetraprolin (TTP), a protein
required for the degradation of mRNAs containing AU-rich
elements (Fabian et al. 2013); the germline determinant
Nanos (Suzuki et al. 2012; Bhandari et al. 2014; Raisch et
al. 2016); and human (Hs) and Drosophila melanogaster
(Dm) Roquin proteins (Leppek et al. 2013; Sgromo et al.
2017).
In metazoans, the CCR4–NOT complex comprises a core
of seven proteins, which bind to independently folding α-he-
lical domains in the central NOT1 scaffold subunit, forming
four subcomplexes or modules: the catalytic module, the
CAF40 module, the NOT module, and the NOT10-NOT11
module (Wahle and Winkler 2013). The catalytic module
comprises two deadenylases, namely CAF1 or its paralog
POP2 (also known as CNOT7 and CNOT8, respectively, in
humans), and CCR4a or its paralog CCR4b (also known as
CNOT6 and CNOT6L, respectively, in humans). CAF1 (or
POP2) binds to a central domain of NOT1 that is structurally
related to the middle portion of eIF4G (termed the NOT1
MIF4G domain) (Basquin et al. 2012; Petit et al. 2012).
CAF1 or POP2 also bind to a leucine-rich repeat domain
(LRR) in CCR4a/b, thus bridging the interaction of CCR4
paralogs with NOT1, and consequently with the assembled
CCR4–NOT complex (Draper et al. 1994, 1995; Dupressoir
et al. 2001; Basquin et al. 2012; Petit et al. 2012; Bawankar
et al. 2013). The NOT1MIF4G domain also serves as a bind-
ing platform for the DEAD-box protein DDX6 (also known
as RCK), which functions as a translational repressor and
decapping activator (Chen et al. 2014a; Mathys et al. 2014).
The CAF40 module consists of the highly conserved CAF40
subunit (also known as NOT9) bound to the NOT1
CAF40/NOT9-binding domain (CN9BD), which is located
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C-terminal to the MIF4G domain (Chen et al. 2014a; Mathys
et al. 2014). The NOT module consists of the NOT2–NOT3
heterodimer bound to the C-terminal NOT1 superfamily ho-
mology domain SHD (Bhaskar et al. 2013; Boland et al.
2013), whereas the NOT10 and NOT11 subunits bind to
the N-terminal end of NOT1 (Bawankar et al. 2013;
Mauxion et al. 2013).
Bag-of-marbles (Bam) is a key differentiation factor that
determines the fate of germline stem cells (GSCs) (Cooley
et al. 1988; McKearin and Spradling 1990; Carreira and
Buszczak 2014). Loss of Bam results in uncontrolled stem
cell proliferation, thus giving rise to germ cell tumors that
characterize the mutant phenotype (McKearin and
Ohlstein 1995). In contrast, ectopic Bam expression causes
stem cell loss (Ohlstein and McKearin 1997). Bam is con-
served in Drosophila and other dipteran species and contains
several predicted α-helices (Fig. 1A), thus suggesting that it is
mainly a folded protein. However, Bam does not display
detectable similarity to other known proteins or domains.
Bam controls GSC differentiation by post-transcriptionally
repressing the expression of nanos and E-cadherinmRNAs (Li
et al. 2009). Bam function requires the assembly of a protein
complex, which includes Benign gonial cell neoplasm (Bgcn),
a putative DEXH RNA helicase protein, and additional pro-
teins such as Tumorous testis (Tut) (Chen et al. 2014b),
Sex-lethal (Sxl) (Chau et al. 2012) and Mei-P26 (Neumüller
et al. 2008; Li et al. 2013). All of these proteins have been im-
plicated in germ cell differentiation in Dm, but their individ-
ual contributions to mRNA binding and repression, as well as
their interactionmodes are not well understood. Bamhas also
been shown to interact with the translation initiation factor
eIF4A and to antagonize its role in translation initiation
(Shen et al. 2009).
Although the mechanism through
which Bam-containing complexes re-
press the expression of specific mRNA
targets has not been fully elucidated, it
apparently involves interaction with the
CCR4 deadenylase subunit of the
CCR4–NOT complex (Fu et al. 2015).
Bam has been proposed to compete
with CAF1/POP2 for direct binding to
the CCR4 LRR domain, thereby displac-
ing CCR4 from the CCR4–NOT com-
plex. In this model, CCR4 participates
in Bam-mediated repression as an isolat-
ed deadenylase and not as an integral
component of the CCR4–NOT complex.
The model was proposed on the basis of
the observation that mutations in the
CCR4 LRR domain disrupt binding to
both Bam and CAF1/POP2 (Fu et al.
2015). However, the mutated residues
are located in the hydrophobic core of
the LRR domain (Basquin et al. 2012)
and most probably destabilize the
domain fold. Therefore, it remains un-
clear whether free CCR4 or the assem-
bled CCR4–NOT complex is required
for Bam-mediated repression.
In the present study, we investigated
the role of the CCR4–NOT complex in
Bam-mediated mRNA regulation. We
found that Bam promotes translational
repression and degradation of bound
mRNAs and that these activities depend
on the N-terminal region of Bam, which
does not contain the previously identified
Bgcn-binding region and putative CCR4-
binding site (Supplemental Fig. S1; Pan
et al. 2014; Fu et al. 2015). We further
FIGURE 1. Bam induces degradation of bound mRNAs through its N-terminal region. (A)
Bam consists of several predicted α-helices (shown in yellow) and a β-strand (shown in cyan).
The position of the CAF40-binding motif (CBM, in red) as well as the boundaries of the Bam-
N and Bam-C fragments are indicated. (B) Tethering assay using the F-Luc-5BoxB reporter
and λN-HA-tagged Bam (full-length or the indicated fragments) in Dm S2 cells. A plasmid ex-
pressing R-Luc mRNA served as a transfection control. For each experiment, F-Luc activity
and mRNA levels were normalized to those of the R-Luc transfection control and set to 100%
in cells expressing the λN-HA peptide. (C) Northern blot of representative RNA samples shown
in B. (D) Western blot analysis showing the equivalent expression of the λN-HA-tagged proteins
used in the tethering assays shown in B and C. Protein size markers (kDa) are shown on the right
of the panel. Full-length Bam and Bam-N display an aberrant mobility in SDS–PAGE, thus result-
ing in a higher apparent molecular weight. (E,F) Tethering assay using the F-Luc-5BoxB-A95-C7-
HhR reporter and λN-HA-tagged Bam (full-length or the indicated fragments) in Dm S2 cells.
The samples were analyzed as described in B and C. In B and E, bars represent mean values
and error bars represent standard deviations from at least three independent experiments.
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show that this N-terminal region contains a CAF40-binding
motif (CBM) that interacts directly with CAF40. A crystal
structure of the Bam CBM peptide bound to CAF40 reveals
a binding mode similar to that observed for the Dm
Roquin CBM (Sgromo et al. 2017). However, in contrast to
Dm Roquin, which recruits the CCR4–NOT complex
through multiple redundant binding sites, Bam relies entirely
on the interaction with CAF40. Disruption of the Bam–
CAF40 interaction also disrupts the interaction with CCR4
and the additional subunits of the CCR4–NOT complex
and abolishes Bam activity. Thus, Bam recruits the assembled
CCR4–NOT deadenylase complex through a direct interac-
tion with CAF40 and this interaction is essential for Bam to
repress bound mRNAs.
RESULTS
The Bam N-terminal region mediates translational
repression and degradation of mRNA targets
Bam promotes stem cell differentiation by repressing the ex-
pression of specific mRNA targets through a mechanism that
involves interaction with the CCR4 deadenylase (Fu et al.
2015). To obtain detailed mechanistic insights into this re-
pressive mechanism and more precisely define the Bam se-
quences responsible for its repressive activity, we used a
λN-based tethering assay in Drosophila melanogaster S2 cells
(Behm-Ansmant et al. 2006). On the basis of sequence align-
ments, we designed Bam N- and C-terminal fragments for
tethering assays (Fig. 1A; Supplemental Fig. S1; Supplemental
Table S1). Full-length Bam and the Bam-N and Bam-C frag-
ments were expressed with λN-HA tags that bind to a coex-
pressed firefly luciferase mRNA reporter containing five
λN-binding sites (BoxB hairpins) in the 3′ UTR (F-Luc-
5BoxB mRNA). An mRNA encoding Renilla luciferase (R-
Luc) served as a transfection control.
λN-HA-tagged Bam decreased the F-Luc expression level
to 10% relative to the λN-HA fusion protein, which was
used as a negative control (Fig. 1B). The decrease in F-Luc ac-
tivity was predominantly explained by a corresponding
decrease in the mRNA abundance (Fig. 1B,C) and a shorten-
ing of themRNA half-life (Supplemental Fig. S2A,B), thus in-
dicating that Bam induces mRNA degradation in S2 cells.
Furthermore, the Bam-N fragment retained the activity of
the full-length protein, whereas the activity of the Bam-C frag-
ment was strongly impaired (Fig. 1B,C). All proteins were ex-
pressed at comparable levels (Fig. 1D), and none of the
proteins affected the expression of an F-Luc reporter lacking
the BoxB hairpins (Supplemental Fig. S2C,D), thus confirm-
ing that Bam must bind to the mRNA to induce degradation.
To determine whether Bam might repress translation in-
dependently of mRNA degradation, we used an mRNA re-
porter containing a 3′ end generated by a self-cleaving
hammerhead ribozyme (HhR) that consequently lacks a
poly(A) tail (F-Luc-5BoxB-A95C7-HhR) (Zekri et al. 2013).
Additionally, the reporter contains an internal, DNA-encod-
ed, oligo(A) stretch of 95 nucleotides and a 3′ oligo(C) stretch
of seven nucleotides upstream of the ribozyme cleavage site.
This reporter is resistant to deadenylation and subsequent
degradation and is efficiently translated in S2 cells (Zekri et
al. 2013). Full-length Bam and the Bam-N fragment re-
pressed the expression of this reporter in S2 cells (Fig. 1E,
F). This repression occurred mainly at the translational level,
because mRNA levels were not decreased to a similar extent
as with the polyadenylated reporter. Together, our results in-
dicated that Bam promotes the degradation of polyadenyl-
ated mRNAs and also represses translation independently
of mRNA degradation when deadenylation is blocked.
Furthermore, the Bam activity resides primarily in the
Bam-N fragment, which does not contain the putative
CCR4-binding region (Supplemental Fig. S1; Fu et al. 2015).
Bam directs bound mRNAs to the 5′-to-3′ decay
pathway
We next investigated whether Bam elicits mRNA degradation
via the 5′-to-3′ decay pathway. In this pathway, deadenylation
is followed by decapping and 5′-to-3′ exonucleolytic degrada-
tion of the mRNA body. We therefore performed tethering
assays in S2 cells depleted of the decapping enzyme DCP2
and overexpressing a catalytically inactive DCP2 mutant
(DCP2 E361Q), which inhibits decapping in a dominant
negative manner (Chang et al. 2014). In these cells, degrada-
tion of the F-Luc-5BoxBmRNA by tethered Bam or the Bam-
N fragment was impaired (Fig. 2A). The F-Luc-5BoxB
mRNA accumulated as a fast-migrating form corresponding
to a deadenylated decay intermediate (A0; Fig. 2B, lanes 5 and
6). Despite the restoration of mRNA levels, F-Luc activity was
not restored (Supplemental Fig. S2E), most likely because
deadenylated transcripts are translated less efficiently. The
expression of the tethered proteins was not affected by coex-
pression of the DCP2 mutant (Fig. 2C). Together, these re-
sults indicated that Bam directs mRNA targets to the 5′-to-
3′ decay pathway.
Bam recruits the CCR4–NOT complex to induce
mRNA degradation
Our results indicated that Bam promotes deadenylation-de-
pendent decapping. To determine whether Bam-mediated
deadenylation requires the assembled CCR4–NOT complex
or, alternatively, whether only the CCR4 subunit acts in iso-
lation, as suggested previously (Fu et al. 2015), we disrupted
CCR4–NOT complex assembly by depleting NOT1, the scaf-
fold subunit of the complex (Wahle and Winkler 2013).
NOT1 depletion partially suppressed degradation of F-Luc-
5BoxB mRNA mediated by Bam and Bam-N (Fig. 2D,E;
Supplemental Fig. S2F), thus suggesting that the assembled
CCR4–NOT complex is required for Bam’s repressive activ-
ity. Furthermore, NOT1 depletion also suppressed Bam-
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mediated translational repression of the reporter that was re-
sistant to deadenylation and decay (F-Luc-5BoxB-A95C7-
HhR; Fig. 2F,G; Supplemental Fig. S2G). Western blot
analysis indicated that NOT1 levels were indeed decreased
to <25% of the control levels in the knockdown cells
(Supplemental Fig. S2H).
Because Bam activity depends on the integrity of the
CCR4–NOT complex and it resides in the N-terminal frag-
ment, which does not contain the putative CCR4-binding re-
gion (Fu et al. 2015), we re-examined Bam interactions with
subunits of the CCR4–NOT complex. We expressed Bam
with an HA tag in S2 cells and tested for interactions with
GFP-tagged subunits of the CCR4–NOT complex in coim-
munoprecipitation assays. Bam interacted with NOT1,
NOT2, NOT3, CCR4, and CAF40 (Supplemental Fig. S3A–
E), thus suggesting that it interacts with the assembled
CCR4–NOT complex. All of these interactions were observed
in the presence of RNaseA. Together, our results indicated
that the CCR4–NOT complex is an important downstream
effector of Bam-mediated mRNA regulation.
FIGURE 2. Bam degrades mRNAs through the 5′-to-3′ mRNA decay pathway. (A) Tethering assay using the F-Luc-5BoxB reporter was performed
in control S2 cells or cells depleted of the decapping enzyme DCP2 (DCP2 KD). The transfectionmixture included plasmids expressing either GFP-V5
or a GFP-tagged catalytically inactive DCP2 mutant (DCP2∗; E361Q). The F-Luc-5BoxB mRNA levels were normalized to those of the R-Luc trans-
fection control and set to 100% in control and knockdown cells expressing the λN-HA peptide. The gray bars represent the normalized F-Luc-5BoxB
mRNA values in control cells expressing GFP-V5. The black bars represent the normalized F-Luc-5BoxB mRNA values in DCP2-depleted cells ex-
pressing GFP-DCP2∗-V5. (B) Northern blot of representative RNA samples shown in A. The positions of the polyadenylated (An) and deadenylated
(A0, dashed red line) mRNA reporter are indicated on the right of the panel. (C) Western blot analysis showing equivalent expression of λN-HA-
tagged proteins in the experiments shown in A and B. (KD) Knockdown. (D,E) Tethering assay using the F-Luc-5BoxB reporter in control S2 cells
or in NOT1-depleted cells. Samples were analyzed as described in Figure 1B–D. (F,G) Tethering assay using the F-Luc-5BoxB-A95-C7-HhR reporter in
control cells and inNOT1-depleted cells. Samples were analyzed as described in Figure 1B–D. InA,D, and F, bars represent mean values and error bars
represent standard deviations from at least three independent experiments. (H) Western blot analysis showing the efficiency of NOT1 depletion in the
experiments shown inD–G. Dilutions of control cell lysates were loaded in lanes 1–4. PABP served as a loading control. Protein size markers (kDa) are
shown on the right in each panel.
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Bam interacts with the CAF40 subunit
of the CCR4–NOT complex
To discriminate between direct and indi-
rect interactions between Bam and the
subunits of the CCR4–NOT complex,
we performed pull-down assays in vitro,
using purified recombinant proteins ex-
pressed in Escherichia coli. Because some
Dm NOT1 domains are not expressed in
a soluble form in bacteria, we first tested
whether Bam could also interact with
the human CCR4–NOT complex. To
this end, we expressed Bam with a V5-
SBP tag in human HEK293T cells and
tested for interactions with endogenous
subunits of the CCR4–NOT complex in
pull-down assays. Bam pulled down all
of the tested subunits of the endogenous
CCR4–NOT complex (NOT1, NOT2,
NOT3 and CAF40; Fig. 3A, lane 4) as
well as HA-tagged CCR4 (Fig. 3B, lane
4) in the presence of RNaseA, thereby in-
dicating that the Bam-binding surface on
the CCR4–NOT complex is conserved.
This result allowed us to test for inter-
actions with individual purified human
CCR4–NOT subcomplexes in vitro, in-
cluding the NOT1-10-11 module, the
catalytic module comprising the NOT1
MIF4G domain bound to CAF1 and
CCR4a, the NOT1 CN9BD domain
bound to CAF40, a C-terminal connector
domain of unknown function (CD), the
NOT module comprising the NOT1
SHD and the C-terminal regions of
NOT2 and NOT3, and an N-terminal
coiled coil domain of NOT3 (Supple-
mental Fig. S3F).MBP-tagged Bam inter-
acted only with the CN9BD–CAF40
module but not with any other subcom-
plex (Supplemental Fig. S3G, lane 25).
The CN9BD–CAF40 module is highly
conserved between Hs and Dm (CN9BD
and CAF40 display 50% and 75% se-
quence identity, respectively). Accord-
ingly, Bam also interacted with the Dm
CN9BD–CAF40module in pull-downas-
says (Fig. 3C, lane 12).
The CAF40-binding motif (CBM) is
required for Bam repressive activity
To more precisely define the region of
Bam that interacts with the CAF40
FIGURE 3. Bam binds directly to CAF40 by using an N-terminal CAF40-binding motif
(CBM). (A) SBP pull-down assay in HEK293T cells expressing V5-SBP-tagged full-length
Bam. V5-SBP-tagged MBP served as negative control. Input (1.5% for the V5-SBP tagged pro-
teins and 1% for endogenous CCR4–NOT subunits) and bound fractions (10% for the V5-
SBP tagged proteins and 30% for the CCR4–NOT subunits) were analyzed by western blotting
using the indicated antibodies. (B) SBP pull-down assay in HEK293T cells expressing V5-SBP-
tagged full-length Bam and HA-CCR4. V5-SBP-tagged MBP served as negative control.
Samples were analyzed as described in A. (C) MBP pull-down assay testing the interaction of
MBP-tagged full-length Bam, the CBM or Bam ΔCBM with the Dm CN9BD–CAF40 complex.
MBP served as a negative control. The inputs (10%) and bound fractions (50%) were analyzed
by SDS–PAGE and subsequent Coomassie staining. (D) MBP pull-down assay showing the inter-
action of MBP-tagged Bam CBM with the Dm and Hs CN9BD–CAF40 complex and Hs CAF40.
Samples were analyzed as in C. (E) Tethering assay using the F-Luc-5BoxB reporter and λN-HA-
tagged Bam (full-length or the indicated fragments) in S2 cells. The samples were analyzed as de-
scribed in Figure 1B–D. The mean values ±SD from three independent experiments are shown.
(F) Northern blot of representative RNA samples shown in E. (G) Western blot showing the
equivalent expression of λN-HA-tagged proteins used in E and F. Protein size markers (kDa)
are shown on the right in each panel.
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module, we performed a series of pull-down assays using var-
ious Bam fragments, which led to the identification of a
CAF40-binding motif (CBM, residues D13–E36) within the
Bam N-terminal fragment. The Bam CBM was sufficient
for binding to the Dm and human CN9BD–CAF40 modules
in pull-down assays (Fig. 3C, lane 14 and Fig. 3D, lanes 14
and 15). Furthermore, the CBM interacted directly with the
isolated Hs CAF40 subunit in the absence of the NOT1
CN9BD (Fig. 3D, lane 16). Importantly, deletion of the
CBM in the context of full-length Bam abolished the interac-
tion with the Dm CN9BD–CAF40 module in vitro (Fig. 3C,
lane 16), thereby indicating that the CBM is the principal
CAF40-binding site in Bam.
To determine the contribution of the CBM to Bam’s re-
pressive activity, we performed tethering assays in S2 cells.
Remarkably, the CBM alone (fragment D13–E36 fused to
GST) was sufficient to induce the repression and degradation
of the F-Luc-5BoxB mRNA to a similar extent as full-length
Bam (Fig. 3E,F). Furthermore, deletion of the CBM was suf-
ficient to abolish the repressive activity of Bam in tethering
assays (Fig. 3E,F). All proteins were expressed at comparable
levels (Fig. 3G) and did not affect the expression of an F-Luc
reporter lacking the BoxB hairpins (Supplemental Fig. S4A,
B). We therefore concluded that the CBM is essential for
Bam’s repressive activity.
Crystal structure of the Bam CBM bound to CAF40
To elucidate the molecular principles underlying the interac-
tion of Bam with the CAF40module, we sought to determine
the crystal structure of the CBM peptide (residues D13–E36)
bound to the Dm and Hs CAF40 armadillo (ARM) domain
(Dm CAF40 E25–G291 and Hs CAF40 R19–E285) as well
as to the CAF40 modules containing the NOT1 CN9BD (res-
idues Dm NOT1 Y1468–T1719 and Hs NOT1 V1351–
L1588). However, only the complexes containing the human
proteins yielded well-diffracting crystals. We solved the struc-
tures of the Bam CBM peptide bound to CAF40 and to the
CN9BD–CAF40 complex and refined them to 3.0 Å and
2.7 Å resolution, respectively (Table 1; Fig. 4A–C).
The asymmetric unit of the CAF40-CBM crystal contained
four complexes that were highly similar to each other
TABLE 1. Data collection and refinement statistics
CAF40–Bam NOT1–CAF40–Bam
Space group P 21 21 2 P 32 2 1
Unit cell
Dimensions a, b, c (Å) 105.6, 200.9, 59.6 106.6, 106.6, 263.4
Angles α, β, γ (°) 90.0, 90.0, 90.0 90.0, 90.0, 120.0
Data collectiona
Wavelength (Å) 1.0396 1.0000
Resolution range (Å) 50.–3.0 (3.08–3.00) 50–2.7 (2.77–2.70)
Rsym (%) 9.5 (100.8) 11.4 (222.4)
Completeness (%) 99.5 (98.8) 99.9 (99.5)
Mean (I/σI ) 13.2 (1.7) 15.5 (1.2)
Unique reflections 26,082 (1852) 48,613 (3529)
Multiplicity 5.5 (5.7) 11.0 (10.7)
CC(1/2) 1.00 (0.65) 1.00 (0.70)
Refinement
Rwork (%) 21.6 20.9
Rfree (%) 26.8 23.7
Number of atoms
All atoms 9358 8481
Protein 9352 8424
Ordered solvent 6 57
Average B factor (Å2)
All atoms 100.8 97.9
Protein 100.7 97.5
Ordered solvent 103.7 149.3
Ramachandran plot
Favored regions (%) 96.4 98.9
Disallowed regions (%) 0.2 0.0
RMSD from ideal geometry
Bond lengths (Å) 0.010 0.002
Bond angles (°) 1.080 0.437
aValues in parentheses are for highest-resolution shell.
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(RMSDs between 0.31 and 0.75 Å; over 237–278 Cα atoms)
and that were arranged as two pairs of dimers (Supplemental
Fig. S5A,B). The dimer interface corresponds to the one pre-
viously observed in the structure of free CAF40 (Supplemen-
tal Fig. S5C; Garces et al. 2007). The asymmetric unit of the
CN9BD–CAF40-CBM crystals contained two almost identi-
cal complexes (RMSD of 0.28 Å over 457 Cα atoms; Supple-
mental Fig. S5D,E). In all complexes, the interaction of the
CBM peptide with the CAF40 concave surface was found to
be almost identical (Fig. 4B,C; Supplemental Fig. S5F), and
the CBM does not contact the NOT1 CN9BD (Fig. 4A–C),
thus confirming that the CBM interacts exclusively with
CAF40. Superposition of the CAF40 dimer bound to the
CBM with the previously determined ligand-free CAF40
dimer (Supplemental Fig. S5C; RMSD of 0.90 Å over 509
Cα atoms; Garces et al. 2007) or with CAF40 bound to the
NOT1 CN9BD (Supplemental Fig. S5G; RMSD of 0.94 Å
over 416 Cα atoms; Chen et al. 2014a), indicated that binding
of the CBM peptide does not induce any major conforma-
tional changes in the CAF40 ARM domain.
The CBM peptide folds into an amphipathic α-helix that is
bound centrally across the concave surface of the crescent-
shaped CAF40 ARM domain, which consists of 17 α-helices
arranged into six armadillo (ARM) repeats (Fig. 4A–C;
Supplemental Fig. S6A,B; Garces et al. 2007; Chen et al.
2014a; Mathys et al. 2014). The α-helix binds to a conserved
hydrophobic patch close to the previously proposed nucleic
acid-binding groove (Garces et al. 2007). In the structure of
the Bam CBM bound to the CAF40 module, the NOT1
CN9BD binds to the convex surface of CAF40 and prevents
CAF40 dimerization, as previously observed (Chen et al.
2014a; Mathys et al. 2014). Importantly however, the
NOT1 CN9BD does not interfere with Bam CBM binding
on the concave surface of CAF40, thus indicating that Bam
can interact with CAF40 also in the context of the fully as-
sembled CCR4–NOT complex (Fig. 4C).
The Bam CBM competes with the Roquin CBM
for binding to CAF40
Remarkably, the BamCBMoccupies the same binding surface
as the previously described CBM of Dm Roquin (Roq)
(Sgromo et al. 2017) and binds CAF40 in a similar manner
(Fig. 4D). The two CBM peptides fold into amphipathic heli-
ces that bind via their hydrophobic sides along a groove on the
concave face of CAF40. Consequently, the two peptides
FIGURE 4. Structure of the Bam CBM bound to CAF40 and to the NOT1 CN9BD–CAF40 module. (A) The Bam CBM peptide (red, backbone
shown in ribbon representation) bound toHsCAF40 (gray). CAF40 helices are depicted as tubes and numbered in black. The orange semicircle marks
the predominantly hydrophobic interface between the CBM peptide and CAF40. (B) Cartoon representation of the Bam CBM peptide bound to Hs
CAF40. Selected CAF40 secondary structure elements are labeled in black. (C) Structure of the CBM peptide bound to the NOT1 CN9BD–CAF40
complex. (D) Superposition of the CAF40–BamCBM structure with the structure of CAF40 bound to the Roq CBM (PDB 5LSW; Sgromo et al. 2017).
The Roq CBM is shown in yellow and CAF40 from the Roq complex in blue. (E) In vitro competition assay. GST-taggedHsCAF40 was incubated with
equimolar amounts of MBP-tagged Bam or Roq CBMs and increasing amounts of His6-NusA-tagged Bam CBM. His6-NusA was used as a negative
control. Proteins bound to GST-CAF40 were pulled down and analyzed by SDS-PAGE and subsequent Coomassie staining. Molar equivalents (eq) are
relative to GST-CAF40.
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cannot bind CAF40 simultaneously and compete for binding
to CAF40 when tested in vitro in a competition assay. In this
assay, GST-tagged CAF40 was incubated with equimolar
amounts of MBP-tagged Bam or Roq CBMs and increasing
concentrations ofHis6-NusA-tagged BamCBM.The peptides
bound to CAF40 were pulled down by using glutathione-aga-
rose beads. Increasing concentrations of the His6-NusA-Bam
CBM competed with the two MBP-tagged CBMs for CAF40
binding (Fig. 4E). Interestingly, the Roquin CBM was com-
peted out more efficiently than the Bam CBM (Fig. 4E, e.g.,
lane 12 versus 17), thus suggesting that Bam has a competitive
advantage.
To obtain information on the affinities of the CBM pep-
tides for CAF40, we performed isothermal titration calorim-
etry (ITC) experiments. The Bam CBM bound to the Dm
CN9BD–CAF40 complex with a dissociation constant (KD)
in the nanomolar range (183 ± 44 nM; Supplemental Fig.
S7A). In contrast, the affinity of the Roq CBM was too low
to be measured by ITC (i.e., the necessary peptide concentra-
tions for measurement could not be reached), thereby ex-
plaining why the Roq CBM competed rather poorly with
the Bam CBM.
The Bam and Roquin CBMs use similar binding modes
The Bam CBM forms a single amphipathic α-helix extending
through residues D13–E33 and the hydrophobic face of this
helix binds in a groove formed by helices α5, α8 and α11 on
the CAF40 concave surface (Fig. 5A,B). The interaction bur-
ies a total surface area of 1638 Å2 and involves the side chains
of Bam residues L17, F21, M24, L28, M31 and V32, which
engage the hydrophobic CAF40-binding surface consisting
of residue A84 in helix α5, residues R130, Y134, L137,
T138, G141 and G144 in helix α8, and residues L177,
T180, V181 and F184 in helix α11 on the CAF40 side (Fig.
5A,B). In addition, the N and C termini of the CBM helix
contact the CAF40 surface through hydrogen bonds between
Bam N20 and CAF40 N88, and Bam E33 and CAF40 K230,
respectively (Fig. 5B). However, these interactions were not
observed in all six complexes, thus indicating some degree
of flexibility of the helix ends.
In the Roq CBM, the N-terminal portion (residues E790–
M797) is no longer α-helical, owing to the insertion of a gly-
cine (G796), which is conserved among Roq proteins from
different Drosophila species (Fig. 5C,D). Instead, the residues
form an extended “hook” that is stabilized by internal hydro-
gen bonds. In contrast, the Bam N-terminal residues (D13–
N20) extend the amphipathic α-helix by another two turns.
Despite this structural difference, Bam residue L17 engages
the same binding pocket as Roq residue I793. Thus, critical
contacts are preserved in both peptides despite the fact that
Roq is no longer helical (Fig. 5C,D). Overall, the all α-helical
conformation of the Bam CBM is likely to be more stable on
its own than the more extended conformation of the Roq
CBM, which probably does not form in the absence of
CAF40. The resulting difference in the binding entropy could
contribute to the higher affinity of the Bam CBM for CAF40
and to its competitive advantage over the Roquin CBM.
Alternatively, differences in the hydrophobic interface resi-
dues may also potentially explain the observed differences
in affinity and competition between the two CBMs, e.g.,
the side chain of residue F21 in the center of the Bam CBM
establishes a more extensive network of hydrophobic interac-
tions along the interface than the side chain of residue M798
at the same structural position in the Roq CBM.
The interaction of Bam with CAF40 is required
for mRNA repression
To assess the importance of the interactions observed in the
crystal structure, we substituted Bam residues L17 or M24
with glutamic acid. These substitutions abolished the interac-
tion of the MBP-tagged Bam with the Dm CAF40 module in
pull-down assays (Fig. 5E; Supplemental Table S1), thus indi-
cating that the CBM is the only CAF40-binding site in Bam.
We also analyzed the effects of amino acid substitutions in
the CAF40 interface on complex formation. A single V186E
substitution or the double Y139D, G146W substitution
(2xMut) inDm CAF40 (corresponding toHs CAF40 residues
V181, Y134 and G141) were sufficient to disrupt the interac-
tion with Bam in vitro (Fig. 5F; Supplemental Table S1). The
equivalent substitutions in Hs CAF40 were also sufficient to
disrupt binding to the Roq CBM (Sgromo et al. 2017), thus
further confirming the similarity in the CBM-bindingmodes.
Next, we assessed the relevance of the interface in S2 cells.
The single amino acid substitution in Dm CAF40 (V186E)
was sufficient to abolish binding to full-length Bam in cell ly-
sates (Supplemental Fig. S3E, lane 6). Conversely, substitu-
tions of CBM residues (4xMut, Supplemental Table S1) in
the context of full-length Bam abolished binding to Dm
CAF40 (Supplemental Fig. S7B).
To assess the functional relevance of the CAF40-Bam in-
teraction in mRNA target repression, we performed tethering
assays in S2 and human cells. Single amino acid substitutions
in the Bam CBM abolished Bam activity in tethering assays in
S2 cells (Fig. 6A,B) a result indicating that the CBM provides
a major contribution to Bam’s repressive activity. All mutants
were expressed at comparable levels (Fig. 6C) and did not af-
fect the expression of a F-Luc mRNA lacking the BoxB hair-
pins (Supplemental Fig. S7C,D).
In human cells, we tethered MS2-HA-tagged full-length
Bam (wild-type or the 4xMut) to a β-globin reporter contain-
ing six binding sites for the MS2 protein in the 3′ UTR. As
observed in Dm cells, wild-type Bam caused degradation of
the β-globin-6xMS2bs reporter, whereas the Bam 4xMut
was inactive (Supplemental Fig. S7E–G). Furthermore, the
CBM alone fused to MBP was as active as full-length Bam
(Supplemental Fig. S7E–G). Thus, Bam depends on the in-
tegrity of the CBM to repress mRNA expression both in hu-
man and S2 cells.
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Bam interaction with CCR4 is indirect and mediated
by CAF40
In the pull-down assays using recombinant proteins, we did
not observe a direct interaction between Bam and the catalyt-
ic module (containing Hs CCR4a, which is 57% identical to
Dm CCR4; Supplemental Fig. S3G). Furthermore, Bam did
not competitively displace the CAF1-NOT1 subcomplex
from CCR4a (Supplemental Fig. S3G, lane 24), as has previ-
ously been suggested (Fu et al. 2015). To determine whether
Bam interaction with CCR4 was direct or mediated by
CAF40, we used CRISPR-Cas9 gene editing to generate a
FIGURE 5. The Bam and Roq CBMs use a similar CAF40-binding mode. (A,B) Close-up views of the CAF40-Bam CBM-binding interface in two
orientations. Selected residues of CAF40 and Bam are shown as orange and red sticks, respectively. Hydrogen bonds are indicated by red dashed lines.
Residues mutated in this study are underlined. (C) Close-up view of the structural superposition of the CAF40-Bam CBM structure with the structure
of the Roq CBMbound to CAF40. The Bam and Roq CBMs are shown in red and yellow, respectively. (D) (Upper panel) Superposition of the Bam and
Roq CBM peptides bound to CAF40. The backbones are shown in ribbon representation, and side chains are shown as sticks. CAF40 is indicated as a
thick gray line. (Lower panel) Sequence alignment of the Bam and Roq CBMs from the indicatedDrosophila species. Hydrophobic residues interacting
with CAF40 are highlighted by a light green background. Gray letters indicate residues that were not included in the crystallization setup. (E) MBP
pull-down assay testing the interaction of MBP-tagged Bam (wild-type or mutants L17E and M24E) with the Dm NOT1-CN9BD–CAF40 complex.
MBP served as a negative control. (F) MBP pull-down assay testing the interaction of MBP-tagged Bam with Dm NOT1-CN9BD–CAF40 complex
(containing CAF40 wild-type or the indicated mutants). MBP served as a negative control.
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CAF40-null HEK293T human cell line in which the CAF40
levels were decreased below detectable levels (Fig. 6D, lanes
3 and 4 versus 1 and 2 and Supplemental Fig. S7H), whereas
the expression of the additional subunits
of the CCR4–NOT complex was not af-
fected (Fig. 6D, lane 3 and 4 versus 1
and 2). In this cell line, Bam did not in-
teract with endogenous NOT1, NOT2
and NOT3 (Fig. 6D, lane 8 versus 6) or
with HA-tagged CCR4 (Fig. 6E, lane 8
versus 6), thus indicating that the interac-
tion of Bam with the subunits of the
CCR4–NOT complex is indeed mediated
by CAF40. Similarly, the combined qua-
druple substitutions in the Bam CBM
(4xMut) abrogated the interaction with
the endogenous subunits of the CCR4–
NOT complex in human cells (Fig. 6F,
lane 8 versus 6) as well as the interaction
with HA-tagged CCR4 (Fig. 6G, lane 8
versus 6). Similarly, the Bam 4xMut did
not interact with CCR4 or NOT2 in S2
cells (Supplemental Fig. S7I,J). Together,
our results indicated that the previously
reported interaction of Bam with CCR4
(Fu et al. 2015), is most likely indirect
and mediated by CAF40 in the context
of the fully assembled CCR4–NOT
complex.
CAF40 is the only Bam-binding
site within the CCR4–NOT
complex
To further validate the relevance of Bam
interaction with CAF40 for the recruit-
ment of the CCR4–NOT complex, we
performed tethering assays inDm S2 cells
overexpressing CAF40 wild-type or the
CAF40V186Emutant,which does not in-
teract with Bam and was thus expected to
suppress Bam activity in a dominant neg-
ative manner. Accordingly, Bam activity
in tethering assays was suppressed in cells
overexpressing the CAF40 V186Emutant
but not when CAF40 wild-type was over-
expressed (Fig. 7A,B). For a control, we
tethered Dm Roq, which in addition to
theCBMcontains additional binding sites
for the CCR4–NOT complex (Sgromo et
al. 2017). Consequently, Roq activity
was only slightly affected in cells overex-
pressing the CAF40 mutant (Fig. 7A,B,
lane 9). Overexpression of CAF40 did
not affect the Bam and Roq expression
levels (Fig. 7C). The differential effect of the CAF40 mutant
onBamandRoqactivities further confirmed thatBam, in con-
trast toRoq, depends entirelyon its interactionwithCAF40 for
FIGURE 6. The CBM is necessary for Bam-mediated mRNA repression. (A) Tethering assay
using the F-Luc-5BoxB reporter and λN-HA-tagged Bam (wild-type or the indicated mutants) in
S2 cells. The samples were analyzed as described in Figure 1B. (B) Northern blot of representative
RNA samples shown in A. (C) Western blot showing the equivalent expression of λN-HA-tagged
proteins used in A and B. (D) SBP pull-down assay in control and CAF40-null HEK293T cells
expressing V5-SBP-tagged full-length Bam. V5-SBP-tagged MBP served as a negative control.
Input (1.5% for the V5-SBP tagged proteins and 1% for endogenous CCR4–NOT subunits)
and bound fractions (10% for the V5-SBP tagged proteins and 30% for the CCR4–NOT subunits)
were analyzed by western blotting using the indicated antibodies. (KO) Knockout. (E) SBP pull-
down assay in control and CAF40-null HEK293T cells expressing V5-SBP-tagged full-length Bam
and HA-CCR4. Samples were analyzed as in D. (F) SBP pull-down assay in HEK293T cells ex-
pressing V5-SBP-tagged full-length Bam or the 4xMut. V5-SBP-tagged MBP served as a negative
control. Input (1.5% for the V5-SBP tagged proteins and 1% for CCR4–NOT subunits) and the
bound fractions (10% for the V5-SBP tagged proteins and 30% for CCR4–NOT subunits) were
analyzed by western blotting using the indicated antibodies. (G) SBP pull-down assay in
HEK293T cells expressing V5-SBP-tagged full-length Bam or the 4xMut and HA-tagged CCR4.
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repression, whereas Roq can recruit the CCR4–NOTcomplex
through additional binding sites.
In an independent approach, we tethered Bam in S2 cells
depleted of CAF40 in which CAF40 levels were decreased
to∼10% of the control levels (Fig. 7D). CAF40 depletion par-
tially suppressed Bam activity in tethering assays in S2 cells
(Fig. 7E,F). The Bam-mediated repression was restored by
transient expression of wild-type CAF40 but not by expres-
sion of the CAF40 V186E mutant, which does not interact
with Bam (Fig. 7E,F), despite comparable expression levels
(Fig. 7G). Thus, Bam requires interactions with CAF40 for
full repressive activity.
DISCUSSION
In this study, we showed that Bam represses the translation
and promotes the degradation of bound mRNAs by directly
recruiting the CCR4–NOT deadenylase complex through
an interaction with CAF40. This interaction is mediated by
a short CAF40-binding motif (CBM) that is necessary and
FIGURE 7. Bam depends on CCR4–NOT complex recruitment to induce mRNA decay. (A) Tethering assay using the F-Luc-5BoxB reporter and
λN-HA-tagged Bam and Roq in S2 cells. The transfection mixtures also contained plasmids for expression of GFP (control) or GFP-CAF40 (wild-type
or the V186Emutant) as indicated. The samples were analyzed as described in Figure 1B. (B) Northern blot of representative RNA samples shown inA.
(C) Western blot showing the equivalent expression of the λN-HA-tagged proteins in cells expressing GFP or GFP-CAF40 (either wild-type or the
V186E mutant) used in A and B. (D) Western blot showing the efficiency of the CAF40 depletion in Dm S2 cells. Dilutions of control cell lysates were
loaded in lanes 1–4 to estimate the efficacy of the depletion. PABP served as a loading control. (KD) Knockdown. (E) Complementation assay using
the F-Luc-5BoxB reporter and λN-HA-tagged Bam in S2 cells depleted of CAF40 (CAF40 KD) or in control cells (control). Samples were analyzed as
described in Figure 1B. (F) Northern blot of representative RNA samples shown in E. (G) Western blot showing the equivalent expression of the λN-
HA-tagged Bam constructs used in E and F.
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sufficient for Bam’s repressive activity. We further elucidated
the structural basis of the interaction of the Bam CBM with
CAF40 and identified the concave surface of CAF40 as a
binding site for amphipathic helices in RNA-associated pro-
teins that recruit the CCR4–NOT complex.
CCR4–NOT complex recruitment is required
for Bam repressive activity
The recruitment of the CCR4–NOT complex via the CAF40-
CBM interaction is required for Bam to repress the transla-
tion of mRNA targets. Unlike other proteins, such as
GW182, TTP, Roq and Dm Nanos, that use multiple redun-
dant motifs to recruit the CCR4–NOT complex (Fabian et al.
2013; Chen et al. 2014a; Mathys et al. 2014; Raisch et al. 2016;
Sgromo et al. 2017), Bam depends entirely on the interaction
between the CBM and CAF40. Indeed, single point muta-
tions in the CBM that abolished the interaction with
CAF40 also disrupted the interaction with CCR4 and addi-
tional subunits of the CCR4–NOT complex and abrogated
Bam’s repressive activity. Similar results were obtained in
cells depleted of CAF40, thus indicating that the previously
reported interaction between Bam and CCR4 is indirect
and is mediated by CAF40 in the context of the assembled
CCR4–NOT complex. These results also indicated that the
CCR4–NOT complex is the main downstream effector com-
plex in Bam-mediated mRNA regulation.
CAF40 serves as a binding platform
of the CCR4–NOT complex
Bam adds to the growing number of examples of RNA-asso-
ciated proteins that directly recruit the CCR4–NOT complex
via short linear motifs to down-regulate mRNA targets.
To date, the motifs that have been characterized have been
found to bind non-overlapping surfaces on the CCR4–
NOT complex. For example, vertebrate and Dm Nanos and
Saccharomyces cerevisiae (Sc) NOT4 bind to non-overlapping
surfaces on the NOT module (Bhandari et al. 2014; Bhaskar
et al. 2015; Raisch et al. 2016). The CAF40 subunit also pro-
vides interaction sites for RNA-associated proteins within the
CCR4–NOT complex. The convex surface of the CAF40 ar-
madillo-repeat domain features two tryptophan-binding sites
that are used by proteins of the GW182 protein family, which
recruit the CCR4–NOT complex to miRNA targets (Chen et
al. 2014a; Mathys et al. 2014). The CAF40 concave surface
provides binding sites for the CBM in the Dm Roq protein
(Sgromo et al. 2017). Here, we found that this surface also
binds to the Bam CBM, thus indicating that Bam and Roq
binding to CAF40 is mutually exclusive. However, the Bam
and Roq proteins share no apparent sequence similarity
and thus their CBMs may have evolved independently to
bind to the same surface of CAF40. The functional relevance
of this competitive binding remains unclear, because it is not
known whether the two proteins are expressed in the same
cell type under the same physiological conditions.
The high conservation of CAF40 (75% sequence identity
between the Hs and Dm proteins, and 57% identity between
Hs and Sc), particularly of the CBM-binding surface, suggests
the existence of additional CBM-containing proteins in eu-
karyotes. Through an in silico search using a consensus pat-
tern derived from the Bam and Dm Roq CBM sequences, we
could indeed identify several potential CBMs in other pro-
teins (Supplemental Fig. S8). However, none of the tested se-
quences interacted with Hs CAF40 in vitro in pull-down
assays (data not shown), thus indicating that the tested frag-
ments are not bona fide CBMs and that the rules guiding
CAF40 binding are still incompletely understood. From
what we know, it is possible and quite likely indeed that if
CBMs exist in other proteins, they do not share an evolution-
ary origin with Bam and Roq and therefore also have no phy-
logenetic sequence conservation. Indeed, sequence searches
conducted with either Bam or Roq did not identify the re-
spective other protein as a CBM-containing protein.
CCR4–NOT complex recruitment is a recurring
mechanism for targeted repression of gene expression
With the expanding repertoire of RNA-binding proteins that
are known to interact with the CCR4–NOT complex, some
underlying principles of recruitment are emerging. First,
many RNA-associated proteins use extended peptide motifs
embedded in unstructured regions for binding to CCR4–
NOT. Interactions of such short linear motifs (SLiMs) are
generally characterized by high specificity and at the same
time relatively low individual affinity (Tompa 2012; Van
Roey et al. 2014). This aspect is important in regulatory com-
plexes such as the CCR4–NOT complex, because the com-
plex must be recruited in a highly specific manner and
need to be released again after exerting its specific function.
Additionally, these motifs usually show high evolutionary
plasticity (Tompa 2012; Van Roey et al. 2014) and are not
conserved in orthologous proteins accross species.
Another common theme is that RNA binding is often spa-
tially separated from CCR4–NOT complex recruitment. In
many cases including Nanos and Roq, RNA binding is medi-
ated by highly conserved RNA-binding domains, whereas
CCR4–NOT complex recruitment is mediated by SLiMs in
long unstructured regions of up to several hundred amino ac-
ids in length. In other cases, RNA binding and CCR4–NOT
recruitment are associated with different polypeptides. For
example, in the miRNA-induced silencing complexes
(miRISCs), RNA binding is achieved by Argonaute proteins
(AGOs), whereas CCR4–NOT complex recruitment is medi-
ated by the GW182 proteins that act as adaptor molecules
downstream from AGOs (Jonas and Izaurralde 2015). In
the case of Bam, it is unknown whether the RNA-binding ac-
tivity resides in the Bam protein itself or whether additional
factors mediate mRNA binding.
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Finally, it is interesting to note that some proteins such as
Bam and vertebrate Nanos (this study; Bhandari et al.
2014), use a single motif with relatively high affinity to in-
teract with the CCR4–NOT complex, whereas others such
as Dm Roq and the GW182 proteins, use avidity effects in
a distributive binding mode involving multiple lower-affin-
ity motifs in disordered protein regions for recruitment
(Chen et al. 2014a; Mathys et al. 2014; Sgromo et al.
2017). The highly diverse sequence motifs bind to several
structured surfaces on the complex. Nevertheless, indepen-
dently of the mode of interaction, the recruitment of the
CCR4–NOT complex by diverse RNA-binding proteins re-
sults in a common functional outcome: the repression of
the mRNA target through deadenylation-dependent and in-
dependent mechanisms and, in cellular contexts in which
deadenylation is coupled to decapping, the degradation of
the mRNA through the 5′-to-3′ mRNA decay pathway.
Thus, the CCR4–NOT complex, through its ability to provide
binding sites for diverse sequence motifs, is a major down-
stream effector complex in post-transcriptional mRNA
regulation.
MATERIALS AND METHODS
DNA constructs
The DNA constructs used in this study are described in the
Supplemental Material and are listed in Supplemental Table S1.
All of the mutants used in this study were generated by site-directed
mutagenesis using a QuikChange mutagenesis kit (Stratagene). All
constructs and mutations were confirmed by sequencing.
Coimmunoprecipitation and SBP pull-down assays
All coimmunoprecipitation and SBP pull-down assays in S2 and
HEK293T cell lysates were performed in the presence of RNaseA
as previously described (Sgromo et al. 2017). All western blots
were developed using an ECL western blotting detection system
(GE Healthcare). The antibodies used in this study are listed in
Supplemental Table S2. A detailed description of these assays is in-
cluded in the Supplemental Material.
Tethering and complementation assays
Knockdown of DCP2, NOT1 and CAF40 in S2 cells using dsRNA
was performed as previously described (Behm-Ansmant et al.
2006). For the λN-tethering assays in Dm S2 cells, 2.5 × 106 cells
per well were seeded in six-well plates and transfected using
Effectene (Qiagen). The transfection mixtures contained the follow-
ing plasmids: 0.1 µg of Firefly luciferase reporters (F-Luc-5BoxB, F-
Luc-V5 or F-Luc-5BoxB-A95C7-HhR), 0.4 µg of the R-Luc transfec-
tion control and various amounts of plasmids expressing λN-HA-
tagged full-length Bam or Bam fragments (0.05 µg for wild-type
or mutant full-length Bam, 0.02 µg for Bam-N, 0.1 µg for Bam-C,
0.1 µg GST-CBM and 0.05 µg of Bam ΔCBM). Cells were harvested
3 days after transfection.
In the experiment shown in Figure 2A, control and DCP2 knock-
down cells were additionally transfected with plasmids expressing
GFP-V5 (0.08 µg) and GFP-DCP2∗-V5 mutant (E361Q; 1 µg), re-
spectively. In the experiment shown in Figure 7A and B, cells were
also transfected with plasmids expressing GFP (0.05 µg) or GFP-
tagged CAF40 (1.5 µg) either wild-type or mutant. In the comple-
mentation assay shown in Figure 7E,F, knockdown cells were also
transfected with plasmids expressing GFP (0.002 µg) or GFP-tagged
CAF40 (0.005 µg) either wild-type or mutant (V186E). To measure
the mRNA half-life, S2 cells were treated with actinomycin D (5 µg/
ml final concentration) 3 d after transfection and collected at the in-
dicated time points. RNA samples were analyzed by northern
blotting.
A detailed description of the procedure to generate the
HEK293T CAF40-null cell line is included in the Supplemental
Material. For the Bam tethering assays in human cells, HEK293T
cells (0.7 × 106 cells per well) were seeded in six-well plates and
transfected using Lipofectamine 2000 (Thermo Fisher Scientific).
The transfection mixtures contained 0.5 µg of the β-globin reporter
containing six MS2-binding sites (β-globin-6xMS2bs), 0.5 µg of
the control plasmid containing the β-globin gene fused to a frag-
ment of the GAPDH gene inserted in the 3′ UTR but lacking
MS2-binding sites (control: β-globin-GAP), and various amounts
of pT7-MS2-HA plasmids for the expression of MS2-HA-fusion
proteins [full-length Bam (1 µg), MBP-Bam CBM (0.2 µg) and
Bam 4xMut (0.5 µg)].
Firefly and Renilla luciferase activities were measured 3 d (S2
cells) or 2 d (HEK293T cells) after transfection by using a Dual-
Luciferase Reporter Assay System (Promega). The total RNA was
isolated using a Trifast Reagent (Peqlab) and analyzed by northern
blotting, as previously described (Braun et al. 2011).
Protein expression and purification
All recombinant proteins were expressed in E. coli BL21 (DE3) Star
cells (Thermo Fisher Scientific) grown in LB medium overnight at
20°C. The cells were lysed with an EmulsiFlex-C3 homogenizer
(AVESTIN) in the indicated lysis buffer supplemented with
DNase I (5 µg/mL), lysozyme (1 mg/mL) and complete EDTA-
free protease inhibitor cocktail (Roche). Bam constructs were ex-
pressed as fusions with an N-terminal, TEV-cleavable MBP tag.
The cells were lysed in a buffer containing 50 mM HEPES (pH
7.5), 300 mM NaCl and 2 mM DTT. The proteins were purified
from cleared cell lysates by using amylose resin (New England
Biolabs), and this was followed by anion chromatography using a
HiTrapQ column (GE Healthcare). The Bam constructs were fur-
ther purified on a Superdex 200 26/600 column (GE Healthcare)
in a buffer containing 10 mM HEPES (pH 7.5), 200 mM NaCl
and 2 mM DTT.
The purification of Hs CAF40 (ARM domain, residues R19–
E285) was as previously described (Sgromo et al. 2017). Briefly,
the protein was expressed with an N-terminal His6 tag cleavable
by the HRV3C protease. Cells were lysed in a buffer containing 50
mM potassium phosphate (pH 7.5), 500 mMNaCl, 10% (v/v) glyc-
erol, 20 mM imidazole and 2 mM β-mercaptoethanol. The protein
was purified from cleared cell lysates with a HiTrap IMAC column
(GE Healthcare). The His6 tag was removed by overnight cleavage
using HRV3C protease during dialysis in a buffer containing 50
mM Tris–HCl (pH 7.5), 150 mM NaCl and 1 mM DTT. After
Structure of a Bam peptide bound to CAF40
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cleavage of the tag, CAF40 was further purified using a HiTrap
Heparin column (GE Healthcare) followed by gel filtration on a
Superdex 200 26/600 column (GE Healthcare) in a buffer contain-
ing 20 mM Tris–HCl (pH 7.5), 150 mM NaCl and 1 mM DTT.
The purification of the Hs NOT1 CN9BD–CAF40 complex has
been previously described (Chen et al. 2014a). The complex was ob-
tained by co-expression of MBP-tagged NOT1-CN9BD (residues
V1351–L1588) with His6-tagged CAF40 (R19–E285). The cells
were lysed in a buffer containing 50 mM potassium phosphate
(pH 7.5), 300 mM NaCl and 2 mM β-mercaptoethanol. The com-
plex was purified from the cleared lysate by using amylose resin, and
this was followed by removal of the His6 and MBP tags by cleavage
with HRV3C protease overnight at 4°C during dialysis in a buffer
containing 50 mMHEPES (pH 7.5), 150 mMNaCl, 10% (v/v) glyc-
erol and 2 mM DTT. The complex was separated from the tags by
binding to a HiTrap Heparin column (GE Healthcare), and this
was followed by elution with a linear gradient to 1 M NaCl.
Finally, size exclusion chromatography was performed using a
Superdex 200 26/600 column in a buffer containing 10 mM
HEPES (pH 7.5), 150mMNaCl, 10% (v/v) glycerol and 2mMDTT.
A detailed description of the purification of the additional mod-
ules of the human and Drosophila CCR4–NOT complex can be
found in the Supplemental Material.
Crystallization, data collection, and structure
determination
A detailed description of the crystallization conditions and the struc-
ture determination process are included in the Supplemental
Material. Diffraction data sets of the CN9BD–CAF40–Bam CBM
complex were recorded on a PILATUS 6M detector at the PXII
beamline of the Swiss Light Source at a temperature of 100 K. The
best data set of the CAF40–Bam CBM complex was recorded on a
PILATUS 6M fast detector (DECTRIS) at the DESY beamline P11.
The diffraction data and refinement statistics are summarized in
Table 1.
In vitro MBP pull-down assays
Purified MBP (20 µg) or MBP-tagged full-length Bam or fragments
(40 µg) were incubated with equimolar amounts of purified CCR4–
NOT complex modules or subunits and amylose resin (New
England Biolabs) in pull-down buffer containing 50 mM HEPES
(pH 7.5), 200 mM NaCl and 2 mM DTT. After 1 h incubation,
the beads were washed five times with pull-down buffer and the pro-
teins were eluted with pull-down buffer supplemented with 25 mM
D-(+)-Maltose. The eluted proteins were precipitated with trichlo-
roacetic acid and analyzed by SDS-PAGE and subsequent
Coomassie staining.
In vitro competition assays
Purified GST-tagged CAF40 (ARM domain, 50 µg) was incubated
with equimolar amounts of either MBP-tagged Bam CBM or
MBP-Roquin CBM, increasing amounts of His6-NusA-tagged
Bam CBM as a competitor, and 50 µL 50% slurry of Protino gluta-
thione agarose 4B (Macherey-Nagel). Purified His6-NusA served as
a negative control. The experiment was performed in pull-down
buffer. After 1 h of incubation, the beads were pelleted and washed
three times with pull-down buffer. The proteins bound to the beads
were eluted by boiling the beads in 2× protein sample buffer. The
eluted proteins were analyzed by SDS-PAGE and subsequent
Coomassie staining.
Isothermal titration calorimetry (ITC)
and bioinformatics analysis
The ITC measurements were performed as previously described
(Igreja et al. 2014). A detailed description of the ITC conditions
and the bioinformatic analysis can be found in the Supplemental
Material.
DATA DEPOSITION
The coordinates for the structure of the Bam CBM peptide bound to
CAF40 and to the CAF40module were deposited in the Protein Data
Bank (PDB) under ID code 5ONB and 5ONA, respectively.
SUPPLEMENTAL MATERIAL
Supplemental material is available for this article.
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Supplemental Table S1. Constructs and mutants used in this study. 
 
Name Bag of marbles (Uniprot P22745) 
Comment 
Bam λN-HA-Bam 1–442  
 SBP-Bam 1–442  
 MS2-HA-Bam 1–442  
 MBP-Bam 1–442  
Bam-N λN-HA-Bam 1–140  
 GFP-Bam 1–140  
 MS2-HA-Bam 1–140  
 MBP-Bam 1–140  
Bam-C λN-HA-Bam 141–442  
 GFP-Bam 141–442  
 MBP-Bam 141–442  
CBM λN-HA-GST-Bam 13–36  
 SBP-MBP-Bam 13–36  
 MS2-HA-MBP-Bam 13–36  
 MBP-Bam 13–36  
 His6-NusA-Bam 13–36  
ΔCBM λN-HA-Bam Δ13–36 Disrupts CAF40 binding 
 MBP-Bam Δ13–36 Disrupts CAF40 binding 
L17E λN-HA-Bam L17E Disrupts CAF40 binding 
 MBP-Bam 1–442 L17E Disrupts CAF40 binding 
M24E λN-HA-Bam M24E Disrupts CAF40 binding 
 MBP-Bam 1–442 M24E Disrupts CAF40 binding 
L28E λN-HA-Bam L28E Disrupts CAF40 binding 
V32E λN-HA-Bam V32E Disrupts CAF40 binding 
4xMut λN-HA-Bam L17E, M24E, L28E, V32E 
Disrupts CAF40 binding 
 SBP-Bam L17E, M24E, L28E, V32E 
Disrupts CAF40 binding 
 MS2-HA-Bam L17E, M24E, L28E, V32E 
Disrupts CAF40 binding 
 
Name Hs NOT1 (Uniprot A5YKK6) 
Comment 
NOT1 N Hs NOT1 1–1000  
NOT1 MIF4G His6-Hs NOT1 1093–1317 MIF4G-like domain 
NOT1 CN9BD MBP-Hs NOT1 1351–1588 CNOT9-binding domain 
NOT1 MIF4G-C MBP-Hs NOT1 1607–1815 Predicted MIF4G-like domain 
NOT1 SHD MBP-Hs NOT1 1833–2361 Superfamily homology domain 
 
Name Hs NOT2 (Uniprot Q9NZN8) 
Comment 
NOT2-C MBP-Hs NOT2 350–540  
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Name Hs NOT3 (Uniprot O75175) 
Comment 
NOT3-N MBP-Hs NOT3 2–212  
NOT3-C His6-Hs NOT3 607–748  
 
Name Hs CCR4a (Uniprot Q9ULM6) 
Comment 
CCR4a full-length MBP-Hs CCR4a  
 
Name Hs CAF1 (Uniprot Q9UIV1) 
Comment 
CAF1 full-length MBP-Hs CAF1  
 
Name Hs CAF40 (Uniprot Q92600) 
Comment 
CAF40-ARM wt His6-Hs CAF40 19–285  
 GST-Hs CAF40 19–285  
CAF40 wt SBP-MBP-CAF40 1–299  
V181E SBP-MBP-CAF40 1–299 V181E  
 
Name Hs NOT10 (Uniprot Q9H9A5) 
Comment 
NOT10 TPR Hs NOT10 25–707  
 
Name Hs NOT11 (Uniprot Q9UKZ1) 
Comment 
NOT11-C Hs NOT11 257–498-His6  
 
Name Dm CAF40 (1–304) (Uniprot Q7JVP2) 
Comment 
CAF40 wt λN-HA-CAF40 1–304  
 GFP-CAF40 1–304 dsRNA resistant 
CAF40-ARM wt His6-CAF40 25–291   
V186E GFP-CAF40 V186E Disrupts CBM binding; dsRNA resistant  
 His6-CAF40 25–291 V186E Disrupts CBM binding 
2xMut His6-CAF40 25–291 Y139E, G146E 
Disrupts CBM binding 
 
Name Dm NOT1  (Uniprot  A8DY81) 
Comment 
NOT1 λN-HA-NOT1  
NOT1-CN9BD λN-HA-NOT1 1467–1719 CAF40-binding domain 
 MBP-NOT1 1468–1719 CAF40-binding domain 
 
	  
4	  
Supplemental Table S2. Antibodies used in this study. 
 
Antibody Source Catalog 
Number 
Dilution Monoclonal/ 
Polyclonal 
Anti-HA-HRP Roche 12 013 819 001 1:5,000 Monoclonal 
Anti-GFP (for western 
blotting) 
Roche 11 814 460 001 1:2,000 Mouse 
Monoclonal 
Anti-GFP (for 
immunoprecipitation) 
In house   Rabbit 
Polyclonal 
Anti-Dm NOT1 Kind gift from 
E. Wahle 
T6199 1:1,000 Rabbit 
Polyclonal 
Anti-Dm CAF40 In house  1:1,000 Rabbit 
Polyclonal 
Anti-Hs NOT1 In house  1:2,000 Rabbit 
Polyclonal 
Anti-Hs NOT2 Bethyl A302-562A 1:2,000 Rabbit 
Polyclonal 
Anti-Hs NOT3 Abcam Ab55681 1:2,000 Monoclonal 
Anti-Hs CAF40 
(RQCD1) 
Proteintech 22503-1-AP 1:1,000 Rabbit 
Polyclonal 
Anti-tubulin Sigma-Aldrich T6199 1:10,000 Monoclonal 
Anti-Dm PABP In house  1:10,000 Rabbit 
Polyclonal 
Anti-V5 AbD Serotec MCA1360GA 1:5,000 Monoclonal 
Anti-mouse-HRP GE Healthcare NA931V 1:10,000 Monoclonal 
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SUPPLEMENTAL FIGURES 
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Supplemental Figure S1. Sequence alignment of Drosophila Bam. The secondary structure 
elements, as predicted by PSIPRED (http://bioinf.cs.ucl.ac.uk/psipred/), are indicated in black. 
Residues conserved in all aligned sequences are shown with a dark red background, and residues 
with >70% similarity are highlighted in light red; conservation scores were calculated using the 
SCORECONS webserver (Valdar 2002). The CAF40-binding motif (CBM) is indicated. Black 
dots indicate residues in the CBM that directly contact CAF40. Green asterisks indicate residues 
mutated in this study.  
 
	  
7	  
 
Supplemental Figure S2. Bam promotes mRNA degradation. (A) Representative northern blot 
showing the decay of the F-Luc-5BoxB mRNA in S2 cells expressing λN-HA or λN-HA-tagged 
Bam or the Bam-N fragment after inhibition of transcription by actinomycin D. (B) F-Luc 
mRNA levels were normalized to those of the rp49 mRNA and plotted against time. (C,D) 
Tethering assay using the F-Luc reporter lacking BoxB sites and λN-HA-tagged Bam (full-length 
or the indicated fragments) in S2 cells. The samples were analyzed as described in Figure 1B–D. 
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The corresponding experiment with the F-Luc-5BoxB reporter is shown in Figure 1B. (E) 
Normalized F-Luc activity values corresponding to the experiment described in Figure 2A and B. 
The F-Luc-5BoxB activity was normalized to that of the R-Luc transfection control and set to 
100% in cells expressing the λN-HA peptide. The grey and green bars represent the normalized 
F-Luc-5BoxB activity in control cells expressing GFP-V5 and in DCP2-depleted cells expressing 
GFP-DCP2*-V5, respectively. (F) Normalized F-Luc-5BoxB activity values corresponding to 
the experiment described in Figure 2D and E. (G) Normalized F-Luc-5BoxB-A95-C7-HhR 
reporter mRNA levels corresponding to the experiment described in Figure 2F and G. 
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Supplemental Figure S3. Bam interacts with the CCR4-NOT complex. (A-E) 
Coimmunoprecipitation assays showing the interaction of HA-tagged Bam with the indicated 
GFP-tagged CCR4-NOT subunits in S2 cell lysates treated with RNase A. In all panels, GFP-F-
Luc served as a negative control. Inputs (1% for the HA-tagged proteins and 3% for the GFP-
tagged proteins) and immunoprecipitates (30% for the HA-tagged proteins and 10% for the GFP-
tagged proteins) were analyzed by western blotting. Protein size markers are shown on the right 
in each panel. (F) Schematic representation of the Hs CCR4-NOT complex. NOT1 contains two 
HEAT repeat domains (shown in blue and petrol), a MIF4G domain composed of HEAT repeats 
(green), a three-helix bundle domain (CN9BD, yellow), a connector domain (CD, light blue) and 
a NOT1 superfamily homology domain (SHD, gray), which also consists of HEAT repeats. The 
additional subunits of the complex are shown at their binding positions on NOT1. (G)  In vitro 
MBP pull-down assay testing the interaction of MBP-tagged full-length Bam with the indicated 
Hs CCR4-NOT subcomplexes. MBP served as a negative control.  
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Supplemental Figure S4. Bam requires binding to the mRNA target to induce degradation. 
(A,B) Tethering assay using the F-Luc reporter lacking BoxB sites and λN-HA-tagged Bam (full-
length or the indicated fragments) in S2 cells. The samples were analyzed as described in Figure 
1B–D. The corresponding experiment with the F-Luc-5BoxB reporter is shown in Figure 3E and 
F. 
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Supplemental Figure S5. Crystal structure of the Bam CBM bound to CAF40 and the CN9BD–
CAF40 module. (A) Crystal packing of the CAF40–Bam CBM complex. The four copies of 
CAF40 (chains A, C, E and G) are shown in different shades of gray, the four Bam CBM 
peptides (chains B, D, F and H) in different colors. (B) Superposition of the four CAF40-Bam 
CBM complexes in the asymmetric unit in ribbon representation. Colors are as in (A). (C) 
Superposition of a CAF40 homodimer (orange and yellow, PDB 2FV2; Garces et al. 2007), with 
a CAF40 homodimer bound to the Bam CBM (chains A–D, colors are as in (A)). (D) Crystal 
packing of the NOT1 CN9BD-CAF40-Bam CBM complex in cartoon representation. The NOT1 
CN9BD is shown in cyan and blue (chains A and D, respectively), CAF40 in gray and black 
(chains B and E), and Bam in red and pink (chains C and F). (E) Superposition of the two NOT1 
CN9BD-CAF40-Bam complexes in the asymmetric unit. Colors are as in (D). (F) Superposition 
of the CAF40-Bam complex and NOT1 CN9BD-CAF40-Bam complex structures. (G) 
Superposition of the NOT1 CN9BD-CAF40-Bam CBM complex with the NOT1 CN9BD-
CAF40 complex with bound tryptophan (PDB 4CRV) (Chen et al. 2014). 
 
	  
14	  
 
Supplemental Figure S6. Simulated annealing electron density of the Bam CBM peptide. (A) 
Stereo view showing the 2FO-FC simulated annealing composite omit map surrounding the 
CN9BD-CAF40-bound CBM peptide contoured at 1.0 σ. This map was generated with 
Phenix.Composite_omit_map (Afonine et al. 2012) using the final refined CN9BD-CAF40-Bam 
model. (B) Stereo view showing the 2FO-FC simulated annealing composite omit map 
surrounding the CAF40-bound CBM peptide contoured at 1.0 σ. This map was generated with 
Phenix.Composite_omit_map (Afonine et al. 2012) using the final refined CAF40-Bam model. 
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Supplemental Figure S7. The CBM is required for Bam activity. (A) Representative isothermal 
titration calorimetry thermogram showing the interaction of the MBP-tagged Bam CBM with the 
NOT1 CN9BD-CAF40 complex. The upper panel shows raw data, and the lower panel shows 
the integration of heat changes associated with each injection. Data were fitted using a one-site 
binding model. (B) Coimmunoprecipitation assay showing the interaction of HA-tagged Bam 
with GFP-tagged CAF40 in S2 cell lysates treated with RNase A. GFP-F-Luc served as a 
negative control. Inputs (1% for the HA-tagged proteins and 3% for the GFP-tagged proteins) 
and immunoprecipitates (30% for the HA-tagged proteins and 10% for the GFP-tagged proteins) 
were analyzed by western blotting. (C,D) Tethering assay using the F-Luc reporter lacking BoxB 
sites and λN-HA-tagged Bam (wild-type or the indicated mutants) in S2 cells. The samples were 
analyzed as described in Figure 1B–D. The corresponding experiment with the F-Luc-5BoxB 
reporter is shown in Figure 6A and B. (E) Tethering assays using the β-globin-6xMS2bs reporter 
and MS2-HA-tagged Bam (full-length, MBP-Bam CBM or the 4xMut) in human HEK293T 
cells. A plasmid expressing a β-globin mRNA reporter lacking MS2-binding sites (Control) 
served as a transfection control. The β-globin-6xMS2bs mRNA level was normalized to that of 
the control mRNA and set to 100% in cells expressing MS2-HA. The mean values ± s.d. from 
three independent experiments are shown in (E). (F) Representative northern blot of samples 
shown in (E). (G) Western blot showing the equivalent expression of the MS2-HA-tagged Bam 
constructs used in (E) and (F). (H) Western blot showing the efficiency of the CAF40 depletion 
in HEK293T cells corresponding to the experiment shown in Figure 6D and E. Dilutions of 
control cell lysates were loaded in lanes (1–4) to estimate the efficacy of the depletion. Tubulin 
served as a loading control. KO: knockout. Protein size markers are shown on the right in each 
panel. (I,J) Coimmunoprecipitation assays showing the interaction of HA-tagged Bam with GFP-
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tagged CCR4 (I) and NOT2 (J) in S2 cell lysates treated with RNaseA. GFP-F-Luc served as a 
negative control. Inputs (1% for the HA-tagged proteins and 3% for the GFP-tagged proteins) 
and immunoprecipitates (30% for the HA-tagged proteins and 10% for the GFP-tagged proteins) 
were analyzed by western blotting. Protein size markers (kDa) are shown on the right in each 
panel. 
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Supplemental Figure S8. Profile-based sequence alignment. Profile-based sequence alignment 
of CBMs from Roquin and Bam of the indicated Drosophila species, as well as putative CBMs 
of proteins from Hs and Dm shown in red. Residues known or expected to interact with CAF40 
are highlighted by a light green background. Gray letters indicate residues that were not included 
in the crystallization setup. Numbers on both sides of the alignment indicate the residue numbers 
of the respective fragment boundaries.  
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SUPPLEMENTAL MATERIAL AND METHODS 
DNA constructs  
The plasmids used for the expression of subunits of the human and Dm CCR4-NOT complex and 
Dm Roq in cells have been previously described (Brau et al. 2011; Bawankar et al. 2013; Sgromo 
et al. 2017). The plasmids for the expression of Hs NOT2-C, NOT3-C, CAF40 ARM domain 
and the NOT1 MIF4G, CN9BD, CD and SHD domains in Escherichia coli have been previously 
described (Petit et al. 2012; Boland et al. 2013; Chen et al. 2014a; Sgromo et al. 2017). The 
plasmids for expression of the β-globin-6xMS2bs and the control β-globin-GAP mRNA in 
human cells were kindly provided by Dr. Lykke-Andersen and have been previously described 
(Lykke-Andersen et al. 2000). The plasmids for tethering assays in S2 cells (F-Luc-5BoxB, F-
Luc-V5, F-Luc-5BoxB-A95C7-HhR, and R-Luc) have been previously described (Behm-Ansmant 
et al. 2006; Zekri et al. 2013). 
For expression of Bam (full-length and fragments) in Dm S2 cells, the corresponding cDNA was 
amplified from total Dm oocyte cDNA and cloned between the XhoI and ApaI restriction sites of 
the pAc5.1-λN-HA and pAc5.1-GFP vectors (Rehwinkel et al. 2005; Tritschler et al. 2007). For 
expression in HEK293T cells, the cDNA encoding Bam was inserted between the BglII and 
BamHI restriction sites of the pT7-V5-SBP-C1 and pT7-MS2-HA vectors (Jonas et al. 2013). 
The plasmids for expression of Bam (full-length, Bam CBM and Bam fragments) in Escherichia 
coli were obtained by inserting the corresponding Bam cDNA fragments between the XhoI and 
AvrII restriction of the pnYC-vM plasmid (Diebold et al. 2011), thus yielding fusion proteins 
carrying N-terminal MBP tags cleavable by the TEV protease. For expression of the Hs NOT1-
10-11 complex, two plasmids were generated. A cDNA fragment encoding the Hs NOT1 N-
terminus (residues M1–D1000) was inserted into the AvrII restriction site of the pnYC vector, 
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which does not encode a solubility tag. cDNA fragments encoding Hs NOT10 (residues D25–
Q707) and Hs NOT11 (residues D257–D498) were cloned in a bicistronic plasmid based on the 
pnEA backbone, thus resulting in the expression of untagged NOT10 and NOT11 with a C-
terminal, TEV-cleavable His6 tag. For expression of the human catalytic module, the His6-tagged 
human NOT1 MIF4G domain (residues E1093-S1317) was coexpressed with a bicistronic 
plasmid expressing untagged CAF1 and CCR4a with an N-terminal MBP-tag cleavable by the 
HRV3C protease. Hs NOT1-CD cDNA was cloned in the pnYC-pM plasmid (Diebold et al. 
2011), thereby generating a fusion protein containing an N-terminal MBP tag that is cleavable by 
the HRV3C protease. The cDNA encoding the NOT3-N fragment (residues A2–D212) was 
inserted between the XhoI and BamH1 restriction sites of the pnEA-pM vector, thus resulting in 
an N-terminally MBP-tagged protein.  
 
Coimmunoprecipitation and SBP-pull-down assays  
For coimmunoprecipitation assays in S2 cells, 2.5×106 cells were seeded per well in 6-well plates 
and transfected using Effectene transfection reagent (Qiagen). The transfection mixtures 
contained plasmids expressing GFP-tagged CCR4-NOT of subunits (2 µg) or HA-tagged Bam (1 
µg). Cells were harvested 3 days after transfection, and coimmunoprecipitation assays were 
performed using RIPA buffer [20 mM HEPES (pH 7.6), 150 mM NaCl, 2.5 mM MgCl2, 1% NP-
40, 1% sodium deoxycholate supplemented with protease inhibitors (Complete protease inhibitor 
mix, Roche)] as previously described (Tritschler et al. 2008). For SBP pull-down assays in 
human cells, HEK293T cells (ATCC, wild-type or CAF40-null cells) were grown in 10-cm 
dishes (4×106 / 10-cm dish) and transfected using TurboFect transfection reagent (Thermo Fisher 
Scientific). The transfection mixtures contained 20 µg, 5 µg and 25 µg of plasmids expressing 
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Bam, MBP-CBM and Bam 4xMut, respectively. For the pull-down assays in Figure 6E and G, 
cells were also co-transfected with 8 µg of a plasmid expressing HA-tagged CCR4. The cells 
were harvested 2 days after transfection, and pull-down assays were performed as previously 
described (Bhandari et al. 2014).  
 
Generation of the CAF40-null cell line 
An sgRNA (sequence: 5’ CCCATGCTGTGGCATTCATT 3’) targeting the second exon of the 
Hs CAF40 gene was designed using CHOPCHOP (http://chopchop.cbu.uib.no) and inserted into 
the pSpCas9(BB)-2A-Puro (PX459) vector (a gift from F. Zhang, Addgene plasmid 48139) (Ran 
et al. 2013). HEK293T cells were transfected with the pSp-CAF40-sgRNA-Cas9(BB)-2A-Puro 
plasmid and selected with puromycin (3 µg/ml) to obtain stable CAF40 knockout cells. To obtain 
clonal cell lines, single cells were distributed in 96-well plates using serial dilutions. Expansion 
of single-cell clones was performed under non-selective conditions. CAF40-null clones were 
identified by western blotting using anti-CAF40 antibodies (Supplemental Table S2). Genomic 
DNA from single clones was isolated using a Wizard SV Genomic DNA Purification System 
(Promega) and the targeted CAF40 locus was amplified by PCR and sequenced to confirm gene 
editing. We observed a deletion of 22nt in one allele and an insertion of one nucleotide in the 
second exon of CAF40 in the other allele, both of which cause a frameshift.  
 
Protein expression, purification and competition assays 
To purify the Dm NOT1 CN9BD-CAF40 complex, MBP-tagged NOT1-CN9BD (residues 
Y1468-T1719) was co-expressed with His6-tagged CAF40 (ARM domain, residues E25–G291). 
The cells were lysed in a buffer containing 50 mM HEPES (pH 7.5), 300 mM NaCl, 20 mM 
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imidazole and 2 mM β-mercaptoethanol. The complex was purified from cleared cell lysates by 
Nickel affinity chromatography using a HiTrap IMAC column and eluted by a linear gradient to 
500 mM imidazole. The complex was further purified on a HiTrapQ column (GE Healthcare), 
and this was followed by removal of the His6 and MBP tags by cleavage with HRV3C protease 
overnight at 4°C. The complex was separated from the tags by size exclusion chromatography 
using a Superdex 200 26/600 column in a buffer containing 10 mM HEPES (pH 7.5), 200 mM 
NaCl and 2 mM DTT. 
For competition assays, the CAF40 ARM domain was expressed with an N-terminal GST tag. 
The cells were lysed in a buffer containing 50 mM HEPES (pH 7.5), 300 mM NaCl and 2 mM 
DTT. The protein was purified from cleared cell lysates by using Protino glutathione agarose 4B 
(Macherey-Nagel) followed by a HiTrapQ column and further purified by size exclusion 
chromatography on a Superdex 200 26/600 column in a buffer containing 10 mM HEPES (pH 
7.5), 200 mM NaCl and 2 mM DTT. The Roquin CBM fused to MBP was purified as previously 
described (Sgromo et al. 2017). Cells expressing either His6-NusA-tagged Bam CBM or His6-
NusA were lysed in a buffer containing 50 mM potassium phosphate (pH 7.5), 300 mM NaCl, 20 
mM imidazole and 2 mM β-mercaptoethanol. The proteins were isolated from the crude cell 
lysate by Nickel affinity chromatography using a HiTrap IMAC column and eluted by a linear 
gradient to 500 mM imidazole. The eluted proteins were directly applied to size exclusion 
chromatography on a Superdex 200 16/600 column in a buffer containing 10 mM HEPES (pH 
7.5), 200 mM NaCl and 2 mM DTT. 
The assembled Hs NOT1-10-11 trimer was obtained by co-expression of C-terminally His6-
tagged NOT11 (residues D257–D498) and untagged NOT1 (residues M1–D1000) and NOT10 
(residues D25–Q707). The cells were lysed in 50 mM potassium phosphate (pH 7.6), 300 mM 
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NaCl, 20 mM imidazole and 2 mM β-mercaptoethanol. The complex was purified from cleared 
cell lysates by using a HiTrap IMAC column and eluted by a linear gradient to 500 mM 
imidazole. The complex was dialyzed in a buffer containing 50 mM HEPES (pH 7.5), 200 mM 
NaCl and 2 mM DTT, and was further purified over a HiTrap Heparin column (GE Healthcare), 
then subjected to size exclusion chromatography over a Superdex 200 26/600 column in a buffer 
containing 10 mM HEPES (pH 7.5), 200 mM NaCl and 2 mM DTT. 
To purify the assembled catalytic module, His6-tagged NOT1 MIF4G domain (residues E1093–
S1317), untagged CAF1 and MBP-tagged CCR4a were co-expressed. Cells were lysed in a 
buffer containing 50 mM potassium phosphate (pH 7.5), 300 mM NaCl and 2 mM β-
mercaptoethanol. The complex was purified from cleared cell lysates using amylose resin and 
eluted with in a buffer containing 50 mM potassium phosphate (pH 7.5), 300 mM NaCl, 20 mM 
imidazole, 25 mM D(+)-maltose and 2 mM β-mercaptoethanol. The complex was further 
purified using a HiTrap IMAC column (GE Healthcare) and eluted by a linear gradient to 500 
mM imidazole. The His6 and MBP tags were removed by cleavage with the HRV3C protease 
overnight at 4°C. The catalytic module was further purified over a Superdex200 (26/600 column; 
GE Healthcare) in a buffer containing 10 mM HEPES (pH 7.5), 200 mM NaCl and 2 mM DTT. 
The Hs NOT3 N-terminus (residues A2–D212) was expressed with an N-terminal MBP tag. 
Cells were lysed in a buffer containing 50 mM HEPES (pH 7.5), 300 mM NaCl and 2 mM DTT. 
The protein was purified from cleared cell lysates with amylose resin, then with a HiTrapQ 
column. The MBP tag was removed by cleavage using the HRV3C protease. After cleavage of 
the tag, the protein was further purified on a Superdex 75 26/600 column (GE Healthcare) using 
a buffer containing 10 mM HEPES (pH 7.5), 200 mM NaCl and 2 mM DTT. 
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The purification procedures for the human NOT1-CD (residues D1607–S1815) and of the NOT 
and CAF40 modules have been previously described (Chen et al. 2014; Raisch et al. 2016; 
Sgromo et al. 2017). The NOT module comprises the NOT1-SHD (residues H1833–M2361), 
NOT2-C (residues M350–F540) and NOT3-C (residues L607–E748). The Hs CAF40 module 
comprises NOT1-CN9BD (residues V1351–L1588) and the CAF40 ARM domain (residues R19-
E285). The Dm Bam CBM peptide (residues D13–E36) used for crystallization was obtained 
from EMC microcollections and solubilized in a buffer containing 10 mM HEPES (pH 7.5), 200 
mM NaCl and 2 mM DTT. 
 
Crystallization  
Crystals of Hs CAF40 (ARM domain) bound to Bam CBM peptide (residues D13–E36) were 
obtained at 22°C using the hanging-drop vapor diffusion method after the protein solution (6 
mg/ml CAF40 and 1.1 mg/ml Bam CBM peptide; 200 nl) was mixed with the crystallization 
reservoir solution (200 nl). Crystals appeared within one day in many conditions. Optimized 
crystals grew at 18°C in hanging drops consisting of 1 µl protein solution (6 mg/ml CAF40 and 
1.1 mg/ml Bam CBM peptide) and 1 µl crystallization reservoir solution containing 100 mM 
HEPES (pH 7.0), 200 mM CaCl2 and 15% PEG 6,000. Crystals were soaked in reservoir solution 
supplemented with 15% ethylene glycol for cryoprotection before being flash-frozen in liquid 
nitrogen. 
Crystals of the Hs NOT1 CN9BD–CAF40 complex bound to the Bam CBM peptide were 
obtained at 22°C by using the hanging-drop vapor diffusion method after mixing the protein 
solution (7.5 mg/ml NOT1 CN9BD–CAF40 and 0.8 mg/ml CBM peptide; 200 nl) with the 
crystallization reservoir solution (200 nl). Crystals appeared within one day in several conditions. 
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Optimized crystals grew in drops of 200 nl protein solution (5 mg/ml NOT1 CN9BD–CAF40 
complex and 0.5 mg/ml CBM peptide) mixed with 200 nl crystallization reservoir solution 
comprising 1.5 M ammonium sulfate, 20 mM MES (pH 6.0) and 80 mM MES (pH 6.5). Crystals 
were soaked in reservoir solution supplemented with 25% glycerol for cryoprotection before 
flash-freezing in liquid nitrogen.  
 
Data collection and structure determination 
X-ray diffraction data for the Hs NOT1 CN9BD–CAF40 bound to the Bam CBM were collected 
at a wavelength of 1.0000 Å on a PILATUS 6M detector (Dectris) at the PXII beamline of the 
Swiss Light Source (SLS) and processed in space group P3221 by using XDS and XSCALE 
(Kabsch 2010) to a resolution of 2.7 Å, aiming at a CC(1/2) value (Karplus and Diederichs 2012) 
of ~70 % as a high resolution cutoff. Initial phases were determined by molecular replacement, 
with two copies of the NOT1 CN9BD–CAF40 complex (PDB 4CRU) used as a search model in 
PHASER (McCoy et al. 2007) from the CCP4 package (Winn et al. 2011). The initial model was 
improved and completed by iterative cycles of building in COOT (Emsley et al. 2010) and 
refinement in PHENIX (Afonine et al. 2012), also optimizing TLS parameters (one TLS group 
per macromolecular chain). Finally, two copies of the Bam CBM peptide were manually built 
into the density (Supplemental Fig. S6A) and improved by further refinement cycles.  
The best crystal of the CAF40 (ARM domain) bound to the Bam CBM peptide was recorded at a 
wavelength of 1.0396 Å on a PILATUS 6M fast detector (DECTRIS) at the DESY beamline 
P11. The dataset was processed in XDS and XSCALE in space group P21212 to a resolution of 
3.0 Å, aiming at a CC(1/2) value (Karplus and Diederichs 2012) of ~70 % as a high resolution 
cutoff. Four copies of the CAF40 ARM domain (PDB 2FV2, chain A) were found in the 
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asymmetric unit by molecular replacement using PHASER from the CCP4 package. This initial 
model was improved and completed by iterative cycles of building in COOT (Emsley et al. 
2010) and refinement using PHENIX (Afonine et al. 2012) and BUSTER (Bricogne et al. 2011) 
using NCS restraints and TLS parameters (one TLS group per macromolecular chain). Finally, 
four copies of the Bam CBM peptide were manually built into the density (Supplemental Fig. 
S6B) and improved through further refinement cycles.  
The stereochemical properties for all of the structures were verified with MOLPROBITY (Chen 
et al. 2010), and illustrations were prepared using PyMOL (http://www.pymol.org). The 
diffraction data and refinement statistics are summarized in Table 1. 
 
Isothermal titration calorimetry (ITC) 
The ITC experiments were performed on a VP-ITC microcalorimeter (Microcal) at 20°C. A 
solution containing the Dm NOT1 CN9BD bound to CAF40 (ARM domain) (6.0 µM in the 
experiments with the Bam CBM and up to 10 µM in the experiments with the Roq CBM) in a 
calorimetric cell was titrated with a solution of MBP-tagged Bam CBM (60 µM) or MBP-tagged 
Roquin CBM (up to 100 µM). All proteins were dissolved in a buffer containing 10 mM HEPES 
(pH 7.5), 200 mM NaCl and 0.5 mM TCEP. The titration experiments consisted of an initial 
injection of 2 µl followed by 28 injections of 10 µl at 240 s intervals. The binding experiment 
was repeated three times. The thermodynamic parameters were calculated using a one-site 
binding model (ORIGIN version 7.0; Microcal). Correction for dilution heating and mixing was 
achieved by subtracting the final baseline, which consisted of small peaks of similar size. The 
first injection was removed from the analysis (Mizoue and Tellinghuisen 2004).  
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Bioinformatic analysis 
To identify proteins featuring potential CBMs in Dm and Hs, we followed a two-step approach. 
In the first step, we searched for homologs of Dm Bam and Roquin in the nonredundant (nr) 
protein sequence database using PSI-BLAST (Boratyn et al. 2013), as implemented in the MPI 
Bioinformatics toolkit (Alva et al. 2016), and extracted the CBMs from the obtained homologs 
originating from different Drosophila species. These motifs were then aligned, and a consensus 
pattern was derived by manual inspection (x-x-x-[LI]-[DENQ]-x(2,3)-[FLM]-x-x-[ILM]-x-x-x-
[IL]-x-x-[ILM]-[LIV]-x-x-x-x). In the second step, the aforementioned consensus pattern was 
submitted to the PatternSearch tool of the MPI Bioinformatics Toolkit to identify proteins in Dm 
and Hs with potential CBMs. This search yielded a total of 1,200 candidate proteins. We next 
analyzed this set further to discard all proteins in which the detected motifs showed no helical 
propensity or were embedded within a domain (as opposed to being embedded in an intrinsically 
disordered region). We also excluded all proteins with obvious functional irrelevance (e.g. 
membrane proteins) from further consideration. Finally, we chose the Hs and Dm homologs of 
four protein families, on the basis of the presence of known or predicted RNA-binding domains 
in the proteins and on the percentage similarity of the putative CBMs to the CBMs of Bam and 
Roquin. These candidate CBMs were then expressed as MBP fusions and tested for CAF40 
binding in in vitro MBP pull-down assays. 
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Abstract 
The CCR4-NOT deadenylase complex plays a crucial role in post-transcriptional 
regulation of gene expression in eukaryotes. The complex assembles around the NOT1 
scaffold subunit which contains α-helical domains that provide binding sites for the 
other subunits. The NOT4 E3 ubiquitin ligase is one of the core subunits of the complex 
in yeast. However, it is not stably associated with the human (Hs) and Drosophila 
melanogaster (Dm) CCR4-NOT complexes. Here, we present data showing that both Hs 
and Dm NOT4 contain motifs in their C-terminal regions that directly interact with the 
CAF40 subunit of the complex. These CAF40 binding motifs (CBM) are necessary for 
NOT4 to induce degradation of bound mRNAs. Co-crystal structures of the Dm NOT4 
CBM bound to CAF40 reveal striking similarities to the interaction of Dm Roquin with 
CAF40. Disruption of the NOT4-CAF40 interaction using structure-based mutations or 
by depleting CAF40 impairs the ability of NOT4 to elicit mRNA degradation. Our 
results explain the molecular basis for the association of metazoan NOT4 proteins with 
the core of the CCR4-NOT complex. 
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Introduction 
The CCR4-NOT complex plays a central role in post-transcriptional regulation of gene 
expression by catalyzing the removal of mRNA poly(A) tails, thereby repressing translation 
and promoting mRNA degradation (Collart, 2016; Wahle and Winkler, 2013). In addition, the 
CCR4-NOT complex has the ability to repress translation independently of deadenylation 
(Cooke et al., 2010; Chekulaeva et al., 2011; Bawankar et al., 2013). The CCR4-NOT 
complex contains a catalytically inactive core of four to six subunits, depending on the 
organism (Chen et al., 2001; Lau et al., 2009; Temme et al., 2010). These subunits interact 
with the central NOT1 protein consisting of a series of α-helical domains which serve as 
binding sites for the other subunits (Bawankar et al., 2013). The N-terminal region of NOT1 
contains helical repeat domains that interact with the NOT10 and NOT11 subunits of the 
complex in many species including metazoans (Basquin et al., 2012; Bawankar et al., 2013; 
Mauxion et al., 2013). A central MIF4G (middle domain of eIF4G) domain of NOT1 provides 
a binding site for the catalytic module, which comprises two deadenylases, namely CAF1 (or 
its paralog POP2) and CCR4a (or its paralog CCR4b). The NOT1 MIF4G domain is followed 
by a helical bundle domain, CN9BD (CAF40/CNOT9 binding domain), which interacts with 
the CAF40 subunit. CAF40 in turn interacts with the GW182/TNRC6 and Roquin proteins 
(Chen et al., 2014; Mathys et al., 2014; Sgromo et al., 2017). The C-terminal region of NOT1 
contains the NOT1 superfamily homology domain (SHD), which interacts with the NOT2-
NOT3 heterodimer to form the NOT module. The NOT module provides binding sites for the 
translational regulators Nanos, Roquin and Bicaudal-C, which recruit the CCR4-NOT 
complex to their mRNA targets (Sgromo et al., 2017; Raisch et al., 2016; Bhandari et al., 
2014; Chicoine et al., 2007). In Saccharomyces cerevisiae (Sc), the NOT1 SHD also interacts 
with NOT4, an integral component of the yeast CCR4-NOT complex (Bai et al., 1999, 
Bhaskar et al., 2015).  
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NOT4 is an evolutionarily conserved E3 ubiquitin ligase that contains a RING domain, a 
coiled-coil region, an RRM domain and a C3H1 type zinc-finger domain at its N-terminus 
(NOT4-N). The C-terminal region (NOT4-C) is not well conserved and is predicted to be 
unstructured. The ubiquitin ligase activity of NOT4 depends on its specific interaction with 
the ubiquitin conjugating E2 enzyme UBCH5B, which has two orthologs in yeast: UBC4 and 
UBC5 (Albert et al., 2002; Bhaskar et al., 2015; Mulder et al., 2007). NOT4 ubiquitinates a 
large number of proteins including the small ribosomal protein RPS7A (Panasenko and 
Collart, 2012), the nascent polypeptide associated complex (NAC; Panasenko et al., 2006), 
the histone demethylase JHD2 (Mersman et al., 2009), Cyclin C (Cooper et al., 2012) and the 
transcription factor YAP1 (Gulshan et al., 2012). While the exact impact of the ubiquitination 
of these targets by NOT4 is not yet clear, it has been proposed that NOT4 plays a role in co-
translational quality control in the context of stalled ribosomes (e.g. in the No-go decay; 
Dimitrova et al., 2009; Matsuda et al., 2014; Panasenko, 2014). In line with this, it has also 
been reported that NOT4 is required for global translational repression under nutritional stress 
and particularly for repression of mRNAs that cause transient ribosome stalling in yeast 
(Preissler et al., 2015). 
Recently, it was shown that Sc NOT4 directly interacts with the C-terminal SHD of NOT1 
(Bhaskar et al., 2015). A crystal structure illustrated how Sc NOT4 uses an elongated 
polypeptide in its unstructured C-terminal region to bind the NOT1 SHD via predominantly 
hydrophobic interactions. However, this region of the protein is not well conserved in species 
other than yeast (Bhaskar et al., 2015), an observation that suggested a different mode of 
interaction between metazoan NOT4 proteins and the core of the CCR4-NOT complex. 
Accordingly, although NOT4 is stably associated with the CCR4-NOT complex in yeast (Bai 
et al., 1999) and can be co-purified with the endogenous and overexpressed complexes 
(Nasertorabi et al., 2011; Stowell et al., 2016; Ukleja et al., 2016), the interaction seems to be 
transient in vivo in metazoans as NOT4 was not detected in mass spectrometric analyses of 
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the native Hs and Drosophila melanogaster (Dm) CCR4-NOT complexes (Lau et al., 2009; 
Temme et al., 2010). However, the human (Hs) NOT4 was shown to interact with the C-
terminal half of NOT1 in yeast-two-hybrid assays (Albert et al., 2002), but the molecular 
basis and relevance of this association with the core complex has remained uncharacterized. 
To elucidate the interaction between Hs and Dm NOT4 and the core CCR4-NOT complex in 
molecular detail, we initially confirm that the unstructured C-terminal region of Hs NOT4 
directly interacts with the CCR4-NOT complex in vitro by multiple contacts, and the C-
terminal regions of Hs and Dm NOT4 promote degradation of bound mRNAs in reporter 
assays. Furthermore, we identify a CAF40 binding motif (CBM) within the C-terminal 
regions of Hs and Dm NOT4 that is necessary and sufficient to mediate direct binding to the 
CAF40 subunit of the CCR4-NOT complex. Co-crystal structures of the Dm NOT4 CBM 
bound to Hs CAF40 confirm an overall similar binding mode as in the case of the Dm Roquin 
CBM, but also reveal striking differences to Roquin (Sgromo et al., 2017). Structure-based 
mutations in the CBMs abrogate the ability of Hs and Dm NOT4 to induce mRNA 
degradation. Moreover, depletion of CAF40 in HEK293T cells abolishes the interaction of Hs 
NOT4 with the CCR4-NOT complex and impairs NOT4-mediated mRNA degradation. Our 
results demonstrate that CAF40 is an important mediator for the association of NOT4 with the 
core CCR4-NOT complex in metazoa. 
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Results 
Hs NOT4 directly interacts with the CCR4-NOT complex via its C-terminal region 
Previous studies have shown that Sc NOT4 can directly interact with the C-terminal NOT1 
SHD using an extended peptide motif in its C-terminal region (Fig. 1A) which is not well 
conserved outside yeast (Bhaskar et al., 2015; Panasenko and Collart, 2011). Hs NOT4 (the 
comparably short isoform 5) has also been shown to interact with the C-terminal half of 
NOT1 in yeast-two-hybrid assays (Albert et al., 2002), but the molecular basis of this 
interaction remained unknown. 
In order to better characterize the interaction of Hs NOT4 with the CCR4-NOT complex, we 
tested the interaction between full-length NOT4 (the longer isoform 1; Fig. 1A and S1) and a 
pentameric complex comprising the C-terminal half of NOT1 plus CAF1 and CAF40, and C-
terminal fragments of NOT2 and NOT3 (Sgromo et al., 2017) in in vitro MBP pulldown 
assays. Consistent with the previous yeast-two-hybrid experiment (Albert et al., 2002), we 
observed a direct interaction of NOT4 with this pentameric complex (Fig. 1B, lane 7). 
Furthermore, based on sequence alignments we generated two NOT4 fragments, one 
comprising the structured and conserved N-terminus (Fig. 1A; NOT4-N; residues M1-T274), 
and another corresponding to the unstructured C-terminal region (Fig. 1A; NOT4-C; residues 
P275-A575). While NOT4-N does not interact with the pentameric CCR4-NOT subcomplex 
(Fig. 1B, lane 8), NOT4-C binds as efficiently as the full-length protein (Fig. 1B, lane 9). This 
shows that the site of interaction is indeed located in the unstructured C-terminus of NOT4, as 
already proposed earlier (Albert et al., 2002). This direct interaction raises the question 
whether NOT4 can recruit the CCR4-NOT complex to bound mRNAs in order to induce their 
degradation. 
 
The C-terminal regions of Hs and Dm NOT4 induce degradation of bound mRNAs 
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To investigate whether NOT4 can induce degradation of mRNAs, we used an MS2-based 
tethering assay in Hs HEK293T cells. Full-length NOT4, NOT4-N and NOT4-C were 
expressed with an MS2-HA tag that binds to a β-globin reporter containing six MS2 binding 
sites in the 3' UTR (β-globin-6xMS2bs; Lykke-Andersen et al., 2000). Tethered Hs NOT4 
caused a strong reduction of the β-globin-6xMS2bs mRNA level compared to the negative 
control MS2-HA (Fig. 1C,D, lane 2). Similarly, tethered NOT4-C had the same effect 
whereas NOT4-N was inactive (Fig. 1C,D). All NOT4 fragments were expressed at 
comparable levels (Fig. 1E) and none of them affected the expression of the control β-globin 
mRNA lacking MS2 binding sites (Fig. 1D; control). 
We also tested the effect of NOT4 tethering on a reporter that contains the Renilla luciferase 
open reading frame and six MS2 binding sites in the 3' UTR (R-Luc-6xMS2bs). Tethered 
NOT4 and NOT4-C caused a significant reduction of the R-Luc activity compared to the 
MS2-HA control (Fig. S3A). The reduction is predominantly explained by a corresponding 
decrease in mRNA abundance of the reporter (Fig. S3A,B). An R-Luc reporter lacking the 
MS2 binding sites was not affected by the expression of MS2-HA-tagged full-length NOT4 or 
fragments (Fig. S3C,D). This suggests that NOT4 can indeed reduce the levels of mRNAs by 
inducing degradation, and that this activity resides exclusively in the C-terminal region of the 
protein. 
As NOT4-C is not well conserved between vertebrates and invertebrates (Fig. S1 and S2), we 
tested whether Dm NOT4 and its C-terminal region can actively induce mRNA degradation as 
well. To this end, we used a N-based tethering assay in Dm S2 cells (Behm-Ansmant et al., 
2006). Similar to the situation in Hs, Dm NOT4 and NOT4-C efficiently reduced the levels of 
the bound F-Luc-5BoxB reporter mRNA (Fig. 1F,G). These effects were matched by a similar 
reduction of F-Luc-5BoxB mRNA levels upon tethering NOT4 and NOT4-C (Fig. 1F). All 
three NOT4 fragments were expressed at comparable levels (Fig. 1H) and none of them 
affected the expression of an F-Luc reporter lacking the BoxB sites (Fig S3E,F). This 
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indicates that the repressive activity of the NOT4 C-terminal region is conserved between Hs 
and Dm. 
The CCR4-NOT complex is known to induce translational repression independently of 
deadenylation (Cooke et al., 2010; Zekri et al., 2013). To assess whether NOT4 can repress 
the expression of mRNAs in the absence of mRNA decay, we used an R-Luc-6xMS2bs 
reporter mRNA that contains a DNA-encoded stretch of 95 adenosine residues followed by 
the 3’-end of the long noncoding RNA MALAT1 which is processed by RNase P to form the 
non-adenylated 3’end of the RNA (R-Luc-6MS2bs-A95-MALAT; Kuzuoglu-Ozturk et al.; 
2016; Wilusz et al., 2012). NOT4 and NOT4-C efficiently repressed the translation of this 
reporter in HEK293T cells (Fig. S3G) without causing reporter mRNA decay (Fig. S3G,H). 
We thus conclude that the repressive activity of NOT4 resides exclusively in the C-terminal 
region. 
 
NOT4 causes mRNA decay via the 5’-to-3’ decay pathway 
The interaction of Hs NOT4 with the CCR4-NOT complex (Fig. 1B) suggests that the 
repressive activity of the protein may depend on the recruitment of CCR4-NOT to bound 
mRNAs. To investigate this question, we inhibited decapping by overexpressing a 
catalytically inactive mutant of the GFP-tagged decapping enzyme DCP2 (E148Q) in 
HEK293T cells (Fig. S3I,J). In these cells, NOT4 caused the accumulation of a shorter, 
deadenylated decay intermediate of the β-globin-6xMS2bs reporter mRNA (Fig. S3I,J, lane 5 
vs. 2). Hs Nanos2, which is known to induce mRNA decay via the 5’-to-3’ decay pathway 
(Bhandari et al., 2014), was used as a positive control (Fig. S3I,J lane 6 vs. 3). These results 
suggest that NOT4 funnels bound mRNAs into the general 5’-to-3’-mRNA decay pathway 
where deadenylation is followed by decapping and exonucleolytic degradation. 
Similar results were obtained in Dm S2 cells when overexpressing a GFP-tagged DCP1 
mutant (R70G-L71S-N72S-T73G) that inhibits decapping in a dominant negative manner 
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(Chang et al., 2014; Kuzuoglu-Ozturk et al., 2016). As observed in Hs HEK293T cells, 
tethered NOT4 caused a stabilization of a deadenylated species of the F-Luc-5BoxB reporter 
mRNA similar to the positive control, the GW182 protein (Fig. S3K,L). The equivalent 
expression level of the overexpressed proteins was confirmed by western blot (Fig. S3M). 
The accumulation of deadenylated mRNA reporters upon NOT4 tethering in decapping-
compromised cells suggests that NOT4 mediates deadenylation-dependent decapping.  
 
Hs NOT4 possesses binding sites for different modules of the CCR4-NOT complex 
To determine which subunits of the CCR4-NOT complex interact with NOT4, we performed 
MBP pulldown assays with different purified modules, namely the NOT10-NOT11 module 
(comprising the N-terminus of NOT1, the C-terminal half of NOT11 and NOT10), the NOT1 
MIF4G bound to CAF1, CAF40 in complex with the NOT1 CN9BD, the NOT1 connector 
domain (CD) and the NOT module consisting of the C-terminal regions of NOT1, NOT2 and 
NOT3 (Fig. 2A; Boland et al., 2013; Chen et al., 2014; Petit et al., 2012; Sgromo et al., 2017). 
Strikingly, both the CN9BD-CAF40 dimer as well as the NOT module, but none of the other 
subcomplexes, can be co-purified with MBP-NOT4 (Fig. 2B, lanes 13 and 17), indicating the 
existence of multiple binding sites for NOT4 in the CCR4-NOT complex. This binding 
pattern is similar to Dm Roquin which also interacts with the CN9BD-CAF40 dimer and the 
NOT module (Sgromo et al., 2017). Additionally, these results show that despite the lack of 
sequence conservation between Sc and Hs NOT4-C, both use the NOT module for docking to 
the CCR4-NOT complex. 
Similarly to Sc NOT4 (Bhaskar et al., 2015), Hs NOT4 binds strongly to the NOT1 SHD (Fig. 
2C, lane 7). On the other hand, we observed only a very weak interaction with the NOT2-3 
dimer (Fig. 2C, lane 9), indicating that the main binding site resides in the NOT1 component 
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of the NOT module. Furthermore, NOT4 interacts directly with CAF40 in the absence of the 
NOT1 CN9BD (Fig.2C, lane 11). 
 
A minimal NOT1 and CAF40 binding region (NCBR) within NOT4-C is sufficient to 
mediate the contact with the CCR4-NOT complex. 
To determine more precisely how NOT4 interacts with NOT1 and CAF40, we generated 
several fragments of NOT4-C and tested them for binding to the NOT module and CAF40. 
We identified a short central region in NOT4-C (residues E377-D428) that is sufficient to 
bind to both complexes (Fig. 3A, lanes 11 and 16), albeit with reduced affinity compared to 
NOT4-C (Fig. 3A, lanes 9 and 14). We therefore termed this region the NOT1 and CAF40 
binding region (NCBR). Neither of the two other fragments flanking the NCBR was able to 
interact with CAF40 (Fig. 3A, lanes 15 and 17), and the C-terminal fragment (residues Q429-
A575) shows only very weak binding to the NOT module while the N-terminal fragment 
(residues P275-S376) does not bind at all (Fig. 3A, lanes 10 and 12). 
To separate the regions in the NCBR responsible for binding to the NOT module and CAF40, 
respectively, we divided the NCBR in two fragments, and tested their interactions in MBP 
pulldowns. The interaction with the NOT module was reduced by deleting the N-terminal half 
of the NCBR (residues E377-D402), similar to the deletion of the full NCBR (Fig. S3N, lanes 
10 and 11). Deletion of the second half (residues E400-D428) had no effect (Fig. S3N, lane 
12). This suggests that the N-terminal half of the NCBR contributes to NOT module binding, 
but that in addition other auxiliary sequences must exist outside the NCBR. In contrast to that, 
deletion of the NCBR as well as the deletion of its C-terminal half strongly impaired the 
interaction of NOT4-C with CAF40 (Fig. S3N, lanes 15 and 17), indicating that the main 
binding site for CAF40 resides inside residues E400-D428. This fragment which includes a 
predicted α-helix was therefore termed a CAF40-binding motif (CBM). Deletion of the N-
terminal half of the NCBR, on the other hand, had almost no effect on the interaction between 
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NOT4-C and CAF40 (Fig. S3N, lane 16). 
 
The NCBR is necessary and sufficient for NOT4-mediated mRNA decay  
To assess the importance of the NCBR interactions with the CCR4-NOT complex, we tested 
all NOT4-C fragments in tethering assays as described in Fig. 1C,D. In agreement with the 
MBP pulldown assay (Fig. 3A), the NCBR elicited degradation of the target mRNA, whereas 
the other two NOT4-C fragments were inactive (Fig. 3B,C). This result clearly indicates that 
the NCBR is important for NOT4-mediated mRNA decay (Fig. 3B,C). Furthermore, regions 
upstream and downstream of the NCBR may facilitate the interaction with NOT1 or CAF40, 
but are not sufficient for strong individual binding to the CCR4-NOT complex (Fig. 3A) and 
induction of mRNA decay (Fig. 3B,C). All tested fragments were expressed at comparable 
levels (Fig. 3D).  
To determine the contribution of the NCBR to the interaction of NOT4 with the endogenous 
CCR4-NOT complex, we expressed V5-SBP-tagged NOT4-C and a deletion of the NCBR in 
HEK293T cells and performed SBP pulldown assays. Consistent with the MBP pulldown 
assays and the previous yeast-two-hybrid assays (Albert et al., 2002), NOT4-C co-purified 
with endogenous NOT1, NOT2, NOT3 and CAF40 (Fig. 3E, lane 7). Deletion of the NCBR 
from NOT4-C resulted in complete loss of binding to all four CCR4-NOT subunits (Fig. 3E, 
lane 8). Deletion of either of the two NCBR motifs individually was also sufficient to disrupt 
the interactions, indicating that both motifs are necessary to establish a strong interaction with 
the complex (Fig. 3E, lanes 9 and 10). 
In line with these results, deletion of the complete NCBR or either of the two motifs abolished 
the NOT4-C-mediated degradation of the β-globin-6xMS2bs reporter mRNA in HEK293T 
cells (Fig 3F,G). These results underline the importance of the NCBR, and therefore most 
likely the recruitment of the CCR4-NOT complex, for the degradative activity of NOT4. All 
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tethered proteins were expressed at a similar level (Fig. 3H).  
 
Crystal structures of the Dm NOT4 CBM bound to CAF40 
To determine the molecular basis of the CAF40-NOT4 interaction, we set out to solve high-
resolution crystal structures of the Hs and Dm NOT4 CBMs (residues E400-D428 and D813-
Q838, respectively) with either Hs or Dm CAF40 (ARM domains). However, the only 
combination that yielded well-diffracting crystals in multiple conditions was the complex of 
the Dm NOT4 CBM and the Hs CAF40 ARM domain. We solved structures of the complex 
in two different crystal forms at 2.1 Å (crystal form 1, space group P21212; Fig. S4A) and 2.2 
Å (crystal form 2, space group I212121; Fig. S4B), respectively. In both crystal forms, the 
asymmetric unit contains two CAF40-NOT4 heterodimers in highly similar arrangements (Fig 
S4C; rmsd 1.06 Å over 544 Cα atoms).  
In each of the CAF40-NOT4 heterodimers, the CAF40 ARM domain adopts the well-known 
fold consisting of six armadillo repeats (Chen et al., 2014; Garces et al., 2007; Mathys et al., 
2014; Sgromo et al., 2017). The Dm NOT4 CBM peptide (residues 813-838) folds partially 
into an α-helix and binds into the concave surface of CAF40 (Fig. 4A-C). This arrangement is 
similar between the two heterodimers within each crystal form (Crystal form 1: rmsd 0.67 Å 
over 267 Cα atoms; crystal form 2: rmsd 0.41 Å over 242 Cα atoms; Fig. S4D,E) and also 
between the dimers of the two crystal forms (rmsd 0.37 Å over 256 Cα atoms; Fig. S4F). 
Indeed, the most pronounced differences between the four heterodimers is observed in the N- 
and C-terminal ends of the NOT4 peptide, indicating structural flexibility of these termini 
(Fig. S4D-F). 
 
Comparison with Roquin reveals significant differences in binding mode 
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Interestingly, the NOT4 CBM peptide binds to the same spot on the concave surface of 
CAF40 as the previously identified CBM of Dm Roquin (Fig. 4D and S4G; PDB 5LSW; 
Sgromo et al., 2017). 
Both peptides fold into amphipathic α-helices that are recognized by the same conserved 
hydrophobic surface of CAF40 (Fig. 4C,D), despite the lack of sequence similarity between 
the CBMs. Nevertheless, an evolutionary relation of the two motifs is unlikely as the relative 
orientation of the peptides on CAF40 is very different, i.e. the NOT4 CBM is flipped by 
almost 180° with respect to the Roquin CBM (compare Fig.4C and D). 
Consequently, the α-helix of the NOT4 CBM lies in an almost antiparallel fashion in the 
groove formed by the CAF40 helices α5, α8 and α11. The core of the predominantly 
hydrophobic interface is formed by residues F821, T824, L828, L831 and M832 of NOT4 that 
are inserted into the pocket lined by CAF40 residues R130, Y134, L137, T138 and L177, but 
also residues L816, F818 and P820 of the extended N-terminus of NOT4 strongly contribute 
as they extend the interface by interacting with CAF40 residues G141, G144, T180 and V181 
(Fig. 4E). In particular, NOT4 P820 might have a key role as it marks the border between the 
α-helix and the N-terminal extension. Finally, there are additional hydrophilic interactions 
that stabilize the interaction, including a hydrogen bond between CAF40 R46 and NOT4 
D819, and NOT4 E835 that stabilizes the C-terminus of the CBM by forming two hydrogen 
bonds to the backbone at the entrance of CAF40 helix α5 (Fig. 4E). 
Compared to Roquin, the overall characteristics of the interaction seem to be very similar as 
also Roquin uses an amphipathic helix to mediate binding. On the other hand, there are 
pronounced differences apart from the obviously flipped orientation of the two peptides. In 
particular, the contribution of the N-terminal extension of the NOT4 CBM to the interaction is 
not observed in the Roquin CBM (Sgromo et al., 2017). Also, a comparison of the 
conformation of CAF40 in both structures shows a small but striking difference: Whereas the 
overall fold is highly similar (Fig. S4G; rmsd 0.65 Å over 239 Cα atoms), and also most side 
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chains involved in the interactions adopt similar conformations, Y134 adopts completely 
different orientations in both structures (Fig. S4H). This small difference in the center of the 
hydrophobic pocket is sufficient to allow the two peptides to bind in opposite directions. 
 
Validation of the binding interface 
To verify the interfaces obtained from the crystal structure, we generated mutations in the 
NOT4-CBM and CAF40 and tested them in MBP pulldown assays. First, we showed that 
similarly to the Hs NOT4 CBM, the Dm NOT4 CBM interacts with Hs CAF40 under these 
conditions (Fig. 4F, lane 14), confirming that it is a bona fide CBM in solution. To disrupt the 
interaction from the CAF40 side, we used either a single point mutation (V181E) or a double 
mutation (2x mut; Y134D+G141W), that were both previously shown to disrupt the 
interaction with the Roquin CBM (Sgromo et al., 2017). In both cases, these mutations 
abolished the interaction of CAF40 with the Dm NOT4-CBM (Fig 4F, lanes 15 and 16). 
Conversely, single F821D and L828E substitutions in the Dm NOT4-CBM were sufficient to 
abrogate the interaction with CAF40 (Fig 4G, lanes 14 and 16). 
Similar to the results obtained with Dm NOT4, a single V181E mutation in CAF40 was 
sufficient to abolish the interaction with the Hs NOT4-CBM (Fig 5A, lanes 14 and 15). 
However, the CAF40 2x mut reduced but did not abolish the interaction with the Hs NOT4-
CBM, indicating the existence of species-specific differences in the molecular details of the 
interaction in Dm and Hs (Fig 5A, lanes 14 and 16).  
 
CAF40 mediates the recruitment of the CCR4-NOT complex by NOT4 
To assess the role of the CAF40-CBM interface in a cellular context, we introduced either 
individual point mutations (F405D, F408A, T411E, L415E) or combinations into V5-SBP-
MBP tagged Hs NOT4-C and tested them for the ability to interact with endogenous CCR4-
NOT subunits in HEK293T cell lysates. All single point mutations modestly affected the 
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binding to NOT1 and CAF40 (Fig. S5A, lanes 11-14). However, a T411E-L415E double 
mutant was sufficient to strongly reduce the interaction (Fig. S5A, lane 15), and the 
combination of all four mutations (4x mut) abolished the interaction with all tested 
endogenous CCR4-NOT complex subunits (Fig. 5B, lane 6, and S5A, lane 16). 
When tested in a tethering assay in HEK293T cells, the 4x mut impaired the ability of both 
NOT4-C and NCBR to degrade the β-globin-6xMS2bs reporter mRNA (Fig. 5C,D). All the 
tethered proteins were expressed at comparable levels (Fig. 5E). These findings underline the 
importance of the CBM for the function of NOT4 and indicate that the CBM is the major site 
for interaction with the CCR4-NOT complex. 
 
The CCR4-NOT complex is required for Hs NOT4-induced mRNA decay 
To assess the role of CAF40 in the recruitment of the CCR4-NOT complex by Hs NOT4, we 
depleted CAF40 from HEK293T cells by CRISPR-Cas9 genome editing. The depletion was 
confirmed by western blot (Fig. 6A, lane 5). CAF40 depletion did not alter the levels of 
endogenous NOT1, NOT2 and NOT3 proteins in the cell (Fig. 6A, lane 5). In this cell line, 
V5-SBP-MBP tagged NOT4-C was unable to pull down components of the endogenous 
CCR4-NOT complex (Fig. 6B, lane 12 vs. 10), confirming that CAF40 plays a major role in 
the interaction of NOT4 with the CCR4-NOT complex. Addition of purified recombinant Hs 
CAF40 (ARM domain) to the cell lysates prior to the pulldown rescued the interaction of 
NOT4-C with endogenous NOT1 (Fig. 6B, lanes 14 and 16), further confirming that CAF40 
is required for association of NOT4 with the CCR4-NOT complex. 
In the CAF40-depleted cell line, the repressive effect on the R-Luc-6xMS2bs reporter mRNA 
upon tethering MS2-HA-tagged NOT4 and NOT4-C was partially impaired in comparison to 
the control cells (Fig. 6C). The finding that CAF40 depletion alone was not sufficient to 
completely abolish the repressive activity of NOT4 suggests that other factors also contribute 
to the NOT4-mediated repression (Fig. 6C). 
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To test whether the remaining activity of NOT4 in the CAF40 knockout cell line is due to the 
recruitment of the CCR4-NOT complex via the NOT module, we knocked down NOT1 in 
control cells or in the CAF40 knockout cell line. In the control cell line, the NOT1 
knockdown moderately reduced the repression by tethered NOT4, similar to the effect of the 
CAF40 knockout (Fig. 6C). However, combination of the CAF40 knockout with the NOT1 
knockdown drastically reduced the activity of tethered NOT4 (Fig. 6C). This indicates that the 
major contribution to NOT4-mediated repression stems from the CCR4-NOT complex. This 
result suggests that binding of NOT4 to both CAF40 and the NOT module is required to 
synergistically maintain the full affinity of the overall interaction, but on the other hand, 
binding to either of the sites is sufficient for a weak association with the CCR4-NOT 
complex. Western blot showed that shRNA-mediated NOT1 knockdown reduced the 
expression of endogenous NOT1 to around 20 % of the control level (Fig. 6D). The 
equivalent expression of NOT4 in all samples was confirmed by western blot (Fig. 6E). 
 
The CAF40-CBM interaction is essential for Dm NOT4-mediated mRNA decay 
To validate the relevance of the CAF40-CBM interaction for the repressive function of Dm 
NOT4, we overexpressed GFP-tagged CAF40 (either wild-type or a V186E mutant; this 
mutant is equivalent to V181E in Hs CAF40 that is unable to interact with NOT4). In this 
context, we performed tethering assays using NOT4 and NOT4-C as described in Fig 1F. In 
this assay, decay of the F-Luc-5BoxB reporter mRNA was not affected by overexpressing 
wild-type CAF40 compared to the control situation where only GFP was overexpressed (Fig. 
S5B,C, lanes 1-6). However, overexpression of the CAF40 V186E mutant resulted in a 
complete inhibition of the NOT4-induced target mRNA degradation (Fig. S5B,C, lane 8 and 
9). This result shows, firstly, that the V186E mutant can displace endogenous CAF40 when 
overexpressed, and, secondly, that this displacement of wild-type CAF40 by the non-
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interacting mutant has a dominant negative effect on the activity of NOT4. This underlines the 
important function of the interaction with CAF40 for the activity of NOT4. The equivalent 
expression of NOT4 and NOT4-C in all samples was confirmed by western blot (Fig. S5D). 
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Discussion 
In this study, we show that Hs and Dm NOT4 directly interact with the CCR4-NOT complex 
through their unstructured C-terminal regions. Hs NOT4 uses at least two binding sites for 
interaction with CCR4-NOT subunits, one site contacting the NOT module, and another motif 
that contacts CAF40. This CAF40-binding motif is conserved in Dm, and it is functionally 
relevant for the recruitment of the CCR4-NOT complex by NOT4. The crystal structures of 
the Dm CBM bound to CAF40 elucidate the molecular basis of the interaction and show 
differences in binding mode compared with the CBM of Dm Roquin. Specific disruption of 
the CAF40-CBM interaction by single residue substitutions or CAF40 depletion impairs the 
ability of NOT4 to induce degradation of bound mRNAs. 
 
Binding of NOT4 to CCR4-NOT is conserved 
Our data show that both Hs and Dm NOT4 interact directly with the CCR4-NOT complex and 
that these interactions are strong enough to be observed by different techniques (i.e., in vitro 
pulldown assays, pulldown assays in Hs cell lysates, and tethering assays in Hs and Dm cells). 
In addition, a previous study showed the association of Hs NOT4 with NOT1 in yeast-two-
hybrid assays (Albert et al., 2002). In contrast to that, several studies that investigated the 
overall composition of the Hs and Dm CCR4-NOT complexes showed that NOT4 does not 
co-purify with the complex, indicating that its association with the complex may be transient 
or regulated (Lau et al., 2009; Temme et al., 2010). 
The situation is different in yeast where NOT4 appears to be an integral component of the 
CCR4-NOT complex (Bai et al., 1999; Bhaskar et al., 2015). This difference in the 
association behavior of NOT4 and the rest of the CCR4-NOT complex may reflect the 
different binding modes in yeast and metazoans. Both Hs and Dm NOT4 share the conserved 
CBM which, as our tethering assays suggest, mediates the major contact with the CCR4-NOT 
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complex. In addition to that, Hs NOT4 also contacts the NOT module with one motif inside 
the NCBR and auxiliary sequences outside the NCBR. It is unclear whether Dm NOT4 also 
contains additional CCR4-NOT binding sites outside the CBM, but since the disruption of the 
CBM-CAF40 interaction is sufficient to completely suppress the activity in tethering assays, 
we propose that the CBM provides the major contact. In Sc, however, the situation is different 
as the peptide that mediates the contact to the NOT1 SHD is sufficient to tether NOT4 to the 
rest of the complex (Bhaskar et al., 2015). Analysis of the sequence of Sc NOT4 shows that 
the protein does not contain any conserved CBM, although it cannot be excluded that 
additional motifs exist that mediate additional contacts. In evolutionary terms, the NOT4 
proteins are similar to other interactors of the CCR4-NOT complex like Nanos and Roquin 
which have also retained the overall interaction with the CCR4-NOT complex, but have 
diversified the modes of interaction during evolution (Bhandari et al., 2014; Raisch et al., 
2016; Sgromo et al., 2017). 
These different binding modes may result in a higher overall affinity of Sc NOT4 for the rest 
of the CCR4-NOT complex compared to the metazoan counterparts which would explain the 
obviously tighter incorporation of NOT4 into the yeast complex. On the other hand, we also 
cannot exclude the possibility that the association of NOT4 with the CCR4-NOT complex 
might be regulated, for example by post-translational modifications, in the different 
organisms. 
 
Comparison with Roquin suggests the existence of other CBM-containing proteins 
Comparing NOT4 with other proteins that interact with the core CCR4-NOT complex reveals 
striking similarities in the nature of these interactions. When comparing NOT4 with Dm 
Roquin, these similarities are quite obvious since also Roquin binds to the CCR4-NOT 
complex via a CBM and additional sequences contacting the NOT module (Sgromo et al., 
2017), leading to an overall similar situation as in the case of NOT4. On the other hand, the 
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different orientations of the CBM peptides and the lack of sequence similarity between the 
regions that are responsible for NOT module binding are strong indicators for the absence of 
an evolutionary link between the two proteins. On the other hand, it is likely that both CBMs 
arose by convergent evolution. This raises the question why both proteins evolved to bind to 
the same binding site on CAF40 via chemically relatively similar binding modes. One 
possibility is that recruiting the CCR4-NOT complex via CAF40 to bound mRNA targets is 
generally beneficial, as it may for example position the nuclease domains of CAF1 and CCR4 
optimally with respect to the 3’-end of the poly(A)-tail in order to assure high enzymatic 
activity. Another possibility is that NOT4 and Roquin might compete with each other for 
binding to the CCR4-NOT complex, which could be an efficient means of differentially 
regulating the translational repression of target mRNAs, and it might also ensure that only one 
E3 ubiquitin ligase activity, either from NOT4 or Roquin, is associated with the CCR4-NOT 
complex at any time. 
The high conservation of the CBM-binding surface of CAF40, also in species like yeast where 
no CBM has been identified so far, suggests that more CBM-containing proteins may exist. 
However, the lacking evolutionary link and the differences in binding mode between NOT4 
and Roquin suggest that these hypothetical CBMs may again have no sequence similarity to 
the known CBMs, which would make their identification by in silico sequence search 
difficult.  
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Materials and methods 
DNA constructs 
For recombinant expression in E.coli, Hs NOT4 cDNA constructs were inserted in the pnEA-
pM plasmid (Diebold et al., 2011) between the XhoI and NheI restriction sites, resulting in 
fusion proteins carrying N-terminal MBP tags cleavable by the HRV3C protease, and in 
addition C-terminal GB1- and 6xHis-tags. For expression in human HEK293T cells, Hs 
NOT4 cDNA constructs were inserted in the pCIneo-V5-SBP-MBP plasmid between the 
XhoI and NotI restriction sites, or into the pcDNA3.1-MS2-HA plasmid using the same 
restriction sites. 
Dm NOT4 cDNA constructs were inserted between the XhoI and BamHI restriction sites of 
the pnYC-vM plasmid, resulting in TEV-cleavable MBP fusion proteins. For expression in 
Drosophila S2 cells, Dm NOT4 cDNA constructs were inserted between the NotI and BstBI 
restriction sites of the pAc5.1B plasmids with N-terminal GFP or λN-HA tags, except for a 
full-length Dm NOT4 construct, where the GFP tag is C-terminal. 
For expression of the Hs NOT1-10-11 complex, two plasmids were created. The N-terminus 
of NOT1 (residues M1-D1000) was cloned in a pnYC plasmid that did not contain any tag 
sequence. NOT10 (residues D25-Q707) and NOT11 (residues D257-D498) were cloned in a 
bicistronic plasmid based on the pnEA backbone, resulting in the expression of untagged 
NOT10 and NOT11 carrying a C-terminal, TEV-cleavable 6xHis tag. 
Plasmids for the expression of the other subcomplexes of the Hs CCR4-NOT complex have 
been described before (Bhandari et al., 2014; Boland et al., 2013; Chen et al., 2014; Petit et 
al., 2012; Sgromo et al., 2017). The DNA constructs used in this study are listed in Table S1. 
 
Protein expression and purification 
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All recombinant proteins were expressed in E. coli BL21 (DE3) Star cells (Invitrogen) in LB 
medium overnight at 20 °C. Hs and Dm NOT4 CBM constructs were expressed with N-
terminal MBP tags. The cells were lysed in a buffer containing 50 mM HEPES pH 7.5, 300 
mM NaCl and 2 mM DTT supplemented with complete EDTA-free protease inhibitors, 
DNaseI and Lysozyme. The proteins were isolated from the lysate using amylose resin (New 
England Biolabs) followed by anion chromatography using a HiTrapQ column (GE 
Healthcare). Finally, the NOT4 constructs were applied to size exclusion chromatography on 
a Superdex 200 26/600 column (GE Healthcare) using a buffer containing 10 mM HEPES pH 
7.5, 200 mM NaCl and 2 mM DTT. 
The purification of Hs CAF40 (residues R19-E285) has been described before (Sgromo et al., 
2017). Briefly, the protein was expressed fused to a 6xHis tag cleavable by the HRV3C 
protease. Lysis was carried out in lysis buffer containing 50 mM potassium phosphate pH 7.5, 
500 mM NaCl, 10 % glycerol, 20 mM imidazole and 2 mM β-mercaptoethanol supplemented 
with complete EDTA-free protease inhibitors, DNaseI and Lysozyme. 6xHis-CAF40 ARM 
was isolated using a HiTrap IMAC column. Then, the 6xHis tag was removed by overnight 
cleavage using HRV3C protease during dialysis in a buffer containing 50 mM Tris-HCl pH 
7.5, 150 mM NaCl and 1 mM DTT. Subsequently, CAF40 was further purified using a 
HiTrap Heparin (GE Healthcare) column followed by gel filtration on a Superdex 200 26/600 
column in a buffer containing 20 mM Tris-HCl pH 7.5, 150 mM NaCl and 1 mM DTT. 
The assembled Hs NOT1-10-11 trimer was obtained by co-expression of C-terminally 6xHis-
tagged NOT11 (residues D257-D498) and untagged NOT1 (residues M1-D1000) and NOT10 
(residues D25-Q707). The cells were lysed in 50 mM potassium phosphate pH 7.6, 300 mM 
NaCl, 20 mM imidazole and 2 mM β-mercaptoethanol supplemented with complete EDTA-
free protease inhibitors, DNaseI and Lysozyme. The complex was isolated from crude lysate 
by Nickel affinity chromatography using a HiTrap IMAC column and eluted by a linear 
gradient to 500 mM imidazole. The complex was dialyzed in Heparin binding buffer 
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containing 50 mM HEPES pH 7.5, 200 mM NaCl and 2 mM DTT, and further purified over a 
HiTrap Heparin column, followed by size exclusion chromatography over a Superdex 200 
26/600 column in gel filtration buffer containing 10 mM HEPES pH 7.5, 200 mM NaCl and 2 
mM DTT. 
The purifications of the other Hs CCR4-NOT complex components have been described 
previously (Chen et al., 2014; Petit et al., 2012; Raisch et al., 2016; Sgromo et al., 2017). 
The Dm NOT4 CBM peptide (residues D813-Q838) for crystallization was obtained 
chemically synthesized from EMC microcollections and solubilized in buffer containing 10 
mM HEPES pH 7.5, 200 mM NaCl and 2 mM DTT. 
 
In vitro MBP pulldown assays 
For in vitro pulldown assays in Fig. 1B, Fig. 2B-C and Fig. 3A, full-length Hs NOT4 and 
fragments thereof were expressed as fusion proteins with N-terminal MBP and C-terminal 
GB1-6xHis tags. The cells were lysed in binding buffer containing 50 mM HEPES pH 7.5, 
300 mM NaCl, 20 mM imidazole and 2 mM β-mercaptoethanol, supplemented with complete 
EDTA-free protease inhibitors, Lysozyme and DNaseI. The proteins were isolated from the 
lysate using Ni-NTA resin (Quiagen), followed by elution with binding buffer supplemented 
with 500 mM imidazole. Then, the NOT4 fragments were immobilized on amylose resin and 
subsequently incubated with purified interactors for 1h. Finally, the amylose beads were 
washed five times with binding buffer, and the proteins were eluted with binding buffer 
supplemented with 25 mM D-(+)-maltose. The eluted proteins were analyzed by SDS-PAGE. 
For pulldowns with Hs and Dm NOT4 CBM constructs, purified MBP (20 µg) or MBP-
tagged NOT4 fragments (40 µg) were incubated with equimolar amounts of the respective 
purified interactors and amylose resin in a buffer containing 50 mM HEPES pH 7.5, 200 mM 
NaCl and 2 mM DTT. After 1 h incubation, the beads were washed five times with the same 
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buffer and the proteins were eluted with the same buffer supplemented with 25 mM D-(+)-
Maltose. The eluted proteins were precipitated with trichloroacetic acid, and analyzed by 
SDS-PAGE. 
 
Tethering assays in human HEK293T cells 
For tethering assays, 0.7x106 HEK293T cells were seeded in 6-well plates and transfected on 
the following day using Lipofectamine 2000 (Invitrogen). The transfection mixtures 
contained 0.5 μg of the control plasmid encoding the β-globin gene fused to the GAPDH 
sequences but lacking MS2 binding sites (Control; β-globin-GAP), 0.5 μg of the β-globin 
reporter containing six MS2-binding sites (β-globin-6xMS2bs) and various amounts of pT7-
MS2-HA plasmids (MS2-HA: 0.5 μg; MS2-HA-NOT4-N: 0.1 μg; MS2-HA-NOT4-C: 1.5 μg) 
for the expression of MS2-HA-fusion proteins. The cells were harvested two days after 
transfection. The total RNA was isolated using the Trifast Reagent (Peqlab) and analyzed by 
Northern blot.   
For tethering assays with Luciferase reporters, the transfection mixtures contained 0.2 µg of 
the control plasmid (F-Luc-GFP) and 0.2 µg of the reporter plasmid containing or lacking six 
MS2-binding sites (R-Luc-6xMS2bs, R-Luc or  R-Luc-6xMS2bs-A95-MALAT) and various 
amounts of pT7-MS2-HA plasmids as described before for the expression of MS2-HA-NOT4 
fusion proteins. The cells were harvested 2 days after transfection. Firefly and Renilla 
luciferase activities were measured using a Dual-Luciferase Reporter Assay system 
(Promega). Northern blotting was performed as previously described (Behm-Ansmant et al., 
2006). For the experiment shown in Fig. S3G,H, cells were co-transfected with 0.5 µg of a 
plasmid expressing either wild-type GFP-DCP2 or the GFP-DCP2 E148Q mutant. 
 
Knockdown in human HEK293T cells 
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For knockdown of NOT1 in Hs HEK293T cells using short-hairpin RNAs (shRNAs), target 
sequences (control: ATTCTCCGAACGTGTCACG; NOT1: ATTCAACATTCCCTTATA) 
were cloned in the pSUPER plasmid (a kind gift from O. Mühlemann) containing a 
puromycin selection marker. Cells were transfected in 12-well plates using Lipofectamine 
2000. The transfection mixtures contained 2 μg of plasmids expressing the respective 
shRNAs. After 1 day, cells were selected for 24 hours in DMEM supplemented with 1.5 
µg/ml puromycin and subsequently seeded in 12-well plates in medium without puromycin. 
The following day, the cells were transfected with the reporter plamsids and the respective 
shRNA plasmids. The transfection mixture contained 0.1 μg of R-Luc-6xMS2bs, 0.1 μg of 
pEGFP-N3-F-Luc transfection control and 1 µg of the respective shRNA-expressing 
plasmids. 24 hours after transfection, cells were selected with puromycin (1.5μg/ml). Cells 
were harvested and luciferase activities were measured 72 hours after the second transfection. 
 
Tethering assays in Drosophila S2 cells 
For the N-tethering assay in Dm S2 cells, 2.5×106 S2 cells were seeded in 6-well plates and 
transfected with Effectene (Qiagen). The transfection mixtures contained the following 
plasmids: 0.1 μg of the F-Luc-5BoxB reporter plasmid, 0.4 μg of R-Luc-A90-HhR and 
different amounts of either a plasmid expressing N-HA or plasmids expressing N-HA-
DmNOT4 proteins (N-HA: 80ng; NOT4-fl: 10 ng; NOT4-N: 80 ng; NOT4-C: 10 ng). Three 
days after transfection, cells were harvested and luciferase activities were measured and 
Northern blotting was performed as described in the previous section. 
For the experiment shown in Fig. S3I,J cells were co-transfected with 1 µg of a plasmid 
expressing either wild-type DCP1 or the R70G-L71S-N72S-T73G mutant. 
 
SBP pulldown assays 
26 
 
HEK293T cells were seeded in 10 cm plates (4x106 cells/plate), and transfected after 1 day 
using Turbofect (Thermo Scientific). Two days after transfection, the cells were lysed on ice 
for 15 minutes in 1 ml NET lysis buffer (50 mM Tris-HCl (pH 7.5), 150 mM NaCl, 0.1 % 
Triton X-100, 1 mM EDTA and 10 % (v/v) glycerol) supplemented with protease inhibitors 
(Roche), then centrifuged at 20,000 x g at 4°C for 15 min. The cleared lysate was treated with 
100 µg/ml RNase A (Qiagen) for 30 min then centrifuged again at 20,000 x g at 4°C for 15 
min. The lysates were incubated for 1 hour at 4°C with 50 µl Streptavidin sepharose resin (GE 
Healthcare). The beads were washed with NET buffer 3 times. The samples were analyzed by 
Western blot, using antibodies listed in Supplemental table S2. The Western blots were 
developed using the ECL Western blotting detection system (GE Healthcare). 
For the experiment shown in Fig. 6B, 5 µg purified GST or the indicated amounts of purified 
recombinant Hs CAF40 ARM was added to the cell lysate and incubated for 1 hour prior to 
the incubation with the Streptavidin sepharose resin. 
 
Crystallization 
The Hs CAF40 ARM domain was mixed with a twofold molar excess of the Dm NOT4 CBM 
peptide. Initial screens were carried out in sitting drops at 22 °C by mixing 200 nl protein 
solution (6 mg/ml CAF40 and 1.2 mg/ml NOT4) with 200 nl crystallization condition 
solution. Crystals appeared within one day in many conditions. Optimized crystals of crystal 
form 2 grew at 18 °C in hanging drops consisting of 1 µl protein solution 6 mg/ml CAF40 and 
1.2 mg/ml NOT4) and 1 µl crystallization condition containing 0.9 M K2HPO4 and 0.3 M 
NaH2PO4. Crystals were cryoprotected with 4 M sodium formate and flash-cooled in liquid 
nitrogen. 
Crystals of crystal form 1 appeared in the initial screen in a condition containing 0.2 M 
Ammonium sulfate, 0.1 M Bis-Tris pH 5.5 and 25 % (w/v) PEG 3,350. The crystals were 
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cryoprotected with crystallization condition supplemented with 25 % glycerol and flash-
cooled in liquid nitrogen. 
 
Data collection and structure determination 
X-ray diffraction data of the Dm NOT4-Hs CAF40 complex were collected on a PILATUS 
6M detector (Dectris) at the PXII beamline of the Swiss Light Source (SLS). The best datasets 
were recorded at a wavelength of 0.99994 Å and processed XDS and XSCALE (Kabsch, 
2010). The best dataset of crystal form 1 (space group P21212) extended to 2.1 Å. Four copies 
of the CAF40 ARM domain (PDB 2FV2, chain A) were found in the asymmetric unit by 
molecular replacement with PHASER (McCoy et al., 2007) from the CCP4 package (Winn et 
al., 2011). This initial model was improved and completed by iterative cycles of building in 
COOT (Emsley et al., 2010) and refinement using PHENIX (Afonine et al., 2012). Four 
copies of the NOT4 CBM peptide were manually modelled into the density and improved by 
further refinement cycles. The final model was refined to Rwork = 19.0 % and Rfree = 21.8 %. 
The best dataset of crystal form 2 (space group I212121) extended to 2.2 Å. Initial phase 
information was obtained by molecular replacement using the CAF40 ARM domain (PDB 
2FV2, chain A) as a search model. This initial model comprising four copies of CAF40 was 
refined using PHENIX and BUSTER (Bricogne et al., 2011); four copies of NOT4 were 
manually modelled and improved by further refinement cycles. The final model was refined 
to Rwork = 19.3 % and Rfree = 23.0 %. 
 
Knockout of CAF40 in HEK293T cells using CRISPR-Cas9 
An sgRNA (Sequence: 5’ CACCGCCCATGCTGTGGCATTCATT 3’) to target the second 
exon of Hs CAF40 was designed using CHOPCHOP (http://chopchop.cbu.uib.no) and cloned 
into the pSpCas9(BB)-2A-Puro (PX459) vector (Addgene plasmid 48139). HEK293T cells 
were transfected with the pSp-CAF40 sgRNA-Cas9(BB)-2A-Puro plasmid and selected with 
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puromycin (3 μg/ml) to obtain stable CAF40 knockout cells. A single colony of knockout 
cells was obtained by serial dilution and expansion of single-cell clones under non-selective 
conditions. Positive clones were validated by Western blot analysis and DNA sequencing of 
the targeted genomic region. Sequencing the genomic region of the positive clones showed a 
22-nt deletion in the targeted exon of CAF40 that causes a frameshift.  
 
Accession numbers 
The NOT4-CAF40 structures were deposited in the Protein Data Bank under accession codes 
XXXX (crystal form 1) and XXXX (crystal form 2). 
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Table 1.  Data Collection and Refinement Statistics 
 
 CNOT9-DmNot4  
 Crystal form 1 Crystal form 2 
Space group P 21 21 2 I 21 21 21 
Unit Cell   
   Dimensions a, b, c (Å) 83.9, 109.6, 69.7 85.6, 90.3, 197.0   
Angles  ()  90.0, 90.0, 90.0 90.0, 90.0, 90.0 
 
Data Collection* 
  
Wavelength (Å) 0.99994 0.99994 
Resolution range (Å) 50-2.1 (2.14-2.10) 50-2.2 (2.25–2.20)  
Rsym (%) 7.0 (91.4) 6.5 (157.3) 
Completeness (%) 99.6 (99.8) 99.9 (99.8) 
Mean I / I) 12.2 (1.5) 16.6 (1.6) 
Unique Reflections 38,143 (2,780) 39,129 (2,831) 
Multiplicity 4.0 (4.2) 8.9 (9.0) 
   
Refinement   
Rwork (%) 19.0 19.3 
Rfree (%) 21.8 23.0 
Number of atoms   
    All atoms 4971 4805 
    Protein 4760 4738 
    Ligands 34 3 
    Water 177 64 
Average B factor (Å2)   
    All atoms 52.7 81.0 
    Protein 52.3 81.1 
    Ligands 95.5 93.7 
    Water 53.7 66.9 
Ramachandran plot   
    Favored regions, % 99.2 98.3 
    Disallowed Regions, % 0.0 0.0 
RMSD from ideal geometry   
    Bond lengths (Å) 0.002 0.010 
    Bond angles () 0.426 1.040 
*Values in parentheses are for highest-resolution shell. 
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Supplemental table S1. Constructs used in this study 
Name NOT4 
NOT4 
  
  
  
  
MS2-HA-Hs NOT4iso1 (Uniprot O95628-1) 
V5-SBP-MBP-Hs NOT4iso1 
MBP-Hs NOT4iso1-GB1-6xHis 
λN-HA-Dm NOT4isoL (Uniprot M9PCL9) 
Dm NOT4isoL-GFP  
NOT4-N 
  
  
  
  
MS2-HA-Hs NOT4iso1_1-274 
V5-SBP-MBP-Hs NOT4iso1_1-274 
MBP-Hs NOT4iso1_1-274-GB1-6xHis 
λN-HA-Dm NOT4isoL_1-249 
GFP-Dm NOT4isoL_1-249 
NOT4-C 
  
  
  
  
MS2-HA-Hs Not4iso1_275-575 
V5-SBP-MBP-Hs Not4iso1_275-575 
MBP-Hs NOT4iso1_275-575-GB1-6xHis 
λN-HA-Dm NOT4isoL_248-1050 
GFP-Dm NOT4isoL_248-1050 
275-376 
  
MS2-HA-Hs NOT4iso1_275-376 
MBP-Hs NOT4iso1_375-376-GB1-6xHis 
NCBR 
  
MS2-HA-Hs NOT4iso1_377-428 
MBP-Hs NOT4iso1_377-428-GB1-6xHis 
429-575 
  
MS2-HA-Hs NOT4iso1_429-575 
MBP-Hs NOT4iso1_429-575-GB1-6xHis 
ΔNCBR 
  
  
MS2-HA-Hs NOT4iso1_275-575 Δ424 
V5-SBP-MBP-Hs Not4iso1_275-575 Δ424 
MBP-Hs NOT4iso1_275-575 Δ424-GB1-6xHis 
Δ377-402 
  
  
MS2-HA-Hs NOT4iso1_275-575 Δ377-402 
V5-SBP-MBP-Hs Not4iso1_275-575 Δ377-402 
MBP-Hs NOT4iso1_275-575 Δ377-402-GB1-6xHis 
ΔCBM 
  
  
MS2-HA-Hs NOT4iso1_275-575 Δ400-428 
V5-SBP-MBP-Hs Not4iso1_275-575 Δ400-428 
MBP-Hs NOT4iso1_275-575 Δ400-428-GB1-6xHis 
CBM MBP-Hs NOT4iso1_400-427 
MBP-Dm NOT4isoL_813-838 
F824D MBP-Dm NOT4isoL_813-838 F824D 
L832E MBP-Dm NOT4isoL_813-838 L832E 
F405D V5-SBP-MBP-Hs NOT4iso1_275-575 F405D 
F408A V5-SBP-MBP-Hs NOT4iso1_275-575 F408A 
T411E V5-SBP-MBP-Hs NOT4iso1_275-575 T411E 
L415E V5-SBP-MBP-Hs NOT4iso1_275-575 L415E 
2x mut V5-SBP-MBP-Hs NOT4iso1_275-575 T411E L415E 
NOT4-C 4x mut 
  
V5-SBP-MBP-Hs NOT4iso1_275-575 F405D F408A T411E L415E 
MS2-HA-Hs NOT4iso1_275-575 F405D F408A T411E L415E 
NCBR 4x mut MS2-HA-Hs NOT4iso1_377-428 F405D F408A T411E L415E 
 
Name CAF40 
CAF40-ARM Hs CAF40_19-285 (Uniprot Q92600) 
CAF40 V5-SBP-MBP-Hs CAF40 shRNAres2 
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HA-CAF40 HA-Dm CAF40 (Uniprot Q7JVP2) 
GFP-CAF40 GFP-Dm CAF40 dsRNAres 
CAF40 4x mut V5-SBP-MBP-Hs CAF40 H58AF60AA64YV71Y-shRNAres2 
V181E V5-SBP-MBP-Hs CAF40 shRNAres2 V181E  
Hs CAF40_19-285 V181E 
V186E GFP-Dm CAF40 dsRNAres V186E  
2x mut Hs CAF40_19-285 Y134D+G141W  
 
Name Dm NOT1 (Uniprot A5YKK6) 
HA-CN9BD HA-Dm NOT1_1467-1717 
HA-NOT1 HA-Dm NOT1 FL 
 
 
Supplemental table S2. Antibodies used in this study 
Antibody Source Catalog 
number 
Dilution Monoclonal/polyclonal 
Anti-NOT1 In house - 1:1000 Rabbit polyclonal 
Anti-NOT2 Bethyl A302-562A 1:2000 Rabbit polyclonal 
Anti-NOT3 Abcam ab55681 1:2000 Mouse monoclonal 
Anti-NOT4 Abcam ab72049 1:1000 Rabbit polyclonal 
Anti-CAF40 Proteintech 22503-1-AP 1:1000 Rabbit polyclonal 
Anti-V5 LSBio LS-C57305 1:5000 Mouse monoclonal 
Anti-HA-HRP Roche 12 013 819 
001 
1:5000 Monoclonal 
Anti-GFP Roche 11 814 460 
001 
1:2000 Mouse monoclonal 
Anti-tubulin Sigma T6199 1:5000 Mouse monoclonal 
Anti-PABP Abcam ab21060 1:10000 Rabbit polyclonal 
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Figure legends 
Figure 1. Metazoan NOT4 directly interacts with the CCR4-NOT complex and induces 
degradation of bound mRNA. 
(A) Schematic representations of NOT4 proteins. NOT4 comprises a RING-type E3 ubiquitin 
ligase domain, a predicted coiled coil region, an RNA-recognition motif (RRM) domain and a 
C3H1-type Zinc-finger domain (ZnF) in its conserved N-terminal region. The divergent C-
terminal regions are predicted to be unstructured. Hs NOT4-C contains a NOT-module-and-
CAF40-binding-region (NCBR) that includes a CAF40-binding motif (CBM). Dm NOT4 
carries a CBM as well. Sc NOT4 harbors a binding site for NOT1 in its C-terminal region. 
(B) MBP pulldown assay showing the interaction of MBP-tagged Hs NOT4 and NOT4-C 
with a pentameric complex including the C-terminal half of NOT1, the NOT2 and NOT3 C-
terminal regions, the armadillo domain of CAF40 and full-length CAF1.  
(C-E) Tethering assay in human HEK293T cells using a β-globin reporter containing 6 
binding sites for the MS2 protein (β-globin-6xMS2bs) and MS2-HA-tagged Hs NOT4 or Hs 
NOT4 fragments. A β-globin-GAPDH reporter lacking MS2 binding sites was used as 
transfection control. The β-globin-6xMS2bs reporter levels were normalized to this control 
and set to 100 in the presence of MS2-HA. Mean values ± standard deviations from three 
independent experiments are shown in (C). (D) Northern blot of representative RNA samples. 
(E) Western blot showing the equivalent expression of MS2-HA-tagged proteins used in the 
tethering assay. 
(F-H) Tethering assay in Dm S2 cells using an F-Luc-5BoxB reporter and the indicated λN-
HA-tagged proteins. A plasmid expressing R-Luc served as a transfection control. The F-Luc-
5BoxB reporter activity (white bars) and mRNA levels (black bars) were normalized to the R-
Luc control and set to 100 in the presence of λN-HA. Mean values ± standard deviations from 
three independent experiments are shown in (F). (G) Northern blot of representative RNA 
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samples. (H) Western blot showing the equivalent expression of λN-HA-tagged proteins used 
in the tethering assay. 
 
Figure 2. Hs NOT4 directly interacts with NOT1-SHD and CAF40. 
(A) Schematic representation of Hs NOT1 and the other CCR4-NOT subunits used in this 
study. NOT1 contains N-terminal HEAT repeat domains (shown in yellow) that interact with 
NOT10 and NOT11, a central MIF4G domain (light blue) that binds CAF1, a CN9BD (dark 
blue) that recruits CAF0, a connector domain (CD, green) and a NOT1 superfamily homology 
domain (N1SHD, yellow) that forms the NOT module together with NOT2 and NOT3.  
(B) MBP pulldown assay testing the interaction of MBP-tagged Hs NOT4 with the following 
Hs CCR4-NOT subcomplexes: The NOT1 N-terminal fragment with NOT10 and NOT11, the 
NOT1 MIF4G domain with CAF1, the NOT1 CN9BD with CAF40, the NOT1 connector 
domain (CD), and the assembled NOT module (containing the NOT1-SHD and the NOT2 and 
NOT3 C-terminal fragments). SM: Starting material. 
(C) MBP pulldown assay testing the interaction of MBP-tagged Hs NOT4 and the Hs NOT1-
SHD, the NOT2–NOT3 dimer (NOT2–3) or CAF40. SM: Starting material. 
 
Figure 3. The NCBR directly interacts with NOT1 and CAF40 and promotes target 
mRNA degradation. 
(A) MBP pulldown assay testing the interaction of MBP-tagged Hs NOT4-C or fragments 
(residues 275-376, NCBR, 429-575) with the NOT module or CAF40. SM: Starting material. 
(B-D) Tethering assay in human HEK293T cells using the β-globin-6xMS2bs reporter and 
MS2-HA-tagged Hs NOT4-C or fragments (residues 275-376, NCBR, 429-575). The β-
globin-6xMS2bs reporter levels were normalized to those of the control mRNA and set to 100 
in the presence of MS2-HA as described in Fig 1C. Mean values ± standard deviations from 
three independent experiments are shown in (B). (C) Northern blot of representative RNA 
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samples. (D) Western blot showing the equivalent expression of MS2-HA-tagged proteins 
used in the tethering assay. 
(E) SBP pulldown assay testing the interaction of V5-SBP-tagged Hs NOT4-C or deletion 
constructs (ΔNCBR, Δ377-402 or ΔCBM) with endogenous NOT1, NOT3, NOT2 and 
CAF40 in HEK293T cell lysates. 
(F-H) Tethering assay using MS2-HA-tagged Hs NOT4-C or deletion constructs in human 
HEK293T cells as mentioned in (B). Mean values ± standard deviations from three 
independent experiments are shown in (F). (G) Northern blot of representative RNA samples. 
(H) Western blot showing the equivalent expression of MS2-HA-tagged proteins used in the 
tethering assay. 
 
Figure 4. Structure of the Dm NOT4 CBM bound to CAF40. 
(A) The Dm NOT4 CBM peptide (blue, backbone shown in ribbon representation) bound to 
Hs CAF40 (grey). The helices of CAF40 are depicted as tubes and numbered in black. The 
orange semicircle marks the predominantly hydrophobic interface between the CBM peptide 
and CAF40. 
(B) Cartoon representation of the Dm NOT4 CBM peptide bound to Hs CAF40. Selected 
secondary structure elements are labeled in black. 
(C-D) The CBM of Dm NOT4 (C) and Roquin (D) bound to CAF40 in the same orientation. 
The CBMs are displayed in cartoon view, CAF40 as surface. The CAF40 residues interacting 
with the respective CBMs are indicated in yellow. 
(E) Close-up view of the CAF40-NOT4 binding interface. Selected residues of CAF40 and 
NOT4 are shown as orange and blue sticks, respectively. Hydrogen bonds are indicated by red 
dashed lines. Residues mutated in this study are underlined.  
(F) MBP pulldown assay testing the interaction of MBP-tagged Dm NOT4-CBM with Hs 
CAF40 (wild-type or the indicated point mutants). 
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(G) MBP pulldown assay testing the interaction of MBP-tagged Dm NOT4-CBM (either 
wild-type or the indicated point mutants) with Hs CAF40. 
 
Figure 5. The CBM is necessary for the mRNA degradative activity of Hs NOT4.  
(A) MBP pulldown assay testing the interaction of MBP-tagged Hs NOT4-CBM with Hs 
CAF40 (either wild-type or the indicated point mutants). 
(B) SBP pulldown assay testing the interaction of SBP-tagged Hs NOT4-C (either wild-type 
or a quadruple mutant, 4x mut) with endogenous Hs NOT1, NOT2, NOT3 and CAF40 in 
HEK293T cell lysates. 
(C-E) Tethering assay using MS2-HA-tagged Hs NOT4-C or the NCBR (either wild-type or 
the 4x mut) in human HEK293T cells. The β-globin-6xMS2bs reporter levels were 
normalized to those of the control mRNA and set to 100 in the presence of MS2-HA. Mean 
values ± standard deviations from three independent experiments are shown in (C). (D) 
Northern blot of representative RNA samples. (E) Western blot showing the equivalent 
expression of MS2-HA-tagged proteins used in the tethering assay. 
 
Figure 6. CAF40 is required for NOT4-mediated mRNA-decay. 
(A) Western blot showing the endogenous levels of CAF40, NOT1, NOT3 and NOT2 in the 
CAF0 knockout HEK293T cell line. Dilutions of control cell lysates were loaded in lanes (1–
4) to estimate the efficacy of the depletion. Tubulin was used as a loading control.  
(B) SBP pulldown assay testing the interaction of SBP-tagged Hs NOT4-C with endogenous 
Hs NOT1, NOT2 and NOT3 in wild-type and CAF40 knockout HEK293T cell lysates, in the 
presence of either 5 µg GST or the indicated amounts of purified Hs CAF40 ARM. 
 (C) Tethering assay using an R-Luc-6xMS2bs reporter and MS-HA tagged NOT4, either in 
wild-type HEK293T cells, in CAF40 knockout cells, NOT1 knockdown cells, or cells 
combining the CAF40 knockout and the NOT1 knockdown. R-Luc activity was normalized to 
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that of an F-Luc transfection control and set to 100 in cells expressing MS2-HA. Mean values 
± standard deviations from three independent experiments are shown. 
(D) Western blot showing the efficiency of the NOT1 knockdown in Hs HEK293T cells used 
in the experiment in (C). Dilutions of control cell lysates were loaded in lanes (1–4) to 
estimate the efficacy of the depletion. PABP served as a loading control. 
(E) Western blot showing the expression of NOT4 and NOT4-C in the knockout and 
knockdown samples of the experiment shown in panel (C). GFP-F-Luc served as a 
transfection control. 
 
Figure S1. Sequence alignment of vertebrate NOT4. 
The secondary structure elements are indicated above the alignment. The CBM helix (as 
determined by the Dm NOT4-CAF40 structures) is indicated in red; the secondary structure 
elements of the RING and RRM domains according to the previously reported NMR 
structures (PDB 1UR6 and 2CPI, respectively) are shown in black; secondary structure 
elements of the structurally not characterized parts of NOT4 are indicated in black as 
predicted by PSIPRED (http://bioinf.cs.ucl.ac.uk/psipred/). Residues conserved in all aligned 
sequences are shown with a purple background, and residues with >70% similarity are 
highlighted in light pink; conservation scores were calculated using the SCORECONS 
webserver (Valdar, 2002). Residues that were mutated in this study are indicated by orange 
asterisks. Species abbreviations are as follows: Hs: Homo sapiens, human; Ec: Equus 
caballus, horse; Gg: Gallus gallus, chicken; Xt: Xenopus tropicalis, western clawed frog; Dr: 
Danio rerio, zebrafish. 
 
Figure S2. Sequence alignment of Drosophila NOT4-C. 
The secondary structure elements are indicated above the alignment. The CBM helix (as 
determined by the CAF40-NOT4 structures) is indicated in red; secondary structure elements 
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of the structurally not characterized parts of NOT4 are indicated in black as predicted by 
PSIPRED (http://bioinf.cs.ucl.ac.uk/psipred/). Residues conserved in all aligned sequences are 
shown with a dark blue background, and residues with >70% similarity are highlighted in 
light blue; conservation scores were calculated using the SCORECONS webserver (Valdar, 
2002). Residues that were mutated in this study are indicated by orange asterisks. Residues in 
the CBM that directly contact CAF40 are marked by green diamonds. 
 
Figure S3. NOT4 mediates mRNA degradation via the 5’-3’ decay pathway as well as 
degradation-independent translational repression 
(A,B) Tethering assay in Hs HEK293T cells using an R-Luc-6xMS2bs reporter, and MS2-
HA-tagged Hs NOT4 and N- and C-terminal fragments. An F-Luc reporter without MS2 
binding sites was used as transfection control. The R-Luc-6xMS2bs reporter levels were 
normalized to this control and set to 100 in the presence of MS2-HA. Luciferase activity 
values (‘Protein’) were also normalized to the F-Luc transfection control. Mean values ± 
standard deviations from three independent experiments are shown in (A). (B) shows a 
representative northern blot. 
(C,D) Tethering assay in Hs HEK293T cells using an R-Luc mRNA lacking MS2 binding 
sites and MS2-HA-tagged Hs NOT4 and N- and C-terminal fragments. Samples were 
processed as described in (A,B). The corresponding experiment with the R-Luc-6xMS2bs 
reporter is shown in (A,B). 
(E,F) Tethering assay in Dm S2 cells using an F-Luc reporter lacking BoxB sites and the 
indicated λN-HA-tagged proteins. A plasmid expressing R-Luc served as a transfection 
control. The F-Luc reporter activity (white bars) and mRNA levels (black bars) were 
normalized to the R-Luc control and set to 100 in the presence of λN-HA. Mean values ± 
standard deviations from three independent experiments are shown in (E). (F) Northern blot 
of representative RNA samples. The corresponding experiment with the F-Luc-5BoxB 
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reporter is shown in Fig. 1F-H. 
(G,H) Tethering assay in Hs HEK293T cells using an R-Luc-6xMS2bs-A95-MALAT 
reporter which is resistant to deadenylation, and MS2-HA-tagged Hs NOT4 and N- and C-
terminal fragments. An F-Luc reporter without MS2 binding sites was used as transfection 
control. The R-Luc-6xMS2bs reporter levels were normalized to this control and set to 100 in 
the presence of MS2-HA. Luciferase activity values (‘Protein’) were also normalized to the F-
Luc transfection control. Mean values ± standard deviations from three independent 
experiments are shown in (G). (H) shows a representative northern blot. 
(I,J) Tethering assay in Hs HEK293T cells using a β-globin-6xMS2bs reporter and MS2-HA-
tagged Hs NOT4 and Nanos2. In addition, either wild-type DCP2 or a catalytically inactive 
mutant (E148Q) was overexpressed. Samples were processed as described in (A,B). 
(K-M) Tethering assay in Dm S2 cells using an F-Luc-5BoxB reporter and λN-HA-tagged 
Dm NOT4 and GW182. In addition, either wild-type DCP1 or a R70G-L71S-N72S-T73G 
mutant was overexpressed. An R-Luc reporter without BoxB elements was used as 
transfection control. The F-Luc-5BoxB reporter levels were normalized to this control and set 
to 100 in the presence of λN-HA. Mean values ± standard deviations from three independent 
experiments are shown in (K). (L) shows a representative Northern blot. (M) Western blot 
showing the expression of the proteins used in the experiment in (I,J). 
(N) MBP pulldown assay testing the interaction of MBP-tagged Hs NOT4-C or the indicated 
deletion constructs thereof with the NOT module or CAF40. 
 
Figure S4. Molecular arrangement in the NOT4-CAF40 crystals and comparison with 
Roquin 
(A) CAF40-NOT4 tetramer found in the asymmetric unit of the crystal in space group P21212 
(crystal form 1). The two CAF40 molecules are shown in grey (chain A) and black (chain C), 
respectively, and the NOT4 CBMs in blue (chain B) and pink (chain D). 
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(B) CAF40-NOT4 tetramer found in the asymmetric unit of the crystal in space group I212121 
(crystal form 2). Colors are chosen as described in panel (A). 
(C) Superposition of CAF40-NOT4 heterotetramers of both crystal forms in ribbon 
representation. CAF40 from crystal form 1 is colored in light (chain A) and dark grey (chain 
C), NOT4 from the same crystal form in blue (chain B) and pink (chain D); the tetramer from 
crystal form 2 is shown in orange. 
(D) Superposition of the two CAF40-NOT4 heterodimers in the asymmetric unit of crystal 
form 1 in ribbon representation. The CAF40 molecules are shown in grey (chain A) and 
yellow (chain C) while the NOT4 molecules are shown in blue (chain B) and orange (chain 
D), respectively. 
(E) Superposition of the two CAF40-NOT4 heterodimers in the asymmetric unit of crystal 
form 2 in ribbon representation. The colors are chosen as described in panel (A). 
(F) Superposition of CAF40-NOT4 heterodimers of both crystal forms in ribbon 
representation. CAF40 and NOT4 from crystal form 1 are colored in grey and blue, 
respectively, and CAF40 and NOT4 from crystal form 2 in black and cyan. 
(G) Superposition of the CAF40-NOT4 heterodimer (crystal form 1) with the CAF40-Roquin 
structure (PDB 5LSW, Sgromo et al., 2017) in ribbon representation. The CAF40-NOT4 
complex is colored as before. CAF40 from the Roquin structure is shown in purple, the 
Roquin CBM in green. 
(H) Close-up view from the top onto the CBM-CAF40 interaction with CAF40 from the 
NOT4 structure (crystal form 1) shown as cartoon with helices depicted as cylinders and the 
CBM backbones of NOT4 (blue) and Roquin (green) shown as ribbons. Selected side chains 
of CAF40 and the CBMs are shown as sticks, highlighting the different orientation of CAF40 
Y134 in both structures. 
 
Figure S5. Disruption of the interaction with CAF40 impairs the degradative activity of 
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metazoan NOT4. 
(A) SBP pulldown assay testing the interaction of V5-SBP-tagged Hs NOT4-C (wild-type or 
the indicated mutants) with endogenous NOT1 and CAF40 in HEK293T cell lysates. 
(B,C) Tethering assay in Drosophila S2 cells using the F-Luc-5BoxB reporter and λN-HA-
tagged Dm NOT4 and Dm NOT4-C. GFP or GFP-tagged Dm CAF40 (wild-type or the 
V186E mutant) was overexpressed. An R-Luc reporter without BoxB elements was used as 
transfection control. The F-Luc-5BoxB reporter levels were normalized to this control and set 
to 100 in the presence of λN-HA. Mean values ± standard deviations from three independent 
experiments are shown in (B). (C) shows a representative Northern blot. 
(D) Western blot showing the expression of GFP, GFP-tagged Dm CAF40 (wild-type or the 
V186E mutant) and λN-HA-NOT4 (full-length or the C-terminus). The additional bands in 
lanes 1-3 marked by the asterisk correspond to GFP which also carries a V5 epitope tag. 
 
Figure 1. Keskeny et al.
A
B
F
Hs NOT4
RR
M
RIN
G
Co
ile
d
co
il
14 57 68 10
4
19
0
21
7
575
27
5
37
7
40
0
42
8
10
9
Zn
F
CB
M
NOT4-N NOT4-C
NCBR
Dm NOT4 1050
13 56 74 10
8
19
2
21
6
RR
M
RIN
G
Co
ile
d
co
il Z
nF
NOT4-N NOT4-C
24
8
81
3
83
8
CB
M
Sc NOT4
RR
M
RIN
G
33 78 94 12
8
22
8
25
6
587
43
0
46
6
13
7
Zn
F
Co
ile
d
co
il NO
T1
 
bin
din
g
sit
e
NO
T4
�λN
-H
A
NO
T4
-N
NO
T4
-C
D
G
Dm cells
Hs cells
C Northern blot
H
E
6xMS2bs
Control
1 2 3 4
NO
T4
 
NO
T4
-N
NO
T4
-C
MS
2-H
A
F-Luc-
5BoxB
R-Luc
1 2 3 4
NO
T4
 
NO
T4
-N
NO
T4
-C
Western blot
Northern blot Western blot
Anti-HA
72
95
1
Anti-GFP
2 3
95
NO
T4
 
NO
T4
-N
NO
T4
-C
MS2-HA-
130
95
72
55
36
F-Luc-V5 72
1 2 3
NO
T4
 
NO
T4
-N
NO
T4
-C
�λN-HA-
Anti-HA
M
B
P
N
O
T4
N
O
T4
-N
N
O
T4
-C
Pe
nt
am
er
ic
M
B
P
N
O
T4
N
O
T4
-N
N
O
T4
-C
66
56
43
35
27
20
NOT1-C
NOT2-C
NOT3-C
NOT7
CAF40
SM MBP pulldown
Pentameric
complex
21 3 4 5 6 7 8 9
NOT4
NOT4-N 
MBP
�λN
-H
A
NOT4-C 
β-globin-6xMS2bs 
F-Luc-5BoxB
R
el
at
iv
e 
F-
Lu
c 
/ R
-L
uc
 le
ve
ls 100
80
60
40
20
0
120
mRNA
Protein
100
80
60
40
20
0
R
el
at
iv
e 
6x
M
S2
bs
 R
N
A 
le
ve
ls
MS
2-H
A
NO
T4
NO
T4
-C
NO
T4
-N
Figure 2. Keskeny et al.
A
C
2376Hs NOT1
NOT3NOT2CAF1 CAF40NOT10
NOT11
CN9BDMIF4G N1SHDHEATHEATHEAT CD
NOT moduleCAF40
module
Catalytic
module
NOT10-NOT11
module
22
8
26
2
68
5
84
0
10
00
10
93
13
17
13
56
15
88
16
10
18
13
18
47
23
61
SM MBP pulldown
M
B
P
N
O
T1
-S
H
D
N
O
T4
N
O
T2
-3
C
A
F4
0
M
B
P
N
O
T4
M
B
P
N
O
T4
M
B
P
N
O
T4
CAF40
NOT1-SHD
NOT2-C
NOT3-C
N
O
T1
-S
H
D
N
O
T2
-3
C
A
F4
0
100
50
20
21 3 4 5 6 7 8 9 10 11
NOT4
MBP
B
N
O
T1
N
+1
0+
11
M
IF
4G
+C
A
F1
C
N
9B
D
+C
A
F4
0
C
D
N
O
T 
m
od
ul
e
M
B
P
N
O
T4
N
O
T1
N
+1
0+
11
M
IF
4G
+C
A
F1
C
N
9B
D
+C
A
F4
0
N
O
T 
m
od
ul
e
M
B
P
N
O
T4
M
B
P
N
O
T4
M
B
P
N
O
T4
M
B
P
N
O
T4
M
B
P
N
O
T4
SM MBP pulldown
66
43
27
21 3 4 5 6 7 8 109 11 12 13 14 15 16 17
C
D
20
MBP
CAF40-ARM
MBP-NOT4
NOT2-C
NOT3-C
NOT1-SHD
NOT1-CN9BD
CAF1
NOT1-N
NOT1-CD
NOT1-MIF4G
NOT10
NOT11
56
35
30
40
B β-globin-6xMS2bs 
Figure 3. Keskeny et al.
A
SM
Hs cells
F β-globin-6xMS2bs 
D E
G
1 2 3 4 5
NO
T4
-C
 
MS
2-H
A
ΔN
CB
R
Δ3
77
-40
2
ΔC
BM
6xMS2bs
Control
C
1 2 3 4
6xMS2bs
Control
5
NO
T4
-C
MS
2-H
A
27
5-3
76
NC
BR
42
9-5
75
F-Luc-GFP
55
34
95
21 3 4
Anti-HA
NO
T4
-C
27
5-3
76
NC
BR
42
9-5
75
MS2-HA-
Northern blot
Northern blot
Western blot
72
Anti-V5
Anti-NOT1
Δ3
77
-40
2
ΔC
BM
GF
P
NO
T4
-C
ΔN
CB
R
Δ3
77
-40
2
ΔC
BM
GF
P
NO
T4
-C
ΔN
CB
R
72
250
28
Anti-NOT2
Input SBP pulldown
21 3 4 5 6 7 8 109
V5-SBP-MBP-
Anti-NOT3
Anti-CAF40
130
H
Anti-HA 55
95
21 3 4
NO
T4
-C
 
ΔN
CB
R
Δ3
77
-40
2
ΔC
BM
MS2-HA-
Western blot
F-Luc-GFP
Hs cells
Hs cells
100
80
60
40
20
0
R
el
at
iv
e 
6x
M
S2
bs
 m
R
N
A 
le
ve
ls
MS
2-H
A
NO
T4
-C
ΔN
CB
R
Δ3
77
-40
2
ΔC
BM
R
el
at
iv
e 
6x
M
S2
bs
 m
R
N
A 
le
ve
ls
100
80
60
40
20
0
120
MS
2-H
A
NO
T4
-C
27
5-3
76
NC
BR
42
9-5
75
NOT4 66
27
20
CAF40
NOT3-C
NOT2-C
NOT1-SHD
27
5-
37
6
N
C
B
R
42
9-
57
5
27
5-
37
6
N
C
B
R
42
9-
57
5
N
O
T4
-C
N
O
T4
-C
M
B
P
M
B
P
27
5-
37
6
N
C
B
R
42
9-
57
5
N
O
T4
-C
M
B
P
MBP pulldown
N
O
T 
m
od
ul
e
C
A
F4
0
NOT module CAF40
21 3 4 5 6 7 8 109 11 12 13 14 15 16 17
43
56
35
A B C
CAF40
1
2
3
4
5
CBM
67
8
9
10
11
12
13
15
14
17
N
C
CBM
CAF40
N
C
C N
α5 α8 α11
N
Cα7
Y134
G141V181
L816
α5
α8
α2
L137
F184
T180
G144
L177
T138
α11
R130
N
C NOT4 CBM
C
N
Roquin CBM
D E F818
P820 D819
F821
T824
L828
L831
M832
E835
R46
Figure 4. Keskeny et al.
F GDm NOT4-CBM - Hs CAF40 WT and mutants Dm NOT4-CBM WT and mutants - Hs CAF40
55
35
25
40MBP
CAF40
w
t
MBP
Input MBP pulldown
1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16
MBP-CBM
2x
 m
ut
MBP-
Dm NOT4-
CBM
V1
81
E
w
t
2x
 m
ut
V1
81
E
w
t
2x
 m
ut
V1
81
E
w
t
2x
 m
ut
V1
81
E
MBP
CAF40-ARM
MBP-
Dm NOT4-
CBM
MBP-CBM
MBP
CAF40
C
A
F4
0
MBP
Input MBP pulldown
1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16
55
35
25
MBP-Dm NOT4-CBM
40
C
A
F4
0
C
A
F4
0
C
A
F4
0
C
A
F4
0
C
A
F4
0
C
A
F4
0
C
A
F4
0
wt F821D L828E MBP
MBP-Dm NOT4-CBM
wt F821D L828E
Figure 5. Keskeny et al.
A Hs NOT4-CBM - Hs CAF40 WT and mutants B
MBP
CAF40
w
t
MBP
Input MBP pulldown
1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16
55
35
25
2x
 m
ut
MBP-
Hs NOT4-
CBM
V1
81
E
w
t
2x
 m
ut
V1
81
E
w
t
2x
 m
ut
V1
81
E
w
t
2x
 m
ut
V1
81
E
MBP
CAF40-ARM
40MBP-CBM
MBP-
Hs NOT4-
CBM
Anti-V5
Anti-NOT1
GF
P
NO
T4
-C
72
250
Anti-CAF40
28
Input SBP
pulldown
NO
T4
-C
 4x
 m
ut
GF
P
NO
T4
-C
NO
T4
-C
 4x
 m
ut
Anti-NOT2
Anti-NOT3
72
130
21 3 4 5 6
V5-SBP-MBP-
Hs cells
C D E
NO
T4
-C
MS
2-H
A
NO
T4
-C
 4x
 m
ut
6xMS2bs
Control
NC
BR
NC
BR
 4x
 m
ut
21 3 4 5
Anti-HA
F-Luc-GFP
21 3 4
55
34
95
NO
T4
-C
NO
T4
-C
 4x
 m
ut
NC
BR
NC
BR
 4x
 m
ut
MS2-HA-
β-globin-6xMS2bs Northern blot Western blot
100
80
60
40
20
0
R
el
at
iv
e 
6x
M
S2
bs
 R
N
A 
le
ve
ls
MS
2-H
A
NO
T4
-C
NO
T4
-C
 4x
 m
ut
NC
BR
NC
BR
 4x
 m
ut
Hs cells
55Anti-tubulin
Figure 6. Keskeny et al.
A
Anti-PABP
Anti-NOT1
12
.5
25 50 10
0
10
0
72
250
21 3 4 5
sh
-N
O
T1
sh
-s
cr
% of input
D
B
Anti-CAF40
12
.5
25 50 10
0
10
0
28
21 3 4 5
C
A
F4
0
K
O
29
3T
W
T
% of input
Anti-NOT1
Anti-NOT3
Anti-NOT2
250
130
72
E
Hs cells Hs cells
Knockdown efficiency
NO
T4
NO
T4
-C
NO
T4
NO
T4
-C
NO
T4
NO
T4
-C
NO
T4
NO
T4
-C
Anti-HA
Anti-GFP
72
95
sc
r
N
O
T1
 K
D
sc
r
N
O
T1
 K
D
95
WT CAF40 KO
21 3 54 6 7 8
CR-Luc-6xMS2bs
Hs cells
100
80
60
40
20
0
R
el
at
iv
e 
R
-L
uc
 / 
F-
Lu
c 
ac
tiv
ity
sh-scr
MS
2-H
A
NO
T4
 W
T 
CA
F4
0 K
O
    
sh-NOT1
CA
F4
0 K
O 
+ 
 N
OT
1 K
D
NO
T1
 K
D
MS
2-H
A
NO
T4
MS
2-H
A
NO
T4
MS
2-H
A
NO
T4
Anti-V5
Anti-NOT1 250
GF
P
NO
T4
-C
V5-SBP-MBP-
WT
+GST
KO
+GST
KO +
CAF40
1µg
KO +
CAF40
5µg
GF
P
NO
T4
-C
GF
P
NO
T4
-C
GF
P
NO
T4
-C
GF
P
NO
T4
-C
GF
P
NO
T4
-C
GF
P
NO
T4
-C
GF
P
NO
T4
-C
WT
+GST
KO
+GST
KO +
CAF40
1µg
KO +
CAF40
5µg
72
95
Input SBP pulldown
21 3 4 5 6 7 8 9 10 11 12 13 14 15 16
Anti-CAF40
26
Hs
Ec
Gg
Xt
Dr
1
1
1
1
1
90
90
90
90
90
MSRSPDAKEDPVECPLCMEPLEIDDINFFPCTCGYQICRFCWHRIRTDENGLCPACRKPYPEDPAVYKPLSQEELQRIKNEKKQKQNERK
MSRSPDAKEDPVECPLCMEPLEIDDINFFPCTCGYQICRFCWHRIRTDENGLCPACRKPYPEDPAVYKPLSQEELQRIKNEKKQKQNERK
MSRSPDAKEDPVECPLCMEPLEIDDINFFPCTCGYQICRFCWHRIRTDENGLCPACRKPYPEDPAVYKPLSQEELQRIKNEKKQKQNERK
MSRSPVVKEDPVECPLCMEPLEIDDINFFPCTCGYQICRFCWHRIRTDENGLCPACRKPYPEDPAVYKPLSQEELQRIKNEKKQKQNERK
MSRSPELKEDPMECPLCMEPLEIDDVNFFPCTCGYQICRFCWHRIRTDENGLCPACRKPYPEDPAVYKPLSQEEIQRIKNEKKQKLNEKK
91
91
91
91
91
180
180
180
180
180
QKISENRKHLASVRVVQKNLVFVVGLSQRLADPEVLKRPEYFGKFGKIHKVVINNSTSYAGSQGPSASAYVTYIRSEDALRAIQCVNNVV
QKISENRKHLASVRVVQKNLVFVVGLSQRLADPEVLKRPEYFGKFGKIHKVVINNSTSYAGSQGPSASAYVTYIRSEDALRAIQCVNNVV
QKISENRKHLASVRVVQKNLVFVVGLSQRLADPEVLKRPEYFGKFGKIHKVVINNSTSYAGSQGPSASAYVTYIRSEDALRAIQCVNNVV
QKISENRKHLASVRVVQKNLVFVVGLSQRLADPEVLKRPEYFGKFGKIHKVVINNSTSYAGSQGPSASAYVTYIRSEDALRAIQCVNNVV
QKVTENRKHLASVRVVQRNLVFVVGLSQRLADAEVLKRPEYFGKFGKIHKVVINNSTSYAGSQGPSASAYVTYIRSEDALRAIQCVNNVI
181
181
181
181
181
267
267
270
267
266
VDGRTLKASLGTTKYCSYFLKNMQCPKPDCMYLHELGDEAASFTKEEMQ---AGKHQEYEQKLLQELYKLNPNFLQLSTGSVDKNKNKVT
VDGRTLKASLGTTKYCSYFLKNMQCPKPDCMYLHELGDEAASFTKEEMQ---AGKHQEYEQKLLQELYKLNPNFLQLSTGSVDKNKNKVT
VDGRTLKASLGTTKYCSYFLKNMQCPKPDCMYLHELGDEAASFTKEEMQAIFAGKHQEYEQKLLQELYKLNPNFLQLSTGTVDKNKNKVT
VDGRTLKASLGTTKYCSYFLKNMQCPKPDCMYLHELGDEAASFTKEEMQ---AGKHQEYEQKLLQELYKLNPNFLQLSTGTVDKNKNKVT
VDGRTLKASLGTTKYCSYFLKSMQCPKPDCMYLHELGDEAASFTKEEMQ---AGKHQEYEQKLLQDLYKANPTFL-LTSTCGEKSKSKSN
268
268
271
268
267
283
283
335
357
349
PLQRYD--------------------------------------------------------------------------TPIDKPSDSL
PLQRYD---T-----------------------------------------------------------------------PIDKPSDSL
ALQRPN---SNNKDAWPSLQSSSKSANGLTMEHRKTPPILENGTDSEHMTPDGADSDFG----------------------PIDKPSDSL
ALQRYDVPNSNNKDAWPSLQNSNRSANGLGLEHRKSPPILDNGLDPDHMTPDGPDSDFGLFWESAEHNVAKFGRVIEDDTSSVDKSSESL
STQRPN---STNKEGWPSLQNYGKMVNGLTTEHRKSPPLLDCLTDSDHMTPDEPDLEQG----TEQNTGLPPFPSALEPTSPIDKPSEPI
284
284
336
358
350
371
371
423
445
439
SIGNGDNSQQISNSDTPSPPPGLSKSNPVIPISSSNHSARSPFEGAVTESQSLFSD--NFRHPNPIPSGLPPFPSSPQTSSDWPTAPEPQ
SIGNGDNSQQISNSDTPSPPPGLSKSNPVLPISSSNHSARSPFEGAVTESQSLFSD--NFRHPNPIPSGLPPFPSSPQTSSDWPTAPEPQ
SIGNGDSSQQITNSDTPSPPPGLTKPNPVIPISSSNHSARSPFEGAVTESQSLFSD--NFRHPNPIPSGLPPFPSSPQTSNDWPTAPEPQ
SIGNGDNLQQILTSDTPSPPPGLSKPNPSVPISSANHSARSPFEDAMTESQSLFSD--NFRHPNPIPSGLPPFPSSPQTSSEWPTAPEPQ
SIGNGENISQTSSSDSPSPPPGLTKPSLVVPISVAELTARSPFEGAAAESQSLFSDNSNFRHPNPIPSGLPPFSNSPQGASDWPMTPEPQ
372
372
424
446
440
458
458
510
531
504
SLFTSETIPVSSSTDWQAAFGFGSS---KQPEDDLGFDPFDVTRKALADLIEKELSVQDQPSLSPTSLQNSSSHTTTAKGPGSGFLHPAA
SLFTSETIPVSSSTDWQAAFGFGSS---KQPEDDLGFDPFDVTRKALADLIEKELSVQDQPSLSPTSLQNSSSHTTTTKGPGSGFLHPAA
SLFTSETIPVSSSTDWQAAFGFGSS---KQQEDDLGFDPFDVTRKALADLIEKELSVQDQPSLSPTSLQNPSPHTTTAKGPGSGFLHPAA
SLFTSETIPVSSSTDWQAAFGFGSS---KQQEDDLGFDPFDITRKALADLIEKELSVQDQPALSPTSLQNPPPH-PAAKGPGSGFLHPTT
SLFTSETIPVSSSTDWQAAFGFGSSAKQQQQDDDLGFDPFDVTRKALADLIEKELSVQEHSPLSP-------------------------
459
459
511
532
505
544
545
597
614
591
ATNANSLNSTFSVLPQRFPQFQQHRAVYNSFSFPGQ-AARYPWMAFP-RNSIMHLNHTANPTSNSNFLDLNLPPQ-HNTGLGGIPVAGE-
PANANSLNSTFSVLPQRFPQFQQHRAVYNSFNFPGQ-AARYPWMAFP-RNSIMHLNHTANPTSNSNFLDLNLPPQ-HNTGLGGIPIADNS
PTNANSLSSTFPVMPQRFPQFQQHRAVYNSFSFPGQ-AARYPWMAFP-RNSIMHLNHTANPTSNSNFLDLNLQPQ-HSTGLGGIPISDNS
AANANSIASTFSVLPQRFPPF-QHRAVYNSFSFPGQ-AARYPWMAFP-RNNIMHLNHTANPTSNSNFLDLSHPPQ-HNTGLGGITVA---
--NPSSHQTGLPNGQQRFPHL-QHRGLYNSFSLPQHMAARHPWMGIPTRNNLTHLNHTATAAAHSHFLDLSMPAQHHSTGLGGIPISENN
545
546
598
615
592
563
628
680
629
681
---------------------------------------------------------------------EEVKVSTMPLSTSS--HSLQQ
SSVESLNVKEWQDGLRALLPNININFGGLPNSSSPSNANHS-------APTSNTATTDSLSWDGPGSWTDPAIITGIPASSGNSLDSLQD
SSVESLNMKEWQDGLRALLPNINISFGGLPNASSPSNANHS-------VPTSNTATTDSLNWDSSGSWMDPAIITGIPASTGNSLDTLQD
---------------------------------------------------------------------------GIPSSTGNGLESLQD
GSVESINVKEWQDGLRALLPNININFGGLPNSTSSSSSSSTSSVNHIGVPIGSAGISHSLSWDSTASWMDPAIITGIPASTGNSLDCLQD
564
629
681
630
682
575
712
764
714
771
GQQPTSLHTTVA------------------------------------------------------------------------------
DNPPHWLKSLQALTEMDGPSAA-PSQTHHSAPF---STQIPLHRAGWNPYPPPS--NPSSFHSPPPGFQTAFRPPSKTPTDLLQSSTLDR
DNPPHWLKSLQALTEVDGPSAA-PSQTHHSNPF---GTQIPLHRASWNPYSPPS--NPTSFHSPPPGFQTAFRPPSKTPTDLLQSSALDR
DNPPHWLKSLQALTEMDGPSSSIPPHHPHNNLF---SAQIPLHRGNWSPYPPPS--NPASFHSPPPGFQTAFRPPTKTPTDLLQSSALDR
DNPPHWLKSLQALTEMDGPPSSSALPQPPHTGLLDAAAHLSLHRAAWAPYLPPPTLTPNQFHSPPPGFQTAFRPQAQTATDILQSAGIDR
Hs
Ec
Gg
Xt
Dr
Hs
Ec
Gg
Xt
Dr
Hs
Ec
Gg
Xt
Dr
Hs
Ec
Gg
Xt
Dr
Hs
Ec
Gg
Xt
Dr
Hs
Ec
Gg
Xt
Dr
Hs
Ec
Gg
Xt
Dr
Hs
Ec
Gg
Xt
Dr
Figure S1. Keskeny et al.
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